Days At A Glance Speakers Posters Session Type Search
Type

    09:00 -  
    Registration
    11:00 - 12:30 
    Symposium 1: GnRH biology - from pulses to longevity
    Supported by Journal of Molecular Endocrinology
    1B
    Chairs: H Christian (Oxford) & R Perrett (Bristol)
    From novel insights into GnRH timing and central control of reproduction to new discoveries in hypothalamic inflammatory change and ageing
    S1.2
    Symposium 1: GnRH biology - from pulses to longevity
    Biological insights from genetically tagged gonadotropes
    S1.3
    Symposium 1: GnRH biology - from pulses to longevity
    GnRH and inflammatory signalling in the ageing hypothalamus
    Bronx, USA
    11:00 - 12:30 
    Symposium 2: The upside of glucocorticoids in metabolism
    Supported by Journal of Endocrinology
    1C
    Chairs: R Stimson (Edinburgh) & S Morgan (Birmingham)
    Amending our thinking of the way GCs work
    S2.1
    Symposium 2: The upside of glucocorticoids in metabolism
    Insulin sensitisation of adipose tissue by glucocorticoids
    S2.2
    Symposium 2: The upside of glucocorticoids in metabolism
    Maintaining the anti-inflammatory action of glucocorticoid without the metabolic side effects
    Toronto, Canada
    S2.3
    Symposium 2: The upside of glucocorticoids in metabolism
    Glucocorticoids and protection from pancreatic beta cell failure
    11:00 - 12:30 
    Symposium 3: Emerging Clinical importance of iodine
    Supported by Endocrine-Related Cancer and the British Thyroid Foundation
    3B
    Chairs: M Vanderpump (London) & J Waung (London)
    New clinical applications in iodine biology
    S3.1
    Symposium 3: Emerging Clinical importance of iodine
    Iodine nutrition and neurodevelopment
    S3.2
    Symposium 3: Emerging Clinical importance of iodine
    Regulation of NIS function in thyroid and breast cancer
    Los Angeles, USA
    S3.3
    Symposium 3: Emerging Clinical importance of iodine
    Use of radioiodine in the imaging and therapy of non-thyroidal tumours
    Munich, Germany
    11:00 - 12:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    12:30 - 13:45 
    Lunch
    Hall 2A
    12:45 - 13:45 
    Internis Industry Sponsored Satellite Symposia
    Vitamin D – the Dark Truth
    1C
    Chair: A Grosso (London)
    Internis Industry Sponsored Satellite Symposia
    Clinical Update on Vitamin D
    Internis Industry Sponsored Satellite Symposia
    Shedding light on the Health Economics of Vitamin D
    Internis Industry Sponsored Satellite Symposia
    The Dark Truth of Prescribing Unlicensed Vitamin D
    12:45 - 13:45 
    HRA Pharma Industry Sponsored Satellite Symposia
    Cushing’s syndrome and adrenocortical carcinoma management: are we making progress?
    1B
    Chair: R Feelders (Rotterdam, Netherlands)
    HRA Pharma Industry Sponsored Satellite Symposia
    Welcome and introduction
    Rotterdam, Netherlands
    HRA Pharma Industry Sponsored Satellite Symposia
    Current challenges in the management of Cushing’s syndrome
    HRA Pharma Industry Sponsored Satellite Symposia
    Use of Steroidogenesis inhibitors for Cushing’s syndrome. Audit of 13 UK tertiary centres
    Sheffield, UK
    HRA Pharma Industry Sponsored Satellite Symposia
    Multimodal therapy in the management of advanced ACC
    HRA Pharma Industry Sponsored Satellite Symposia
    Questions and Answers
    13:45 - 15:15 
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Supported by Journal of Endocrinology
    1B
    Chairs: G Lavery (Birmingham) & D Macfarlane (Dundee)
    How to assess and quantitate energy usage and interpret the data
    APW1.1
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Assessing energy demand in living organisms
    Stockholm, Sweden
    APW1.2
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Lipid metabolism: from mice to men?
    APW1.3
    Applied Physiology Workshop: A guide to the analysis of energy metabolism
    Tracking lipid energy partitioning in human liver
    13:45 - 15:15 
    Oral Communications 1: Young Endocrinologists' Prize Session
    1A
    Chairs: C McCabe (Birmingham) & S Mirczuk (London)
    OC1.1
    Oral Communications 1: Young Endocrinologists' Prize Session
    The Thr92Ala substitution in deiodonase-2 is associated with increased odds of a sub-optimal IQ score in children with low-normal thyroid function
    OC1.2
    Oral Communications 1: Young Endocrinologists' Prize Session
    Characterisation of adrenocortical progenitor cells: isolation of mesenchymal stem cell-like cell populations from human adrenal cortex
    OC1.3
    Oral Communications 1: Young Endocrinologists' Prize Session
    Angiogenic factors sFlt1 and PlGF are novel determinants of newborn thyroid (dys)function: the Generation R study
    OC1.4
    Oral Communications 1: Young Endocrinologists' Prize Session
    Single molecule analysis of GPCR transactivation reveals oligomeric complexes that regulate signal sensitivity
    London, UK
    OC1.5
    Oral Communications 1: Young Endocrinologists' Prize Session
    Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment
    OC1.6
    Oral Communications 1: Young Endocrinologists' Prize Session
    A loss-of-function mutation in the prolactin receptor (PRLR) causes familial hyperprolactinaemia
    Birmingham, UK
    13:45 - 15:15 
    Symposium 4: Putting flesh on the bones
    3B
    Chairs: N Shaw (Birmingham) & S Howles (Oxford)
    Genetic disorders of bone and mineral metabolism
    S4.1
    Symposium 4: Putting flesh on the bones
    Assessment of abnormalities of skeletal development
    S4.2
    Symposium 4: Putting flesh on the bones
    Osteogenesis imperfecta - management beyond childhood
    S4.3
    Symposium 4: Putting flesh on the bones
    Management of hypophosphatemic rickets
    New Haven, USA
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 17:15 
    Education Workshop 1: Teaching and learning in Endocrinology
    3B
    Chairs: A Crown (Brighton) & H Christian (Oxford)
    EW1.1
    Education Workshop 1: Teaching and learning in Endocrinology
    Endocrinologists as teachers: integrating teaching and practice in the real world
    EW1.2
    Education Workshop 1: Teaching and learning in Endocrinology
    Using technology to enhance your teaching in endocrinology
    EW1.3
    Education Workshop 1: Teaching and learning in Endocrinology
    Exams, and the future of assessment in medicine. A view from the MRCP(UK)
    EW1.4
    Education Workshop 1: Teaching and learning in Endocrinology
    Interprofessional learning through and for multidisciplinary working
    Education Workshop 1: Teaching and learning in Endocrinology
    Questions and discussion
    15:45 - 17:15 
    Clinical Management Workshop 1: Management of complex obesity
    Supported by Clinical Endocrinology
    1A
    Chairs: B McGowan (London) & K McCullough (London)
    CMW1.1
    Clinical Management Workshop 1: Management of complex obesity
    Have the new commissioning guidelines for bariatric surgery improved patient's pathways?
    CMW1.2
    Clinical Management Workshop 1: Management of complex obesity
    Medical management of severe obesity

    Unknown speaker

    Liverpool, United Kingdom
    CMW1.3
    Clinical Management Workshop 1: Management of complex obesity
    Endocrine and metabolic complications post-bariatric surgery
    London, United Kingdom
    15:45 - 17:15 
    Oral Communications 2: Endocrine regulation of cell behaviour
    1B
    Chairs: G Lavery (Birmingham) & G WIllis (Cardiff)
    OC2.1
    Oral Communications 2: Endocrine regulation of cell behaviour
    A novel modulator of cell invasion and metastasis
    OC2.2
    Oral Communications 2: Endocrine regulation of cell behaviour
    Inhibition of human NET cell proliferation by a peptide identified through phage display screening
    OC2.3
    Oral Communications 2: Endocrine regulation of cell behaviour
    A20 confers protection against TRAIL-induced apoptosis in the pancreatic beta-cell
    OC2.4
    Oral Communications 2: Endocrine regulation of cell behaviour
    Influence of glucocorticoid receptor density on development and remodelling of the heart
    OC2.5
    Oral Communications 2: Endocrine regulation of cell behaviour
    Beta-cells require CFTR for glucose-induced insulin secretion
    OC2.6
    Oral Communications 2: Endocrine regulation of cell behaviour
    A potential role for food-derived microRNAs in human placental development
    15:45 - 17:15 
    Symposium 5: Endocrine consequences of major trauma
    1C
    Chairs: A Logan (Birmingham) & M Sherlock (Dublin, Ireland)
    Pathophysiological changes associated with injury
    S5.1
    Symposium 5: Endocrine consequences of major trauma
    Endocrine mechanisms of sarcopenia
    S5.2
    Symposium 5: Endocrine consequences of major trauma
    Pituitary sequelae of traumatic brain injury
    Dublin, Ireland
    S5.3
    Symposium 5: Endocrine consequences of major trauma
    Thyroid hormone economy in critical illness
    Amsterdam, The Netherlands
    17:25 - 18:25 
    SfE Young Endocrinologists' Prize Lectures
    1A
    Chairs: J Franklyn (Birmingham) & K Chapman (Edinburgh)
    YEP1.1
    SfE Young Endocrinologists' Prize Lectures
    Basic Prize Lecture: Sox2+ cells of the postnatal pituitary can differentiate into hormone producing cells in vivo and have tumour-inducing potential
    YEP1.2
    SfE Young Endocrinologists' Prize Lectures
    Clinical Prize Lecture: Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation during IVF treatment
    18:25 - 19:15 
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    1A
    Chair: B Walker (Edinburgh)
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    For:
    Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
    Against:
    19:15 - 21:00 
    Welcome Reception
    Hall 2A
    20:15 - 22:00 
    Young Endocrinologists' Social Evening and Quiz
    3AB

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    London, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff University, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth
    Understanding growth hormone action through the growth plate
    S8.2
    Symposium 8: Chronic disease and growth
    Targeting SOCS Proteins to Combat Inflammation
    S8.3
    Symposium 8: Chronic disease and growth
    Managing abnormalities of growth in chronic disease
    Paris, France
    14:00 - 15:30 
    Symposium 9: MEN1- from molecular pathology to therapies
    Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
    1A
    Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
    Current understanding and future perspectives in MEN1
    S9.1
    Symposium 9: MEN1- from molecular pathology to therapies
    Current understanding and future perspectives in MEN1
    Bethesda, USA
    S9.2
    Symposium 9: MEN1- from molecular pathology to therapies
    Genetics, pathophysiology and translational models of MEN1
    Oxford, United Kingdom
    S9.3
    Symposium 9: MEN1- from molecular pathology to therapies
    Practical management of patients with MEN1
    Uppsala, Sweden
    15:30 - 16:00 
    Tea & Coffee
    Hall 2A
    16:00 - 16:45 
    Meet the Expert 3 (repeat)
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    3B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3 (repeat)
    Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
    London, UK
    16:00 - 17:30 
    Oral Communications 5: Pituitary
    1B
    Chairs: J Davies (Manchester) & R Watkins (Birmingham)
    OC5.1
    Oral Communications 5: Pituitary
    Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
    OC5.2
    Oral Communications 5: Pituitary
    Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
    OC5.3
    Oral Communications 5: Pituitary
    The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
    OC5.4
    Oral Communications 5: Pituitary
    GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
    OC5.5
    Oral Communications 5: Pituitary
    Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
    OC5.6
    Oral Communications 5: Pituitary
    A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
    16:00 - 17:30 
    Symposium 10: Fat and bone
    Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
    1A
    Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
    Body composition and bone
    S10.1
    Symposium 10: Fat and bone
    Fat and its influence on bone
    S10.2
    Symposium 10: Fat and bone
    Obesity and fractures - what is the inter-relationship?
    S10.3
    Symposium 10: Fat and bone
    Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
    16:45 - 17:30 
    Meet the Expert 5
    Supported by Clinical Endocrinology
    3B
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5
    Pituitary replacement therapy
    17:40 - 18:10 
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: J Connell (Dundee)
    PL3
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Adrenocortical tumours - from bench to bedside and back
    Würzburg, Germany
    19:30 -  
    Conference dinner and Awards Ceremony
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 5 (repeat)
    Supported by Clinical Endocrinology
    1A
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5 (repeat)
    Pituitary replacement therapy (repeat)
    08:00 - 08:45 
    Meet the Expert 6
    Supported by Clinical Endocrinology
    3B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6
    Delayed puberty
    08:00 - 08:45 
    Meet the Expert 7
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7
    Who should the endocrinologist ask the ophtalmologist to review?
    London, UK
    08:00 - 08:45 
    Society for Endocrinology Journal Awards
    1C
    Chair: D Ray (Manchester)
    JA 1
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
    Rochester, USA on behalf of the author group
    JA 2
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
    Louvain-la-Neuve, Belgium on behalf of the author group
    JA 3
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
    Baltimore, USA on behalf of the author group
    JA 4
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
    JA 5
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
    Milan, Italy on behalf of the author group
    08:45 - 09:25 
    Society for Endocrinology AGM
    1A
    09:30 - 11:00 
    Education Workshop 2: Practical publishing advice
    3B
    Chair: D Ray (Manchester)
    EW2.1
    Education Workshop 2: Practical publishing advice
    Introduction
    EW2.2
    Education Workshop 2: Practical publishing advice
    Publishing ethics: Fabrication, Falsification and Plagiarism
    EW2.3
    Education Workshop 2: Practical publishing advice
    The peer review process
    Stockholm, Sweden
    EW2.4
    Education Workshop 2: Practical publishing advice
    Writing an attention grabbing abstract
    Essen, Germany
    EW2.5
    Education Workshop 2: Practical publishing advice
    Responding to reviewer comments
    EW2.6
    Education Workshop 2: Practical publishing advice
    The art of scientific writing
    London, UK
    EW2.7
    Education Workshop 2: Practical publishing advice
    Open Access
    Education Workshop 2: Practical publishing advice
    Questions and discussion
    09:30 - 11:00 
    Nurse Session 1 - Cushing's Syndrome
    1B
    Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
    N1.1
    Nurse Session 1 - Cushing's Syndrome
    Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
    N1.2
    Nurse Session 1 - Cushing's Syndrome
    The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
    Rotterdam, The Netherlands
    N1.3
    Nurse Session 1 - Cushing's Syndrome
    Why do ‘cured’ Cushing’s patients need long-term follow up?
    Barcelona, Spain
    N1.4
    Nurse Session 1 - Cushing's Syndrome
    Cushing’s patient experience
    09:30 - 11:00 
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    1C
    Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
    Emerging biology of brown adipose tissue
    S11.1
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    Mechanisms of brown adipocyte determination
    Philadelphia, USA
    S11.2
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    The metabolic capacities of brown adipose tissue
    Stockholm, Sweden
    S11.3
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    How brown is human brown adipose tissue?
    Gothenburg, Sweden
    09:30 - 11:00 
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Supported by Clinical Endocrinology
    1A
    Chairs: H Gleeson (Leicester) & R El-Khairi (London)
    CMW3.1
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adolescent health care in the UK in 2014
    CMW3.2
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adrenal replacement in adolescents and young adults
    London, UK
    CMW3.3
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Optimising bone health in adolescents and young adults
    Birmingham, UK
    11:00 - 11:30 
    Tea & Coffee
    Exhibtion Hall
    11:30 - 12:00 
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    1A
    Chair: G Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    Mechanisms of thyroid hormone resistance
    Rotterdam, Netherlands
    12:00 - 12:30 
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL5
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    Transcriptional Coordination of Circadian and Metabolic Physiology
    Philadelphia, USA
    12:30 - 13:45 
    Lunch & poster viewing
    Shortlisted posters attended
    Hall 2A
    12:45 - 13:45 
    Viropharma Industry Sponsored Satellite Symposia
    New insights in the management of Adrenal Insufficiency in the UK
    3AB
    Chair: S Pearce (Newcastle-Upon-Tyne)
    Viropharma Industry Sponsored Satellite Symposia
    Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
    Newcastle, UK
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: the Salford project
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: a report from the EU-AIR registry
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Viropharma Industry Sponsored Satellite Symposia
    Patient cases and physician experience
    Naples, Italy
    Viropharma Industry Sponsored Satellite Symposia
    Closing remarks
    Newcastle, UK
    13:45 - 14:30 
    Meet the Expert 8
    1C
    Chair: C McCabe (Birmingham)
    MTE8
    Meet the Expert 8
    Growing organs in the lab
    13:45 - 15:15 
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    1B
    Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
    N2.1
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Background on the journey of endocrine nursing research
    N2.2
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    How to audit and evaluate your own practice
    N2.3
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    The role of the endocrine nurse in clinical trials
    N2.4
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Independent nursing research
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Questions and discussion
    13:45 - 15:15 
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Supported by Endocrine Connections
    1A
    Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
    How the brain orchestrates glucose metabolism
    S12.1
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    How the brain senses blood glucose
    S12.2
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Vagal control of energy metabolism
    S12.3
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Does glucagon need the brain for its effects on blood glucose?
    13:45 - 15:15 
    Oral Communications 6: Clinical
    3B
    Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
    OC6.1
    Oral Communications 6: Clinical
    Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
    OC6.2
    Oral Communications 6: Clinical
    Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
    OC6.3
    Oral Communications 6: Clinical
    Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
    OC6.4
    Oral Communications 6: Clinical
    Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
    OC6.5
    Oral Communications 6: Clinical
    Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
    OC6.6
    Oral Communications 6: Clinical
    11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
    14:30 - 15:15 
    Meet the Expert 9
    1C
    Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
    MTE9
    Meet the Expert 9
    Novel techniques to assess angiogenesis
    Paris, France
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 16:15 
    Oral Communication and Poster Prize Ceremony
    1A
    Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
    16:15 - 16:45 
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: G Williams (London)
    PL6
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Disorders of thyroid hormone action: insights from human genetics
    Cambridge, UK
    16:45 - 17:15 
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL7
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    The clock in the pituitary gland: timing annual cycles
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 1 (repeat)
    Supported by Clinical Endocrinology
    1B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1 (repeat)
    Medical management of Cushing's syndrome (repeat)
    08:00 - 08:45 
    Meet the Expert 2 (repeat)
    Supported by Clinical Endocrinology
    1C
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2 (repeat)
    Vitamin D replacement: how much, how often and for whom? (repeat)
    08:45 - 09:15 
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Supported by the Clinical Endocrinology Trust
    1A
    Chair: JS Bevan (Aberdeen)
    PL8
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Understanding glucocorticoid action, and the role of the glucocorticoid receptor
    09:15 - 09:45 
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    1A
    Chair: C McCabe (Birmingham)
    PL9
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    Male Fertility Regulation; achievements and frustrations
    Clayton, Australia
    09:45 - 10:15 
    Society for Endocrinology Emergency Endocrine Guidance
    1A
    Chair: J Franklyn (Birmingham)
    SFE1.1
    Society for Endocrinology Emergency Endocrine Guidance
    Acute Hypercalcaemia and Acute Hypocalcaemia
    UK
    SFE1.2
    Society for Endocrinology Emergency Endocrine Guidance
    Pituitary Apoplexy
    10:15 - 10:45 
    Tea & Coffee
    3AB
    10:45 - 11:30 
    Meet the Expert 6 (repeat)
    1B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6 (repeat)
    Delayed puberty (repeat)
    10:45 - 12:15 
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
    1A
    Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
    CMW4.1
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in Turner's syndrome
    CMW4.2
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Valvular disease in prolactinomas- weighing up the evidence
    London, UK
    CMW4.3
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in childhood cancer survivors
    10:45 - 12:45 
    Senior Endocrinologists' Session
    1C
    Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
    SE1.4
    Senior Endocrinologists' Session
    The Foundling Hospital
    SE1.2
    Senior Endocrinologists' Session
    1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
    SE1.3
    Senior Endocrinologists' Session
    Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
    Dublin, Ireland
    SE1.1
    Senior Endocrinologists' Session
    How important is luck for major discoveries?
    SE1.5
    Senior Endocrinologists' Session
    Steroid Merchants of Edinburgh
    11:30 - 12:15 
    Meet the Expert 7 (repeat)
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7 (repeat)
    Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
    London, UK

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    London, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff University, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth
    Understanding growth hormone action through the growth plate
    S8.2
    Symposium 8: Chronic disease and growth
    Targeting SOCS Proteins to Combat Inflammation
    S8.3
    Symposium 8: Chronic disease and growth
    Managing abnormalities of growth in chronic disease
    Paris, France
    14:00 - 15:30 
    Symposium 9: MEN1- from molecular pathology to therapies
    Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
    1A
    Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
    Current understanding and future perspectives in MEN1
    S9.1
    Symposium 9: MEN1- from molecular pathology to therapies
    Current understanding and future perspectives in MEN1
    Bethesda, USA
    S9.2
    Symposium 9: MEN1- from molecular pathology to therapies
    Genetics, pathophysiology and translational models of MEN1
    Oxford, United Kingdom
    S9.3
    Symposium 9: MEN1- from molecular pathology to therapies
    Practical management of patients with MEN1
    Uppsala, Sweden
    15:30 - 16:00 
    Tea & Coffee
    Hall 2A
    16:00 - 16:45 
    Meet the Expert 3 (repeat)
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    3B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3 (repeat)
    Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
    London, UK
    16:00 - 17:30 
    Oral Communications 5: Pituitary
    1B
    Chairs: J Davies (Manchester) & R Watkins (Birmingham)
    OC5.1
    Oral Communications 5: Pituitary
    Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
    OC5.2
    Oral Communications 5: Pituitary
    Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
    OC5.3
    Oral Communications 5: Pituitary
    The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
    OC5.4
    Oral Communications 5: Pituitary
    GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
    OC5.5
    Oral Communications 5: Pituitary
    Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
    OC5.6
    Oral Communications 5: Pituitary
    A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
    16:00 - 17:30 
    Symposium 10: Fat and bone
    Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
    1A
    Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
    Body composition and bone
    S10.1
    Symposium 10: Fat and bone
    Fat and its influence on bone
    S10.2
    Symposium 10: Fat and bone
    Obesity and fractures - what is the inter-relationship?
    S10.3
    Symposium 10: Fat and bone
    Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
    16:45 - 17:30 
    Meet the Expert 5
    Supported by Clinical Endocrinology
    3B
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5
    Pituitary replacement therapy
    17:40 - 18:10 
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: J Connell (Dundee)
    PL3
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Adrenocortical tumours - from bench to bedside and back
    Würzburg, Germany
    19:30 -  
    Conference dinner and Awards Ceremony
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 5 (repeat)
    Supported by Clinical Endocrinology
    1A
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5 (repeat)
    Pituitary replacement therapy (repeat)
    08:00 - 08:45 
    Meet the Expert 6
    Supported by Clinical Endocrinology
    3B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6
    Delayed puberty
    08:00 - 08:45 
    Meet the Expert 7
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7
    Who should the endocrinologist ask the ophtalmologist to review?
    London, UK
    08:00 - 08:45 
    Society for Endocrinology Journal Awards
    1C
    Chair: D Ray (Manchester)
    JA 1
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
    Rochester, USA on behalf of the author group
    JA 2
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
    Louvain-la-Neuve, Belgium on behalf of the author group
    JA 3
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
    Baltimore, USA on behalf of the author group
    JA 4
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
    JA 5
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
    Milan, Italy on behalf of the author group
    08:45 - 09:25 
    Society for Endocrinology AGM
    1A
    09:30 - 11:00 
    Education Workshop 2: Practical publishing advice
    3B
    Chair: D Ray (Manchester)
    EW2.1
    Education Workshop 2: Practical publishing advice
    Introduction
    EW2.2
    Education Workshop 2: Practical publishing advice
    Publishing ethics: Fabrication, Falsification and Plagiarism
    EW2.3
    Education Workshop 2: Practical publishing advice
    The peer review process
    Stockholm, Sweden
    EW2.4
    Education Workshop 2: Practical publishing advice
    Writing an attention grabbing abstract
    Essen, Germany
    EW2.5
    Education Workshop 2: Practical publishing advice
    Responding to reviewer comments
    EW2.6
    Education Workshop 2: Practical publishing advice
    The art of scientific writing
    London, UK
    EW2.7
    Education Workshop 2: Practical publishing advice
    Open Access
    Education Workshop 2: Practical publishing advice
    Questions and discussion
    09:30 - 11:00 
    Nurse Session 1 - Cushing's Syndrome
    1B
    Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
    N1.1
    Nurse Session 1 - Cushing's Syndrome
    Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
    N1.2
    Nurse Session 1 - Cushing's Syndrome
    The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
    Rotterdam, The Netherlands
    N1.3
    Nurse Session 1 - Cushing's Syndrome
    Why do ‘cured’ Cushing’s patients need long-term follow up?
    Barcelona, Spain
    N1.4
    Nurse Session 1 - Cushing's Syndrome
    Cushing’s patient experience
    09:30 - 11:00 
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    1C
    Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
    Emerging biology of brown adipose tissue
    S11.1
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    Mechanisms of brown adipocyte determination
    Philadelphia, USA
    S11.2
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    The metabolic capacities of brown adipose tissue
    Stockholm, Sweden
    S11.3
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    How brown is human brown adipose tissue?
    Gothenburg, Sweden
    09:30 - 11:00 
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Supported by Clinical Endocrinology
    1A
    Chairs: H Gleeson (Leicester) & R El-Khairi (London)
    CMW3.1
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adolescent health care in the UK in 2014
    CMW3.2
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adrenal replacement in adolescents and young adults
    London, UK
    CMW3.3
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Optimising bone health in adolescents and young adults
    Birmingham, UK
    11:00 - 11:30 
    Tea & Coffee
    Exhibtion Hall
    11:30 - 12:00 
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    1A
    Chair: G Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    Mechanisms of thyroid hormone resistance
    Rotterdam, Netherlands
    12:00 - 12:30 
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL5
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    Transcriptional Coordination of Circadian and Metabolic Physiology
    Philadelphia, USA
    12:30 - 13:45 
    Lunch & poster viewing
    Shortlisted posters attended
    Hall 2A
    12:45 - 13:45 
    Viropharma Industry Sponsored Satellite Symposia
    New insights in the management of Adrenal Insufficiency in the UK
    3AB
    Chair: S Pearce (Newcastle-Upon-Tyne)
    Viropharma Industry Sponsored Satellite Symposia
    Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
    Newcastle, UK
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: the Salford project
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: a report from the EU-AIR registry
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Viropharma Industry Sponsored Satellite Symposia
    Patient cases and physician experience
    Naples, Italy
    Viropharma Industry Sponsored Satellite Symposia
    Closing remarks
    Newcastle, UK
    13:45 - 14:30 
    Meet the Expert 8
    1C
    Chair: C McCabe (Birmingham)
    MTE8
    Meet the Expert 8
    Growing organs in the lab
    13:45 - 15:15 
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    1B
    Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
    N2.1
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Background on the journey of endocrine nursing research
    N2.2
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    How to audit and evaluate your own practice
    N2.3
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    The role of the endocrine nurse in clinical trials
    N2.4
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Independent nursing research
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Questions and discussion
    13:45 - 15:15 
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Supported by Endocrine Connections
    1A
    Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
    How the brain orchestrates glucose metabolism
    S12.1
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    How the brain senses blood glucose
    S12.2
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Vagal control of energy metabolism
    S12.3
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Does glucagon need the brain for its effects on blood glucose?
    13:45 - 15:15 
    Oral Communications 6: Clinical
    3B
    Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
    OC6.1
    Oral Communications 6: Clinical
    Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
    OC6.2
    Oral Communications 6: Clinical
    Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
    OC6.3
    Oral Communications 6: Clinical
    Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
    OC6.4
    Oral Communications 6: Clinical
    Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
    OC6.5
    Oral Communications 6: Clinical
    Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
    OC6.6
    Oral Communications 6: Clinical
    11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
    14:30 - 15:15 
    Meet the Expert 9
    1C
    Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
    MTE9
    Meet the Expert 9
    Novel techniques to assess angiogenesis
    Paris, France
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 16:15 
    Oral Communication and Poster Prize Ceremony
    1A
    Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
    16:15 - 16:45 
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: G Williams (London)
    PL6
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Disorders of thyroid hormone action: insights from human genetics
    Cambridge, UK
    16:45 - 17:15 
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL7
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    The clock in the pituitary gland: timing annual cycles
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 1 (repeat)
    Supported by Clinical Endocrinology
    1B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1 (repeat)
    Medical management of Cushing's syndrome (repeat)
    08:00 - 08:45 
    Meet the Expert 2 (repeat)
    Supported by Clinical Endocrinology
    1C
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2 (repeat)
    Vitamin D replacement: how much, how often and for whom? (repeat)
    08:45 - 09:15 
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Supported by the Clinical Endocrinology Trust
    1A
    Chair: JS Bevan (Aberdeen)
    PL8
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Understanding glucocorticoid action, and the role of the glucocorticoid receptor
    09:15 - 09:45 
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    1A
    Chair: C McCabe (Birmingham)
    PL9
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    Male Fertility Regulation; achievements and frustrations
    Clayton, Australia
    09:45 - 10:15 
    Society for Endocrinology Emergency Endocrine Guidance
    1A
    Chair: J Franklyn (Birmingham)
    SFE1.1
    Society for Endocrinology Emergency Endocrine Guidance
    Acute Hypercalcaemia and Acute Hypocalcaemia
    UK
    SFE1.2
    Society for Endocrinology Emergency Endocrine Guidance
    Pituitary Apoplexy
    10:15 - 10:45 
    Tea & Coffee
    3AB
    10:45 - 11:30 
    Meet the Expert 6 (repeat)
    1B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6 (repeat)
    Delayed puberty (repeat)
    10:45 - 12:15 
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
    1A
    Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
    CMW4.1
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in Turner's syndrome
    CMW4.2
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Valvular disease in prolactinomas- weighing up the evidence
    London, UK
    CMW4.3
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in childhood cancer survivors
    10:45 - 12:45 
    Senior Endocrinologists' Session
    1C
    Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
    SE1.4
    Senior Endocrinologists' Session
    The Foundling Hospital
    SE1.2
    Senior Endocrinologists' Session
    1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
    SE1.3
    Senior Endocrinologists' Session
    Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
    Dublin, Ireland
    SE1.1
    Senior Endocrinologists' Session
    How important is luck for major discoveries?
    SE1.5
    Senior Endocrinologists' Session
    Steroid Merchants of Edinburgh
    11:30 - 12:15 
    Meet the Expert 7 (repeat)
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7 (repeat)
    Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
    London, UK

    07:45 - 08:00 
    Breakfast
    07:45 -  
    Registration
    08:00 - 08:45 
    Meet the Expert 1
    Supported by Clinical Endocrinology
    3B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1
    Medical management of Cushing's syndrome
    08:00 - 08:45 
    Meet the Expert 2
    Supported by Clinical Endocrinology
    1A
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2
    Vitamin D replacement: how much, how often and for whom?
    08:00 - 08:45 
    Meet the Expert 3
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    1B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3
    Endocrine and non-endocrine management of Klinefelter's Syndrome
    London, UK
    08:00 - 08:45 
    Meet the Expert 4
    Supported by Clinical Endocrinology
    1C
    Chair: L Heisler (Cambridge)
    MTE4
    Meet the Expert 4
    Optogenetics illuminates neuroendocrinology
    09:00 - 10:30 
    Symposium 6: Thyroid cell biology comes to your clinic
    Supported by Journal of Molecular Endocrinology
    1C
    Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
    Emerging models of clinical relevance to thyroid disease
    S6.1
    Symposium 6: Thyroid cell biology comes to your clinic
    Development of functional thyroid tissue from embryonic stem cells
    Brussels, Belgium
    S6.2
    Symposium 6: Thyroid cell biology comes to your clinic
    Factors involved in thyroid gland development and survival
    S6.3
    Symposium 6: Thyroid cell biology comes to your clinic
    PBF signalling in thyroid tumourigenesis
    Birmingham, UK
    09:00 - 10:30 
    Clinical Management Workshop 2: How do I do it?
    Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
    1A
    Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
    CMW2.1
    Clinical Management Workshop 2: How do I do it?
    How do I localise parathyroid tumours?
    CMW2.2
    Clinical Management Workshop 2: How do I do it?
    How and when do I initiate treatment for central hypothyroidism?
    Milan, Italy
    CMW2.3
    Clinical Management Workshop 2: How do I do it?
    How do I manage adrenal replacement in pregnancy?
    CMW2.4
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage sweating?
    CMW2.5
    Clinical Management Workshop 2: How do I do it?
    How and when do I treat the older male with a borderline testosterone?
    CMW2.6
    Clinical Management Workshop 2: How do I do it?
    How do I investigate and manage hyponatraemia?
    09:00 - 10:30 
    Oral Communications 3: Steroids
    3B
    Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
    OC3.1
    Oral Communications 3: Steroids
    Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
    OC3.2
    Oral Communications 3: Steroids
    5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
    OC3.3
    Oral Communications 3: Steroids
    The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
    OC3.4
    Oral Communications 3: Steroids
    Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
    OC3.5
    Oral Communications 3: Steroids
    Linking GWAS to gene function - CYP17A1 in hypertension
    OC3.6
    Oral Communications 3: Steroids
    Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
    09:00 - 10:30 
    Symposium 7: Natriuretic peptides: so much more than salt and water
    1B
    Chairs: C McArdle (Bristol) & S Mirczuk (London)
    Novel functions for natriuretic peptides
    S7.1
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Guanylyl cyclases in cardiomyopathy
    Wuerzburg, Germany
    S7.2
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in pituitary development and function
    S7.3
    Symposium 7: Natriuretic peptides: so much more than salt and water
    Natriuretic peptides in cardiovascular disease
    10:30 - 11:00 
    Tea & Coffee
    Hall 2A
    11:00 - 11:30 
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    1A
    Chair: A Grossman (Oxford)
    PL1
    Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
    Nuclear receptors, metabolism and the hunger games
    La Jolla, USA
    11:30 - 12:00 
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    1A
    Chair: A Grossman (Oxford)
    PL2
    Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
    Coactivators: Master Genes for Physiology and Pathology
    Pittsburg, USA
    12:00 - 14:00 
    Lunch & poster viewing
    Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
    Hall 2A
    12:45 - 13:45 
    Ipsen Industry Sponsored Satellite Symposia
    Optimising outcomes for patients with acromegaly and NETs
    3AB
    Chair: A Grossman (Oxford)
    Ipsen Industry Sponsored Satellite Symposia
    High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
    Ipsen Industry Sponsored Satellite Symposia
    SAGIT – A disease staging tool to personalise patient management for acromegaly
    Hamburg, Germany
    Ipsen Industry Sponsored Satellite Symposia
    New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
    Cardiff University, United Kingdom
    14:00 - 15:30 
    Oral Communications 4: Thyroid and Bone
    1C
    Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
    OC4.1
    Oral Communications 4: Thyroid and Bone
    Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
    OC4.2
    Oral Communications 4: Thyroid and Bone
    PHOSPHO1: roles beyond skeletal mineralisation
    OC4.3
    Oral Communications 4: Thyroid and Bone
    TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
    OC4.4
    Oral Communications 4: Thyroid and Bone
    Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
    OC4.5
    Oral Communications 4: Thyroid and Bone
    A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
    OC4.6
    Oral Communications 4: Thyroid and Bone
    An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
    Birmingham, UK
    14:00 - 15:30 
    Young Endocrinologists' Symposium: Establishing successful collaborations
    1B
    Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
    Making the most of interdisciplinary collaborations and peer-to-peer networking
    YE1.1
    Young Endocrinologists' Symposium: Establishing successful collaborations
    What makes a successful collaboration between a basic scientist and a clinician?
    YE1.2
    Young Endocrinologists' Symposium: Establishing successful collaborations
    How do I talk to a bioinformatician/mathematician/engineer?
    YE1.3
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Industrial collaborations - where to start?
    YE1.4
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Biobanking – what is it, and how could they be beneficial to me?
    YE1.5
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Peer-to-peer collaborations: Importance of YE groups
    Young Endocrinologists' Symposium: Establishing successful collaborations
    Panel discussion
    14:00 - 15:30 
    Symposium 8: Chronic disease and growth
    3B
    Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
    Chronic inflammation and growth hormone signalling
    S8.1
    Symposium 8: Chronic disease and growth
    Understanding growth hormone action through the growth plate
    S8.2
    Symposium 8: Chronic disease and growth
    Targeting SOCS Proteins to Combat Inflammation
    S8.3
    Symposium 8: Chronic disease and growth
    Managing abnormalities of growth in chronic disease
    Paris, France
    14:00 - 15:30 
    Symposium 9: MEN1- from molecular pathology to therapies
    Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
    1A
    Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
    Current understanding and future perspectives in MEN1
    S9.1
    Symposium 9: MEN1- from molecular pathology to therapies
    Current understanding and future perspectives in MEN1
    Bethesda, USA
    S9.2
    Symposium 9: MEN1- from molecular pathology to therapies
    Genetics, pathophysiology and translational models of MEN1
    Oxford, United Kingdom
    S9.3
    Symposium 9: MEN1- from molecular pathology to therapies
    Practical management of patients with MEN1
    Uppsala, Sweden
    15:30 - 16:00 
    Tea & Coffee
    Hall 2A
    16:00 - 16:45 
    Meet the Expert 3 (repeat)
    Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
    3B
    Chair: H Jones (Barnsley)
    MTE3
    Meet the Expert 3 (repeat)
    Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
    London, UK
    16:00 - 17:30 
    Oral Communications 5: Pituitary
    1B
    Chairs: J Davies (Manchester) & R Watkins (Birmingham)
    OC5.1
    Oral Communications 5: Pituitary
    Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
    OC5.2
    Oral Communications 5: Pituitary
    Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
    OC5.3
    Oral Communications 5: Pituitary
    The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
    OC5.4
    Oral Communications 5: Pituitary
    GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
    OC5.5
    Oral Communications 5: Pituitary
    Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
    OC5.6
    Oral Communications 5: Pituitary
    A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
    16:00 - 17:30 
    Symposium 10: Fat and bone
    Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
    1A
    Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
    Body composition and bone
    S10.1
    Symposium 10: Fat and bone
    Fat and its influence on bone
    S10.2
    Symposium 10: Fat and bone
    Obesity and fractures - what is the inter-relationship?
    S10.3
    Symposium 10: Fat and bone
    Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
    16:45 - 17:30 
    Meet the Expert 5
    Supported by Clinical Endocrinology
    3B
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5
    Pituitary replacement therapy
    17:40 - 18:10 
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: J Connell (Dundee)
    PL3
    Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
    Adrenocortical tumours - from bench to bedside and back
    Würzburg, Germany
    19:30 -  
    Conference dinner and Awards Ceremony
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 5 (repeat)
    Supported by Clinical Endocrinology
    1A
    Chair: P Trainer (Manchester)
    MTE5
    Meet the Expert 5 (repeat)
    Pituitary replacement therapy (repeat)
    08:00 - 08:45 
    Meet the Expert 6
    Supported by Clinical Endocrinology
    3B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6
    Delayed puberty
    08:00 - 08:45 
    Meet the Expert 7
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7
    Who should the endocrinologist ask the ophtalmologist to review?
    London, UK
    08:00 - 08:45 
    Society for Endocrinology Journal Awards
    1C
    Chair: D Ray (Manchester)
    JA 1
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
    Rochester, USA on behalf of the author group
    JA 2
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
    Louvain-la-Neuve, Belgium on behalf of the author group
    JA 3
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
    Baltimore, USA on behalf of the author group
    JA 4
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
    JA 5
    Society for Endocrinology Journal Awards
    Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
    Milan, Italy on behalf of the author group
    08:45 - 09:25 
    Society for Endocrinology AGM
    1A
    09:30 - 11:00 
    Education Workshop 2: Practical publishing advice
    3B
    Chair: D Ray (Manchester)
    EW2.1
    Education Workshop 2: Practical publishing advice
    Introduction
    EW2.2
    Education Workshop 2: Practical publishing advice
    Publishing ethics: Fabrication, Falsification and Plagiarism
    EW2.3
    Education Workshop 2: Practical publishing advice
    The peer review process
    Stockholm, Sweden
    EW2.4
    Education Workshop 2: Practical publishing advice
    Writing an attention grabbing abstract
    Essen, Germany
    EW2.5
    Education Workshop 2: Practical publishing advice
    Responding to reviewer comments
    EW2.6
    Education Workshop 2: Practical publishing advice
    The art of scientific writing
    London, UK
    EW2.7
    Education Workshop 2: Practical publishing advice
    Open Access
    Education Workshop 2: Practical publishing advice
    Questions and discussion
    09:30 - 11:00 
    Nurse Session 1 - Cushing's Syndrome
    1B
    Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
    N1.1
    Nurse Session 1 - Cushing's Syndrome
    Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
    N1.2
    Nurse Session 1 - Cushing's Syndrome
    The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
    Rotterdam, The Netherlands
    N1.3
    Nurse Session 1 - Cushing's Syndrome
    Why do ‘cured’ Cushing’s patients need long-term follow up?
    Barcelona, Spain
    N1.4
    Nurse Session 1 - Cushing's Syndrome
    Cushing’s patient experience
    09:30 - 11:00 
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    1C
    Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
    Emerging biology of brown adipose tissue
    S11.1
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    Mechanisms of brown adipocyte determination
    Philadelphia, USA
    S11.2
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    The metabolic capacities of brown adipose tissue
    Stockholm, Sweden
    S11.3
    Symposium 11: Some like it hot - new insights into brown adipose tissue
    How brown is human brown adipose tissue?
    Gothenburg, Sweden
    09:30 - 11:00 
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Supported by Clinical Endocrinology
    1A
    Chairs: H Gleeson (Leicester) & R El-Khairi (London)
    CMW3.1
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adolescent health care in the UK in 2014
    CMW3.2
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Adrenal replacement in adolescents and young adults
    London, UK
    CMW3.3
    Clinical Management Workshop 3: Improving the care of young people in endocrinology
    Optimising bone health in adolescents and young adults
    Birmingham, UK
    11:00 - 11:30 
    Tea & Coffee
    Exhibtion Hall
    11:30 - 12:00 
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    1A
    Chair: G Williams (London)
    PL4
    Plenary Lecture 4: Society for Endocrinology European Medal Lecture
    Mechanisms of thyroid hormone resistance
    Rotterdam, Netherlands
    12:00 - 12:30 
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL5
    Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
    Transcriptional Coordination of Circadian and Metabolic Physiology
    Philadelphia, USA
    12:30 - 13:45 
    Lunch & poster viewing
    Shortlisted posters attended
    Hall 2A
    12:45 - 13:45 
    Viropharma Industry Sponsored Satellite Symposia
    New insights in the management of Adrenal Insufficiency in the UK
    3AB
    Chair: S Pearce (Newcastle-Upon-Tyne)
    Viropharma Industry Sponsored Satellite Symposia
    Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
    Newcastle, UK
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: the Salford project
    Viropharma Industry Sponsored Satellite Symposia
    Adrenal Insufficiency today: a report from the EU-AIR registry
    Leeds Teaching Hospitals NHS Trust, Leeds, UK
    Viropharma Industry Sponsored Satellite Symposia
    Patient cases and physician experience
    Naples, Italy
    Viropharma Industry Sponsored Satellite Symposia
    Closing remarks
    Newcastle, UK
    13:45 - 14:30 
    Meet the Expert 8
    1C
    Chair: C McCabe (Birmingham)
    MTE8
    Meet the Expert 8
    Growing organs in the lab
    13:45 - 15:15 
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    1B
    Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
    N2.1
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Background on the journey of endocrine nursing research
    N2.2
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    How to audit and evaluate your own practice
    N2.3
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    The role of the endocrine nurse in clinical trials
    N2.4
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Independent nursing research
    Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
    Questions and discussion
    13:45 - 15:15 
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Supported by Endocrine Connections
    1A
    Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
    How the brain orchestrates glucose metabolism
    S12.1
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    How the brain senses blood glucose
    S12.2
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Vagal control of energy metabolism
    S12.3
    Symposium 12: Getting excited about sugar - the brain and blood glucose control
    Does glucagon need the brain for its effects on blood glucose?
    13:45 - 15:15 
    Oral Communications 6: Clinical
    3B
    Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
    OC6.1
    Oral Communications 6: Clinical
    Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
    OC6.2
    Oral Communications 6: Clinical
    Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
    OC6.3
    Oral Communications 6: Clinical
    Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
    OC6.4
    Oral Communications 6: Clinical
    Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
    OC6.5
    Oral Communications 6: Clinical
    Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
    OC6.6
    Oral Communications 6: Clinical
    11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
    14:30 - 15:15 
    Meet the Expert 9
    1C
    Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
    MTE9
    Meet the Expert 9
    Novel techniques to assess angiogenesis
    Paris, France
    15:15 - 15:45 
    Tea & Coffee
    Hall 2A
    15:45 - 16:15 
    Oral Communication and Poster Prize Ceremony
    1A
    Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
    16:15 - 16:45 
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Supported by Clinical Endocrinology Trust
    1A
    Chair: G Williams (London)
    PL6
    Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
    Disorders of thyroid hormone action: insights from human genetics
    Cambridge, UK
    16:45 - 17:15 
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    1A
    Chair: D Ray (Manchester)
    PL7
    Plenary Lecture 7: Society for Endocrinology Medal Lecture
    The clock in the pituitary gland: timing annual cycles
    07:45 - 08:00 
    Breakfast
    08:00 - 08:45 
    Meet the Expert 1 (repeat)
    Supported by Clinical Endocrinology
    1B
    Chair: J Newell-Price (Sheffield)
    MTE1
    Meet the Expert 1 (repeat)
    Medical management of Cushing's syndrome (repeat)
    08:00 - 08:45 
    Meet the Expert 2 (repeat)
    Supported by Clinical Endocrinology
    1C
    Chair: N Gittoes (Birmingham)
    MTE2
    Meet the Expert 2 (repeat)
    Vitamin D replacement: how much, how often and for whom? (repeat)
    08:45 - 09:15 
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Supported by the Clinical Endocrinology Trust
    1A
    Chair: JS Bevan (Aberdeen)
    PL8
    Plenary Lecture 8: Clinical Endocrinology Trust Lecture
    Understanding glucocorticoid action, and the role of the glucocorticoid receptor
    09:15 - 09:45 
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    1A
    Chair: C McCabe (Birmingham)
    PL9
    Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
    Male Fertility Regulation; achievements and frustrations
    Clayton, Australia
    09:45 - 10:15 
    Society for Endocrinology Emergency Endocrine Guidance
    1A
    Chair: J Franklyn (Birmingham)
    SFE1.1
    Society for Endocrinology Emergency Endocrine Guidance
    Acute Hypercalcaemia and Acute Hypocalcaemia
    UK
    SFE1.2
    Society for Endocrinology Emergency Endocrine Guidance
    Pituitary Apoplexy
    10:15 - 10:45 
    Tea & Coffee
    3AB
    10:45 - 11:30 
    Meet the Expert 6 (repeat)
    1B
    Chair: C Brain (London)
    MTE6
    Meet the Expert 6 (repeat)
    Delayed puberty (repeat)
    10:45 - 12:15 
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
    1A
    Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
    CMW4.1
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in Turner's syndrome
    CMW4.2
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Valvular disease in prolactinomas- weighing up the evidence
    London, UK
    CMW4.3
    Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
    Cardiovascular risk in childhood cancer survivors
    10:45 - 12:45 
    Senior Endocrinologists' Session
    1C
    Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
    SE1.4
    Senior Endocrinologists' Session
    The Foundling Hospital
    SE1.2
    Senior Endocrinologists' Session
    1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
    SE1.3
    Senior Endocrinologists' Session
    Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
    Dublin, Ireland
    SE1.1
    Senior Endocrinologists' Session
    How important is luck for major discoveries?
    SE1.5
    Senior Endocrinologists' Session
    Steroid Merchants of Edinburgh
    11:30 - 12:15 
    Meet the Expert 7 (repeat)
    Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
    1B
    Chair: J Gilbert (London)
    MTE7
    Meet the Expert 7 (repeat)
    Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
    London, UK
A Abbara
Mon 24 14:45
OC1.5
Oral Communications 1: Young Endocrinologists' Prize Session
Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment
S Agarwal
Bethesda, USA
Tue 25 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
Wed 26 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
Thu 27 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
S Akker
Tue 25
MTE1
Meet the Expert 1
Medical management of Cushing's syndrome
Tue 25
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Wed 26
MTE1
Meet the Expert 1
Medical management of Cushing's syndrome
Wed 26
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Thu 27
MTE1
Meet the Expert 1
Medical management of Cushing's syndrome
Thu 27
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Bruno Allolio
Würzburg, Germany
Tue 25
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
Wed 26
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
Thu 27
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
C Andoniadou
Mon 24
YEP1.1
SfE Young Endocrinologists' Prize Lectures
Basic Prize Lecture: Sox2+ cells of the postnatal pituitary can differentiate into hormone producing cells in vivo and have tumour-inducing potential
W Arlt
Mon 24 11:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Tue 25 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Tue 25 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
Wed 26 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Wed 26 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
Thu 27 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Thu 27 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
S Aylwin
Mon 24 13:20 - 13:35
HRA Pharma Industry Sponsored Satellite Symposia
Multimodal therapy in the management of advanced ACC
S Baldeweg
Tue 25
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
Wed 26
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
Thu 27
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
S Ball
Mon 24 11:45
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Mon 24 16:05
EW1.2
Education Workshop 1: Teaching and learning in Endocrinology
Using technology to enhance your teaching in endocrinology
Tue 25 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Tue 25 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
Wed 26 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Wed 26 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
Thu 27 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Thu 27 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
J Barth
Mon 24 15:45
CMW1.1
Clinical Management Workshop 1: Management of complex obesity
Have the new commissioning guidelines for bariatric surgery improved patient's pathways?
J Bassett
Tue 25 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
Wed 26 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
Thu 27 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
J Bevan
Tue 25
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
Wed 26
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
Thu 27
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
J Blair
Tue 25
MTE6
Meet the Expert 6
Delayed puberty
Tue 25
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
Wed 26
MTE6
Meet the Expert 6
Delayed puberty
Wed 26
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
Thu 27
MTE6
Meet the Expert 6
Delayed puberty
Thu 27
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
U Boehm
Mon 24 11:30
S1.2
Symposium 1: GnRH biology - from pulses to longevity
Biological insights from genetically tagged gonadotropes
A Boelen
Amsterdam, The Netherlands
Mon 24 16:45
S5.3
Symposium 5: Endocrine consequences of major trauma
Thyroid hormone economy in critical illness
Amsterdam, The Netherlands
G Brent
Los Angeles, USA
Mon 24 11:30
S3.2
Symposium 3: Emerging Clinical importance of iodine
Regulation of NIS function in thyroid and breast cancer
Los Angeles, USA
D Burdakov
Tue 25
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
Wed 26
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
Thu 27
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
D Cai
Bronx, USA
Mon 24 12:00
S1.3
Symposium 1: GnRH biology - from pulses to longevity
GnRH and inflammatory signalling in the ageing hypothalamus
Bronx, USA
B Cannon
Stockholm, Sweden
Tue 25 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
Wed 26 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
Thu 27 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
T Carpenter
New Haven, USA
Mon 24 14:45
S4.3
Symposium 4: Putting flesh on the bones
Management of hypophosphatemic rickets
New Haven, USA
P Carroll
Tue 25
MTE5
Meet the Expert 5
Pituitary replacement therapy
Tue 25
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
Wed 26
MTE5
Meet the Expert 5
Pituitary replacement therapy
Wed 26
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
Thu 27
MTE5
Meet the Expert 5
Pituitary replacement therapy
Thu 27
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
M Caulfield
Mon 24
Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
Against:
K Chapman
Tue 25 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Wed 26 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Thu 27 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
M Chapman
Tue 25 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Wed 26 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Thu 27 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
K Chapman
Tue 25 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Wed 26 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Thu 27 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
M Chapman
Tue 25 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Wed 26 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Thu 27 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
K Chapman
Tue 25 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Wed 26 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Thu 27 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
M Chapman
Tue 25 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Wed 26 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Thu 27 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Professor Krishna Chatterjee
Cambridge, UK
Tue 25
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
Wed 26
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
Thu 27
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
A Clark
Tue 25 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
Wed 26 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
Thu 27 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
J Compston
Tue 25 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
Wed 26 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
Thu 27 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
C Conover
Rochester, USA on behalf of the author group
Tue 25 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
Wed 26 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
Thu 27 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
B Cooke
Tue 25 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Wed 26 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Thu 27 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Professor Sabine Costagliola
Brussels, Belgium
Tue 25 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
Wed 26 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
Thu 27 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
E Crowne
Tue 25 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
Wed 26 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
Thu 27 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
C Cummins
Toronto, Canada
Mon 24 11:30
S2.2
Symposium 2: The upside of glucocorticoids in metabolism
Maintaining the anti-inflammatory action of glucocorticoid without the metabolic side effects
Toronto, Canada
J Dacre
Mon 24 16:25
EW1.3
Education Workshop 1: Teaching and learning in Endocrinology
Exams, and the future of assessment in medicine. A view from the MRCP(UK)
E Daniel
Tue 25 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
Wed 26 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
Thu 27 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
S Davies
Mon 24 12:45 - 13:05
Internis Industry Sponsored Satellite Symposia
Clinical Update on Vitamin D
L Diver
Tue 25 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
Wed 26 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
Thu 27 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
M Donaldson
Tue 25 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Wed 26 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Thu 27 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Professor William Drake
London, UK
Tue 25 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Wed 26 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Thu 27 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Maralyn Druce
London, UK
Tue 25 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
Wed 26 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
Thu 27 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
S Enerback
Gothenburg, Sweden
Tue 25 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
Wed 26 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
Thu 27 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
R Evans
La Jolla, USA
Tue 25
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Wed 26
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Thu 27
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
M Evans
Tue 25 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Wed 26 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Thu 27 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
R Evans
La Jolla, USA
Tue 25
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Wed 26
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Thu 27
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
M Evans
Tue 25 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Wed 26 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Thu 27 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
R Evans
La Jolla, USA
Tue 25
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Wed 26
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Thu 27
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
M Evans
Tue 25 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Wed 26 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Thu 27 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Dr Daniel Ezra
London, UK
Tue 25
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Tue 25
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK
Wed 26
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Wed 26
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK
Thu 27
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Thu 27
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK
Colin Farquharson
Tue 25 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
Wed 26 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
Thu 27 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
K Featherstone
Tue 25 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
Wed 26 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
Thu 27 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
R Feelders
Rotterdam, Netherlands
Mon 24 12:45 - 12:50
HRA Pharma Industry Sponsored Satellite Symposia
Welcome and introduction
Rotterdam, Netherlands
P Feldschreiber
Mon 24 13:25 - 13:45
Internis Industry Sponsored Satellite Symposia
The Dark Truth of Prescribing Unlicensed Vitamin D
Professor Nick Finer
London, United Kingdom
Mon 24 16:45
CMW1.3
Clinical Management Workshop 1: Management of complex obesity
Endocrine and metabolic complications post-bariatric surgery
London, United Kingdom
L Flook
Tue 25 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
Wed 26 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
Thu 27 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
R Fowkes
Tue 25 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
Wed 26 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
Thu 27 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
D Freeth
Mon 24 16:45
EW1.4
Education Workshop 1: Teaching and learning in Endocrinology
Interprofessional learning through and for multidisciplinary working
E Gan
Mon 24 14:00
OC1.2
Oral Communications 1: Young Endocrinologists' Prize Session
Characterisation of adrenocortical progenitor cells: isolation of mesenchymal stem cell-like cell populations from human adrenal cortex
C Gaston-Massuet
Tue 25 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
Wed 26 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
Thu 27 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
W Geilvoet
Rotterdam, The Netherlands
Tue 25 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
Wed 26 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
Thu 27 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
S Germain
Paris, France
Tue 25
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
Wed 26
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
Thu 27
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
N Gittoes
Mon 24 14:15
S4.2
Symposium 4: Putting flesh on the bones
Osteogenesis imperfecta - management beyond childhood
Caroline Gorvin
Birmingham, UK
Mon 24 15:00
OC1.6
Oral Communications 1: Young Endocrinologists' Prize Session
A loss-of-function mutation in the prolactin receptor (PRLR) causes familial hyperprolactinaemia
Birmingham, UK
Tue 25 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
Wed 26 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
Thu 27 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
A Grossman
Mon 24 12:50 - 13:00
HRA Pharma Industry Sponsored Satellite Symposia
Current challenges in the management of Cushing’s syndrome
C Harlow
Tue 25 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Wed 26 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Thu 27 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Z Hassan-Smith
Tue 25 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
Wed 26 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
Thu 27 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
P Hindmarsh
London, UK
Tue 25 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
Wed 26 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
Thu 27 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
A Hobbs
Tue 25 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
Wed 26 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
Thu 27 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
L Hodson
Mon 24 14:45
APW1.3
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Tracking lipid energy partitioning in human liver
S Howles
Tue 25 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Tue 25 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
Wed 26 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Wed 26 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
Thu 27 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Thu 27 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
C Høybye
Stockholm, Sweden
Tue 25 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
Wed 26 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
Thu 27 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
C Jayasena
Mon 24
YEP1.2
SfE Young Endocrinologists' Prize Lectures
Clinical Prize Lecture: Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation during IVF treatment
Dr Kim Jonas
London, UK
Mon 24 14:30
OC1.4
Oral Communications 1: Young Endocrinologists' Prize Session
Single molecule analysis of GPCR transactivation reveals oligomeric complexes that regulate signal sensitivity
London, UK
E Kinning
Mon 24 13:45
S4.1
Symposium 4: Putting flesh on the bones
Assessment of abnormalities of skeletal development
T Korevaar
Mon 24 14:15
OC1.3
Oral Communications 1: Young Endocrinologists' Prize Session
Angiogenic factors sFlt1 and PlGF are novel determinants of newborn thyroid (dys)function: the Generation R study
O Koulouri
Tue 25 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
Wed 26 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
Thu 27 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
M Kuhn
Wuerzburg, Germany
Tue 25 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
Wed 26 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
Thu 27 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
R Lauro
Tue 25 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
Wed 26 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
Thu 27 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
M Lazar
Philadelphia, USA
Tue 25
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
Wed 26
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
Thu 27
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
G Leese
Tue 25 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
Wed 26 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
Thu 27 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
D Lewis
Tue 25 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
Wed 26 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
Thu 27 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
S Llahana
Tue 25 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
Wed 26 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
Thu 27 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
J Logan
Tue 25 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
Wed 26 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
Thu 27 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
J Lord
Mon 24 15:45
S5.1
Symposium 5: Endocrine consequences of major trauma
Endocrine mechanisms of sarcopenia
A Loudon
Tue 25
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
Wed 26
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
Thu 27
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
I MacFarlane
Tue 25 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
Wed 26 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
Thu 27 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
MC Many
Louvain-la-Neuve, Belgium on behalf of the author group
Tue 25 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
Wed 26 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
Thu 27 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
A Marland
Tue 25 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
Wed 26 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
Thu 27 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
I Mason
Tue 25 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
Wed 26 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
Thu 27 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
C McArdle
Tue 25 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Wed 26 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Thu 27 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Professor  Chris McCabe
Birmingham, UK
Tue 25 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
Wed 26 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
Thu 27 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
R McCrimmon
Tue 25 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
Wed 26 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
Thu 27 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
J McKenna
Dublin, Ireland
Tue 25 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
Wed 26 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
Thu 27 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
R McLachlan
Clayton, Australia
Tue 25
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
Wed 26
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
Thu 27
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
K Meeran
Mon 24 15:45
EW1.1
Education Workshop 1: Teaching and learning in Endocrinology
Endocrinologists as teachers: integrating teaching and practice in the real world
Tue 25 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
Wed 26 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
Thu 27 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
A Mel
Tue 25
MTE8
Meet the Expert 8
Growing organs in the lab
Wed 26
MTE8
Meet the Expert 8
Growing organs in the lab
Thu 27
MTE8
Meet the Expert 8
Growing organs in the lab
A Mitchell
Tue 25 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
Wed 26 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
Thu 27 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
S Morgan
Tue 25 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
Wed 26 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
Thu 27 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
N Morton
Mon 24 12:00
S2.3
Symposium 2: The upside of glucocorticoids in metabolism
Glucocorticoids and protection from pancreatic beta cell failure
J Munday
Tue 25 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Wed 26 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Thu 27 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Robert Murray
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 25 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 26 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Thu 27 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
M Nasiri
Tue 25 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
Wed 26 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
Thu 27 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
J Nedergaard
Stockholm, Sweden
Mon 24 13:45
APW1.1
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Assessing energy demand in living organisms
Stockholm, Sweden
John Newell-Price
Sheffield, UK
Mon 24 13:00 - 13:20
HRA Pharma Industry Sponsored Satellite Symposia
Use of Steroidogenesis inhibitors for Cushing’s syndrome. Audit of 13 UK tertiary centres
Sheffield, UK
B O'Malley
Pittsburg, USA
Tue 25
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
Wed 26
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
Thu 27
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
S O'Rahilly
Mon 24
Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
For:
K Oldknow
Tue 25 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
Wed 26 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
Thu 27 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
V Parker
Tue 25 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
Wed 26 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
Thu 27 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
A Patrick
Tue 25 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
Wed 26 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
Thu 27 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
S Pearce
Newcastle, UK
Tue 25 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Tue 25 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
Wed 26 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Wed 26 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
Thu 27 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Thu 27 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
L Persani
Milan, Italy
Mon 24 11:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Tue 25 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Wed 26 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Thu 27 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
S Petersenn
Hamburg, Germany
Tue 25
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
Wed 26
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
Thu 27
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
J Piner
Tue 25 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
Wed 26 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
Thu 27 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
R Pivonello
Naples, Italy
Tue 25 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
Wed 26 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
Thu 27 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
C Poole
Mon 24 13:05 - 13:25
Internis Industry Sponsored Satellite Symposia
Shedding light on the Health Economics of Vitamin D
Richard Quinton
London, UK
Tue 25
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Tue 25
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
Wed 26
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Wed 26
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
Thu 27
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Thu 27
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
D Ray
Tue 25 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Tue 25
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
Wed 26 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Wed 26
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
Thu 27 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Thu 27
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
M Rayman
Mon 24 11:00
S3.1
Symposium 3: Emerging Clinical importance of iodine
Iodine nutrition and neurodevelopment
Aled Rees
Cardiff University, United Kingdom
Tue 25
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
Wed 26
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
Thu 27
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
R Richardson
Mon 24 16:30
OC2.4
Oral Communications 2: Endocrine regulation of cell behaviour
Influence of glucocorticoid receptor density on development and remodelling of the heart
J Robinson
Mon 24 16:45
OC2.5
Oral Communications 2: Endocrine regulation of cell behaviour
Beta-cells require CFTR for glucose-induced insulin secretion
D Scott-Coombes
Mon 24 11:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Tue 25 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Wed 26 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Thu 27 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
P Seale
Philadelphia, USA
Tue 25 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
Wed 26 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
Thu 27 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
P Selby
Tue 25
MTE2
Meet the Expert 2
Vitamin D replacement: how much, how often and for whom?
Tue 25
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
Wed 26
MTE2
Meet the Expert 2
Vitamin D replacement: how much, how often and for whom?
Wed 26
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
Thu 27
MTE2
Meet the Expert 2
Vitamin D replacement: how much, how often and for whom?
Thu 27
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
N Shaw
Birmingham, UK
Tue 25 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
Wed 26 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
Thu 27 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
L Shepherd
Tue 25 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
Wed 26 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
Thu 27 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
D Simon
Paris, France
Tue 25 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
Wed 26 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
Thu 27 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
B Skogseid
Uppsala, Sweden
Tue 25 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
Wed 26 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
Thu 27 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
A Spada
Milan, Italy on behalf of the author group
Tue 25 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
Wed 26 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
Thu 27 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
C Spitzweg
Munich, Germany
Mon 24 12:00
S3.3
Symposium 3: Emerging Clinical importance of iodine
Use of radioiodine in the imaging and therapy of non-thyroidal tumours
Munich, Germany
M Stevenson
Mon 24 16:00
OC2.2
Oral Communications 2: Endocrine regulation of cell behaviour
Inhibition of human NET cell proliferation by a peptide identified through phage display screening
Tue 25 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
Wed 26 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
Thu 27 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
F Swords
Mon 24 12:15
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Tue 25 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Wed 26 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Thu 27 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
J Tata
Tue 25 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
Wed 26 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
Thu 27 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
P Taylor
Mon 24 13:45
OC1.1
Oral Communications 1: Young Endocrinologists' Prize Session
The Thr92Ala substitution in deiodonase-2 is associated with increased odds of a sub-optimal IQ score in children with low-normal thyroid function
Raj Thakker
Oxford, United Kingdom
Tue 25 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
Wed 26 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
Thu 27 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
C Thompson
Dublin, Ireland
Mon 24 16:15
S5.2
Symposium 5: Endocrine consequences of major trauma
Pituitary sequelae of traumatic brain injury
Dublin, Ireland
I Thompson
Tue 25 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Tue 25 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
Wed 26 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Wed 26 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
Thu 27 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Thu 27 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
K Timms
Mon 24 17:00
OC2.6
Oral Communications 2: Endocrine regulation of cell behaviour
A potential role for food-derived microRNAs in human placental development
J Tobias
Tue 25 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
Wed 26 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
Thu 27 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
J Tomlinson
Mon 24 11:00
S2.1
Symposium 2: The upside of glucocorticoids in metabolism
Insulin sensitisation of adipose tissue by glucocorticoids
P Trainer
Tue 25 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
Wed 26 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
Thu 27 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
S Trapp
Tue 25 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
Wed 26 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
Thu 27 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
James Turner
UK
Tue 25
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
Wed 26
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
Thu 27
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
M Udiawar
Tue 25 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
Wed 26 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
Thu 27 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
S Virtue
Mon 24 14:15
APW1.2
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Lipid metabolism: from mice to men?
T Visser
Rotterdam, Netherlands
Tue 25
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
Wed 26
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
Thu 27
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
J Walsh
Tue 25 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
Wed 26 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
Thu 27 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
R Watkins
Mon 24 15:45
OC2.1
Oral Communications 2: Endocrine regulation of cell behaviour
A novel modulator of cell invasion and metastasis
S Webb
Barcelona, Spain
Tue 25 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
Wed 26 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
Thu 27 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
F Weber
Essen, Germany
Tue 25 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
Wed 26 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
Thu 27 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
B White
Tue 25 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
Wed 26 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
Thu 27 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
John Wilding
Liverpool, United Kingdom
Mon 24 16:15
CMW1.2
Clinical Management Workshop 1: Management of complex obesity
Medical management of severe obesity

Unknown speaker

Liverpool, United Kingdom
I Wilkinson
Tue 25 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
Wed 26 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
Thu 27 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
F Wu
Mon 24 12:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Tue 25 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Wed 26 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Thu 27 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
M Xing
Baltimore, USA on behalf of the author group
Tue 25 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
Wed 26 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
Thu 27 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
S Yarwood
Tue 25 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
Wed 26 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
Thu 27 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
R Yates
Mon 24 16:15
OC2.3
Oral Communications 2: Endocrine regulation of cell behaviour
A20 confers protection against TRAIL-induced apoptosis in the pancreatic beta-cell
Bone
P1
Primary Hyperparathroidism in pregnancy
Jehangir Abbas, Rudy Bilous
P2
Primary hyperparathyroidism in pregnancy presenting as hyperemesis
Rashmi Manjunatha, Jyothi Nippani, Deborah Markham, Rajni Mahto
P3
The Utility of Bone Turnover Markers in Paget’s Disease of Bone
Mark J Hannon, Isolda M Frizelle, Mark Kilbane, Malachi J McKenna
P4
An audit of the clinical indications for initiating  Denosumab as a treatment for Osteoporosis in a secondary care clinic.
Angela Collie, Khun Phyomaung, Menai Shahim, Stephen Gallacher, Andrew Gallagher, Fergus McLean, John Ahukannah, John Hinnie
P5
Value of sequential 25-hydroxyvitamin D measurements prior to denosumab and zoledronic acid treatment
Pushpa Singh, Neil Gittoes
P6
Impact of vitamin D replacement in patients with primary hyperparathyroidism and co-existing vitamin D deficiency
Gautam Das, Vinay Eligar, Jyothish Govindan, Stephen Davies
P7
Monitoring the Bisphosphonate Treatment Holiday
Clare Mumby, Shazli Azmi, Peter Selby, Katharine Hayden, Judith Adams
P8
Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice
Marie Pereira, Jeshmi Jeyabalan, Camilla Sofie Jørgensen, Mark Cleasby, Mark Hopkinson, Chantal Chenu
P9
Pre-operative localisation studies in primary hyperparathyroidism: concordance with surgical findings and histology
Edward McKeever, Robert Kennedy, Stephen Kirk, Roy Harper, Darren McLaughlin, C Mulligan, Tom Lynch, Clive Majury, CM McHenry
P11
Unusual cause of Hypocalcemia
Lavanya Pelluri, Christian Hariman, Narasimha Murthy
P12
The influence of gender on the bone health of adolescent patients with hormonal deficiencies  
Kerrie Grounds, Pamela Corlett, Aftab Ahmad, Pauline Whittingham
P13
Mutational Analysis of the Adaptor Protein 2 Sigma Subunit (AP2S1) gene: Search for Autosomal Dominant Hypocalcaemia Type 3 (ADH3).
Angela Rogers, M. Andrew Nesbit, Fadil M. Hannan, Sarah A. Howles, Treena Cranston, Jeremy Allgrove, John S. Bevan, Gul Bano, Caroline Brain, Vipan Datta, Shirley V. Hodgson, Louise Izatt, Lynne Millar-Jones, Simon H. Pearce, Lisa Robertson, Peter L. Selby, Brian Shine, Katie Snape, Justin Warner, Rajesh V. Thakker
P14
Clinical studies of adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 reveal genotype-phenotype correlations and effectiveness of cinacalcet
Fadil Hannan, Angela Rogers, Sarah Howles, Treena Cranston, Malachi McKenna, Tristan Richardson, Valerie Babinsky, Anita Reed, Clare Thakker, Detlef Bockenhauer, Rosalind Brown, Jacqueline Cook, Ken Darzy, Sarah Ehtisham, Una Graham, Tony Hulse, Steven Hunter, Dhavendra Kumar, John McKnight, Patrick Morrison
P15
Identification of twelve Adaptor Protein-2 Sigma 2 Subunit (AP2σ) mutations in Familial Hypocalciuric Hypercalcaemia type 3 (FHH3) and expansion of phenotypic spectrum.
Angela Rogers, Fadil M. Hannan, Sarah A. Howles, Treena Cranston, Clare E. Thakker, Detlef Bockenhauer, Rosalind Brown, Jacqueline A. Cook, Ken Darzy, Sarah Ehtisham, Tony Hulse, Dhavendra Kumar, Malachi McKenna, John McKnight, Zulf Mughal, Simon H. Pearce, Tristan Richardson, Isabelle Scheers, Timothy Wang, M. Andrew Nesbit
P16
Role of cortisol in the pathogenesis of postmenopausal osteoporosis: relationship to bone structure
Miguel Debono, Selina Bratherton, Margaret Paggiosi, Fatima Gossiel, Brian Keevil, Richard Ross, Richard Eastell
P17
The calcilytic NPS2143 rectifies the gain-of-function associated with G-protein alpha 11 mutations causing autosomal dominant hypocalcaemia type 2 (ADH2)
Valerie Babinsky, Fadil Hannan, M. Andrew Nesbit, Sarah Howles, Jianxin Hu, Allen Spiegel, Rajesh Thakker
P18
Baseline Characteristics of Patients Presenting with Primary Hyperparathyroidism (PHPT)
Alice Blackwell, Zana Ameen, Sarah Goellner, Abd Tahrani, Andrew Bates, Asad Rahim
P19
Treatment of Vitamin D Deficiency in Primary Hyperparathyroidism (PHPT) with Different Vitamin D Preparations
Sarah Goellner, Zana Ameen, Alice Blackwell, Abd Tahrani, Andrew Bates, Asad Rahim
P20
Is parathyroid hormone venous sampling useful? Correlation of parathyroid hormone selective venous sampling (PTHSVS) and histopathological results in patients who underwent parathyroidectomy between 2006-2013
Andrzej Rys, Robert Dyer, David Cunliffe, Simon Hickey, Richard Seymour
P21
Predictors of postoperative hypocalcaemia in parathyroidectomy patients: Local audit.
Venkata Katreddy, David Blundell, Harit Buch
P22
A rare germline Leu63Pro missense mutation in CDC73 resulting in familial primary hyperparathyroidism with variable phenotype
Khyatisha Seejore, Robert Murray, Stephen Orme, Afroze Abbas
P23
HYPOGONADISM MASQUERADING AS METABOLIC BONE DISEASE IN AN YOUNG MALE
Mallikarjuna Jeeragi, Arpandev Bhattacharyya, S Vidhyadhara, Karthik Prabhakar
P24
Unusual parathyroid location- A case of primary hyperparathyroidism(PTHP) with failed right parathyroidectomy
TANNAZ VAKILGILANI, YOUNGYOUNG LING, DAVID WOODS, AGNIESZKA FALINSKA, JEANNIE F TODD
P25
Is the Response to high dose oral Vitamin D replacement predictable?
Deepak Chandrajay, Marina Milic, Gwen Al-Khaili, Afroze Abbas, Stephen Orme
P26
Functional read out of defective osteoclast function in an in vitro model of Gaucher's disease.
Sarbjit Nijjar, Neil Gittoes, Tarekegn Geberhiwot
P27
The diagnosis of osteoporosis among South Indian male and female subjects with low impact hip fracture and comparison between Indian Council of Medical Research (ICMR) and Caucasian Bone Mineral Density Databases
NIHAL THOMAS, SAHANA SHETTY, NITIN KAPOOR, ASHA HS, DUKHABANDHU NAIK, VISALAKSHI P, THOMAS PAUL
P28
Evaluation of a glucocorticoid-induced osteoporosis model using ImageJ
Elda Pacheco-Pantoja, Francisco Arias-Garcia, Ximena Montes-de-Oca, Sergio Hernandez-Rosado, Luis Cab-Cesar, Brahim Rojano-Carrillo, Gustavo Rico-Toro
P29
The worlds of Primary and Secondary Hyperparathyroidism often collide; What effect do variable regimens of supplementing Vitamin D have in primary hyperparathyroidism?
Antonia Ugur, Emma Ward
P30
An ectopic parathyroid adenoma presenting with reduced conscious level and severe hypertension
Rediet Wiebel, Kimberley Lambert, Azraai Nasruddin
Clinical biochemistry
P31
Effects of light at night and rotating shift on circadian pattern of neuroendocrine chronomolecules
B Anjum, Narsingh Verma, Sandeep Tiwari, Ranjana Singh, Abbas Mahdi
P32
Limitations of dexamethasone suppression tests for Cushing’s disease – a reminder!
Emanuela Bejinariu, Shiu-Ching Soo, Ritwik Banerjee
P33
Are we investigating and managing Hyponatremia in hospitalised patients properly: a re-audit
Laura Pearson, Ranganatha Rao, Parijat De
P34
A routine combined LC-MS/MS assay for male androgens
Laura Owen, Brian Keevil
P35
URINARY KISSPEPTIN AS A NOVEL MARKER OF PREGNANCY
Alexander Comninos, Channa Jayasena, Shakunthala Narayanaswamy, Ali Abbara, Gurjinder Nijher, Mansimran Cheema, Zainab Malik, Mohammad Ghatei, Stephen Bloom, Waljit Dhillo
P36
'The effects of climate on the incidence of thiazide diuretic induced hyponatraemia (TIH) in the UK'.
Christopher Redford, Thomas Skinner, Andrzej Rys, Jamie Smith
P37
Title: Generation of a long acting GCSF for treatment of neutropenia and stem cell harvest
Abdulrahman Alshehri, Richard Ross, Ian Wilkinson
P38
Hypercalcaemia referrals from primary care: A retrospective audit
Negar Maghsoodi, Caje Moniz, Royce Vincent
P39
Development of a LC-MS/MS method for the measurement of serum 17-hydroxyprogesterone during the follicular and luteal phases of the menstrual cycle
Charlotte Hill, Andrew Davison
P40
Audit on short synacthen test- are 30and 60 min samples necessary?
Yasmeen Khalid, Edward Kearney, Stonny Joseph
P41
A Comparison Of Calculated Bioavailable Testosterone With Calculated Free Testosterone In Males With Hypogonadism
David Tesh, Timothy Davies, Miles Levy, Trevor Howlett
P42
Urinary 3-Methoxytyramine as a biomarker of Phaeochromocytoma and Paraganglioma tumours
Christina Neophytou, Sarah Darch, Jasdeep Singh Gill, Maggie Hancock, Karim Meeran, Fausto Palazzo, Tricia Tan
P43
EVALUATION THE OF EFFICACY OF TRANSDERMAL DELIVERY OF CHLOROQUINE ON PLASMODIUM BERGHEI-INFECTED MALE SPRAGUE-DAWLEY RATS: EFFECTS ON BLOOD GLUCOSE AND RENAL ELECTROLYTE HANDLING
Happiness Sibiya, Metse Serumula, Cephas T Musabayane
P44
Measurement of dexamethasone by LC-MS/MS after a 1mg overnight dexamethasone suppression test.
Miguel Debono, John Newell-Price, James Hawley, Brian Keevil
P45
Serum 5HIAA: a better biomarker than urine for detecting and monitoring neuroendocrine tumours?
Joanne Adaway, Rebecca Dobson, Jennifer Walsh, Daniel Cuthbertson, Philip Monaghan, Juan Valle, Brian Keevil
P46
High testosterone? Look again!
Tarig Babiker, Mandy Perry, Timothy McDonald, Antonia Brooke, John O'Connor
P47
Vitamin D status in patients visiting a large teaching hospital
Shaina Hirany, Mihail Firan, Ibrahim Hashim
P48
Development of a whole blood assay for the LC-MS/MS measurement of 5-hydroxyindole acetic acid
Suzanne Armitage, Joanne Adaway, Brian Keevil
P49
Do we need method specific cortisol cut off limits for dynamic function tests?
Kate Braha, Suzannah Phillips, John Dutton, Anna Milan
P50
Reference ranges for salivary steroid measurement during short synacthen tests
Rohan Shotton, Ilias Perogamvros, Brian Keevil, Philip Monaghan, Peter Trainer, Claire Higham
P51
Hyponatraemia prior to discharge from hospital after a general medical admission is associated with a significantly increased risk of readmission within 28 days.
Pratik Solanki, Benjamin Whitelaw, Christine Leong, John Miell, Simon Aylwin
Clinical practice/governance and case reports
P52
Clinical Application of the Levothyroxine Absorption Test
Muhammad Butt, Nidhi Gupta, Fiona Greenfield, Najeeb Waheed
P53
Recurrent Hypomagnesaemia, tackling modifiable risk factors
Moayed Alhelfi, Yared N Demssie
P54
Thyrotoxicosis After Severe Hypothyroidism in a Patient With a History of Hodgkin’s Lymphoma And Neck Irradiation.
Krzysztof Lewandowski, Katarzyna Dabrowska, Jacek Makarewicz, Andrzej Lewinski
P55
Large testicular adrenal rest tumours in a patient with congenital adrenal hyperplasia: a consequence of poor drug compliance.
JEYANTHY RAJKANNA, SO OYIBO
P56
A case of precocious puberty in a 4 year old boy: differential diagnosis and treatment goals
Ella-Grace Kirton
P57
Fixed dose radioactive iodine treatment for hyperthyroidism - Experience of a district general hospital
Rashmi Manjunatha, Katherine Harris, Sarfraz Nawaz, Rajni Mahto, Peter Horrocks
P58
Investigation of inpatient hyponatraemia in a teaching hospital
Ploutarchos Tzoulis, Devaki Nair, Rebecca Leyland, Emma Woolman, Nick Martin, Pierre Marc Bouloux
P59
Unexpected  Adrenocortical Carcinoma 8yrs after Diagnosis of Adrenal Incidentaloma
Mahender Yadagiri, David Barton
P60
Characteristics, comorbidities and aetiology of hospitalised patients with hyponatraemia
Ploutarchos Tzoulis, Pierre Marc Bouloux
P61
Endocrine complications of Thalassemia and its treatment: a local experience
Serena Deller, Radhika Mistry, Wyn Burbridge, Shivan Pancham, Christine Wright, Parijat De
P62
Juvenile Granulosa Cell Tumour of the Ovary presenting with hyperprolactinaemic amenorrhoea and galactorrhoea.
Ahmed Iqbal, Alexandra Lubina-Solomon, Jonathan Webster
P63
Analysis of hyponatraemic inpatients who died in a teaching hospital
Ploutarchos Tzoulis, Pierre Marc Bouloux
P64
Elevated Hounsfield units and Large Tumour size on Radiological Imaging are both suggestive of Functionality in Incidental Adrenal Tumours.
Dilip Abraham, Jadwiga Raasz, Edward Kearney, Stonny Joseph
P65
Spontaneous Hypoglycaemia in a Non-Diabetic Patient with Insulin Antibodies
Una Graham, Laura McQuillan, John Lindsay
P66
Severe hypercalcaemia requiring emergency haemodialysis due to postpartum hypophysitis and thyroiditis
Jing Mia Gao, Benjamin Whitelaw, Omar Mustafa, Salim Cheeroth
P67
Parathyroid adenoma presenting solely as acute necrotising pancreatitis in an adolescent girl
Mallikarjuna Jeeragi, Shabber Zaveri, Nagaraj Palankar, Karthik Prabhakar
P68
Pseudo-secondary hyperparathyroidism due to vitamin D deficiency and coexisting familial hypocalciuric hypercalcaemia.
Anna Louise Mitchell, Richard Bliss, Simon H S Pearce
P69
An unusual cause and an unusual complication of Cushing’s Syndrome
Zana Ameen, Rakhi Kakad, John Watkinson, Kristien Boelaert
P70
Not every Gestational Diabetes is Mellitus!
Zana Ameen
P71
A rare endocrine cause of severe resistant hypoglycaemia
Zana Ameen
P72
Enigma of an 18 year Acromegalic Window: what your mind knows but eyes may still miss?
Danielle Foucault, Parijat De
P73
ADRENAL MASSES-A BLEEDING PROBLEM
You-Jin Chang, Angela Alina Khan, Sobia Arshad, Ian Scobie
P75
Stuttering Priapism
Ahmed Imran Siddiqi
P76
Recovery of adrenal function in confirmed Addison's Disease
Mark Baxter, Sondra Gorick, Francesca Swords
P77
Hypercalcaemia - a mixed family picture
Leanne Hunt, Robert Robinson, Pallia Shillo, Treena Cranston, Rajesh Thakker
P78
Severe Hypercalcaemia and Acute Kidney Injury secondary to Graves' thyrotoxicosis
Thinzar Min, Lawrance Cozma, Silas Benjamin
P79
Patient feedback on receiving copies of clinic correspondence
Ram Prakash Narayanan, Preeti Chiran, Steven J McNulty, Upendram Srinivas Shankar, Niall Furlong
P80
Carbimazole induced agranulocytosis: A case report in the setting of a young female, on low dose and duration of treatment of more than one year
Hiang Leng Tan, Isy Douek
P81
The patient with broken Heart.
Alexandra Lubina Solomon, Ahmed Iqbal, Barney Harrison, Jonathan Webster, William Bennet
P82
Do you know where the hypo box on the ward is? A revealing audit...
Michelle Willmott
P83
Plasma 25-hydroxycholecalciferol before and after supplementation in paediatric oncology patients from Scotland: a time-series cross-sectional study
Raquel Revuelta Iniesta, Ilenia Paciarotti, Jane McKenzie, Mark Brougham, David Wilson
P84
Long-term follow up of Patients Treated with Tolvaptan for resistant hyponatraemia
Malik Asif Humayun, Rosina Elliot, Michael Cummings, Partha Kar, Darryl Meeking, Iain Cranston
P85
A Rare Cause of Primary Adrenal Insufficiency
Bethany Watt, Catrin Barwick, Catrin Searell, Tony Wilton
P86
A Feminising Adrenocortical Carcinoma
Bethany Watt, Sarah Wenham, Kakali Mitra, Avril Wayte, Tony Wilton
P87
Look Before You Leap...  An Adrenal Mass and Elevated Metadrenalines May Not Be Phaeochromocytoma.
Iona Galloway, Vincent McAulay, Stewart Ferguson
P88
Is Demeclocycline safe and effective in the treatment of SIADH ?
Shiva Mongolu, Azraai Nasruddin
P89
Low dose tolvpatan (7.5 mg) is effective in the management of SIADH in oncology patients (results from a retrospective audit at The Christie Hospital and Wythenshawe Pulmonary Oncology Unit)
Jennifer King, Angelos Kyriacou, Basil Issa, Paul Taylor, Claire Higham
P90
Teriparatide infusion for post-thyroidectomy hypocalcaemia: a case report
Khaliq Hamdan, Jawad Bashir, Ishrat Khan, Onyebuchi Okosieme, Neera Agarwal, Andrew Aldridge
P91
KALLMANN SYNDROME, GENDER DYSPHORIA, THROMBOPHILIA AND MULTIPLE SCLEROSIS: A COMPLEX CASE REPORT
Aniruthan Renukanthan, Richard Quinton, Ben Turner, Marta Korbonits
P92
An audit of clinical follow up and management of adult patients with Turner's Syndrome at the Royal Devon & Exeter.
Elizabeth Whittle, Mollie Donohoe, Antonia Brooke
P93
Can a random cortisol predict outcome of Short Synacthen test in non-acute patients with low pre-test probability?
Rajendran Bellan Kannan, Senthil Krishnasamy, Ananth Nayak, Biju Jose, Laks Varadhan
P94
An unusual case of recurrent hypercalcaemia. Sleeping parathyroid hyperplasia?
Una Graham, Fiona Eatock, Brew Atkinson
P95
Hypokalaemia attributed to liquorice use - not Allsorted!
Louise Hunter, Shailesh Agarwal, James Tymms, Sushmita Pearce
P96
Pre clinic tests accelerate decision making, reduce delays in treatment and are highly popular with endocrinology patients and staff.
Vidya Srinivas, Javier Gomez, Susan Kerry, Francesca Swords
P97
Carbimazole-induced Antineutrophil Cytoplasmic Antibody (ANCA) positive vasculitis: A case report
Kah Fai Wong, Harit Buch
P98
Outcomes following pituitary surgery - a single centre audit
Konstantinos Manolopoulos, Andrew S Bates, Amjad Shad, Assad Rahim
P99
Hyperparathyroidism in early pregnancy: a case report
Yong Yong Ling, Agnieszka Falinska, David Woods, Tannaz Vakilgilani, Raj Tanday, Jeannie Todd
P100
Distinguishing between primary hyperparathyroidism and familial hypocalciuric hypercalcaemia - the role of genetic testing in patient with equivocal results
Yong Yong Ling, Agnieszka Falinska, Tannaz Vakilgilani, Raj Tanday, Jeannie Todd
P101
Efficacy and safety of  doxazosin in perioperative management of phaeochromocytoma .
Gautam Das, James Clark, Benjamin Field, Sunil Zachariah
P102
Are we appropriately referring patients for Short Synacthen Testing?
Danielle Foucault, Sara Guthrie, Parijat De
P103
The use of subcutaneous denosumab for cases of hypercalcaemia refractory to intravenous bisphosphonate therapy
Muhammad Khan, Karen Perkins, Franklin Joseph
P104
Localised Charcot of the Hallux
Andrzej Rys, Tania Woodrow, Harvey Chant, Kim Farmer, Michael Butler, Duncan Browne
P105
Phaeochromocytomas and Paragangliomas - A 20 year experience
Anand Velusamy, Vanitha Karunakaran, David Kirtchuk, John Quin
P106
Autoimmune adrenal insufficiency presenting as severe hypercalcaemia
Matthew Carroll, Angelos Kyriacou, Tim Cooksley, Stephen McGlynn
P107
Somatostatin analogue therapy with good biochemical response in a patient with Ectopic ACTH secretion due to high grade metastatic neuroendocrine tumour.
Nidhi Choudhary, Tabinda Dugal, Steven Creely, Benjamin Hopwood, Duncan Browne
P108
Improving the quality of endocrinology teaching to clinical medical students   
Philippa Vega, Faye Gishen, Andrew Solomon
P109
An audit into the screening tests used for Cushing’s Syndrome
Mark Platt
P110
testicular adrenal axis lymphoma
Madhurima Vidyarthi, Awad Awad-Elkarim, Khalid Saja, Alison Brownell, Frederick Nkonge
P111
A Rare Case of Cushing's Syndrome caused by ‘cyclical' Ectopic ACTH secretion
Preeshila Behary, Raghunath Kadiyala, Agnieszka Falinska, Hannah Beckwith, James Jackson, Catherine Mitchell, Jeannie F Todd
P112
Management of hyponatremia in secondary care
Sophie Mescall, Amataullah Hashi, Polly Begum, Muhammad Ali Karamat
P113
A case of severe hypercalcaemia
Vilashini Arul Devah, Xiang Lee, Paul Turner, Vinutha Shetty, Komal Imtiaz, Simon Howell, Kalpana Kaushal
P114
Baseline assessment of patients referred for ‘Metabolic surgery' : Managing the myriad of metabolic abnormalities
Hafsa Imran, George Varughese, Chandra Cheruvu, Ananth Nayak, Emily Cooper, Lakshminarayanan Varadhan
P115
Detecting Vitamin D Deficiency in South Asians: is a population or targeted method better?
Samiul Mostafa, Kamlesh Khunti, Danielle Bodicoat, David Webb, Melanie Davies
P116
Endocrinology in a District General Hospital; it’s not all thyroid disease.
Emily Brown, Momin Shah, Simon Saunders
P117
Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required
Rahila Bhatti, Belinda Grimmett, Maeve McCarthy, Tomas Agusttson, Barbara McGowan, Jake Powrie, Paul Carroll
P118
Gastrinoma: Difficult to Diagnose Difficult to Treat
Ahmed Imran Siddiqi
P119
Severe hyponatraemia, hypokalaemia and associated seizure following the administration of sodium picosulfate/magnesium citrate (picolax) - a case report
John Storrow, Urmar Raja
P120
Bilateral Adrenal Hyperplasia - A Rare cause of Cushing's Syndrome in Children
Akshatha Taranath Kamath, Shiny Goyal Mandliya, Sanjay Rao, Sampath Satish Kumar
P121
Micrometastases in a paraganglioma
Fareeda Tabassum, Belayat Hossain
P122
Mitotane ameliorates testostoxicosis due to metastatic Leydig cell tumour
Nicholas Johal, Michael Cullen, Peter Guest, Emilio Porfiri, Wiebke Arlt
P123
Hypomagnesaemia during proton pump inhibitor therapy causing functional hypoparathyroidism
Senthilkumar Krishnasamy, Vineet Abbott, Rajendran Bellan Kannan, George Varughese, Ananth Nayak, Laks Varadhan, Biju Jose
P124
Anti-GAD ANTIBODY ENCEPHALITIS: A potentially treatable syndrome
Senthilkumar Krishnasamy, George Varughese, Adnan Al-araji, Laks Varadhan, Ananth Nayak, Indira Natarajan, Biju Jose
P125
Intravascular pituitary invasion by large B cell lymphoma is a rare cause of SIADH and hypopituitarism; a case report.
Marc Aitken, Simeen Akhtar, Edward Jude
P126
Double trouble - Pseudo-phaeochromocytoma in a patient with Adrenocortical Cancer
Christine May, Vidhya Jahagirdar, Vasileios Chortis, David Jenkins, Wiebke Arlt, John Ayuk
P127
Audit on investigations and diagnosis of hyponatremia in in-patients at a district general hospital
NIRUTHIKA SITHAMPARNATHAN, REBECCA DOOLEY, ISHA MALIK
P128
Three cases of octogenarians with Cushing's syndrome
Jodie Sabin, Urvi Popli, John Gibson, Alex Kraus, Catrin Searell, Tony Wilton
P129
Spontaneous hypoglycaemia induced by ACE-inhibitor: A case report
Kah Fai Wong, Varadarajan Baskar, Rajeev Raghavan
P130
The role of genetic analysis in the diagnosis of Familial Hypocalciuric Hypercalcaemia (FHH)
Zana Ameen, Jayadave Shakher
P131
Epidural abscess as a complication of infected diabetic foot ulcers: a case report.
Marc Aitken, Abdelaziz Marzoug, Edward Jude
P132
Alternating high and low TSH levels post subacute thyroiditis
Marie-France Kong, Rafik Karmali
P133
Pituitary apoplexy during a second pregnancy in a woman with prolactinoma
Monica Livia Gheorghiu, Andra Caragheorgheopol, Anda Dumitrascu, Virgil Ionescu
P134
Endocrine considerations in ever-improving HIV-related mortality outcomes - a clinical perspective
Sarah Mensforth, Biju Jose, George Varughese, Neena Bodasing, Gurdeep Singh, Kieran Fernando
P135
Next Generation Sequencing Approach for Molecular Genetic Diagnosis of Familial Partial Lipodystrophy
NIHAL THOMAS, ASHA HS, AARON CHAPLA, MANIKA V., SHRINATH SHETTY
P136
THE H SYNDROME & Next Generation Sequencing for Molecular Genetic Diagnosis
NIHAL THOMAS, MAHESH D.M., AARON CHAPLA, ASHA HS, SHRINATH SHETTY, SAHANA SHETTY, LYDIA M, RENU GEORGE
P137
Adrenal Incidentalomas, a district general hospital perspective.
Brian Mtemererwa, Anne de Bray, Anne- Marie O'neill, Alice Webster, Halimah Alazzani, Priyo Sada, Diana Raskauskiene
P138
Acute confusional state in the thyroid clinic - autoimmunity as a multi-edge knife
Vasileios Chortis, Matthew Edmunds, Edward Littleton, Kristien Boelaert
P139
Jumping the gun - an audit of adrenal biopsies in a tertiary referral centre 
Vasileios Chortis, Kassiani Scordilis, Wiebke Arlt, Rachel Crowley
P140
Is levothyroxine availability enhanced by grapes?
Ishrat Khan, Andrew Aldridge, Ruhina Ahmed, Onyebuchi OE
P141
Granulomatosis with Polyangiitis (GPA) presenting as a pituitary lesion
Louise Christou, Mahesh Katreddy, Shouma Dutta, Sanjeet Kamath, Simon Shaw, Biju Jose
P142
A case of hypoadrenalism
Funke Akiboye, Adam Nicholls, Triston Richardson
P143
Mayer-Rokitansky-Kuster-Hauser syndrome and Pituitary adenoma - a co-incidence?
Rajendran Bellan Kannan, Ananth Nayak, Laks Varadhan, George Varughese, Biju Jose
P144
Madness on the medical ward: ectopic ACTH producing tumour
Amar Puttanna, Viraj Patel, Diana Raskauskiene, Richard Clayton
P145
Training Needs in Adolescent Health and Transition in Paediatric and Adult trainees in Diabetes & Endocrinology in the UK
Helena Gleeson, Rohana Wright, Rachel Besser, Kelly Cheer, Paul Dimitri, Simon Chapman, on behalf of AYASIG
P146
Delayed hypocalcaemia following treatment of malignant hypercalcaemia with denosumab
Amar Puttanna, Ahsan Khan, Noushad Padinjakara
P147
Non Islet Cell Tumour Hypoglycaemia: management strategies for a rare and challenging condition
Dhanya Kalathil, Simon Roughneen, Momin Shah, Ali Akram, Reza Zaidi, Tejpal Purewal, Aftab Ahmad, Philip Weston
P148
Diabetes: The forgotten complication of parathyroidectomy
Nantia Othonos, Vinod Patel, Rajiv Nair, Stephen Ayre, Ponnusamy Saravanan
P149
Adrenocortical Carcinoma, where’s the delay?
Aftab Aziz, Rob Dyer, Julie Dunn, Andy Goodman, Antonia Brooke
P150
Tertiary hyperparathyroidism. A long term complication of pseudohypoparathyroidism type 1b?
Justyna Witczak, Penelope Owen, Mike Page
P151
Liraglutide as an effective therapeutic agent in a patient with Prader Willi Syndrome and type 2 diabetes.
Justyna Witczak, Penelope Owen
P152
Cushing's Disease with Hepatic Adrenal Rests
Daniel Border, Saboor Aftab, Lavanya Pelluri, Thomas Barber, Harpal Randeva
P153
The prevalence and mortality in Hospitalised Patients with Mild, Moderate and Severe Hyponatremia
Jayadave Shakher, Nirav Gandhi, Lisa Shepherd, Christopher Pitt, Kamaljit Chatha
P154
Profound hyponatraemia secondary to indapamide
Julia Prague, Ben Zalin
Cytokines and growth factors
P155
Modelling hepatic encephalopathy in vitro: molecular and functional consequences of hyperammonaemia and C-type natriuretic peptide signalling in C6 glioma cells
Samantha Mirczuk, Camille Robson, Emily Stacey, Robert Fowkes, Victoria Lipscomb
P156
Spatial Expression Profiling Reveals Tissue-Specific Sexual Dimorphism of the Natriuretic Peptide System in mice
Samantha Mirczuk, Camille Robson, Benjamin Robinson, Andrew Lessey, Victoria Lipscomb, Imelda McGonnell, Robert Fowkes
P157
The remote organ effects of acute kidney injury in a porcine model
Louise Dunford, David Gardner, Benjamin Duckworth, Saoirse O'Sullivan, Mark Devonald
Growth and development
P158
Novel Genes Influencing The Timing of Puberty
Sasha Howard, Leo Guasti, Helen Storr, Lou Metherell, Anna Cariboni, Michael Barnes, Claudia Cabrera, Karoliina Wehkalampi, Leo Dunkel
P159
Identification and characterisation of human foetal adrenocortical progenitor cells
Jessica Sampson, David Wilson, Ita O'Kelly
P160
Relationships between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
Thang Han, Roland Stimson, Aled Rees, Nils Krone, Debbie Willis, Gerard Conway, Wiebke Arlt, Brian Walker, Richard Ross
P161
CUL7, OBSL1 and CCDC8 modulate alternative splicing of exon 11 of the insulin receptor gene
Daniel Hanson, Graeme Black, Peter Clayton
P163
C-type natriuretic peptide regulates growth and pituitary development in the zebrafish (Danio rerio)
Andrew Lessey, Samantha Mirczuk, Imelda McGonnell, Robert Fowkes
P164
Distinct gene expression is associated with epigenetic and growth related network modules in relation to gender differences in the timing of the pubertal growth spurt
Chiara De Leonibus, Pierre Chatelain, Peter Clayton, Adam Stevens
P165
Altered Frequency of Sequence Variants in Growth Related Genes in Children with Short Stature
Philip Murray, Adam Stevens, Daniel Hanson, Andrew Whatmore, Mireille Bonnemarie, Laurent Naudin, Pascale Dutailly, Patrice Denefle, Peter Clayton
P166
Differential effects of grazing and meal feeding on skeletal growth and femoral strength in male rats
Thomas W Tilston, Anna L Hopkins, Richard C Brown, Bradley Arms-Williams, Sam L Evans, Timothy Wells
Neoplasia, cancer and late effects
P167
Calycosin suppresses breast cancer cell growth via ERβ-mediated inhibition of IGF-1R pathway
jian chen, jing tian
P168
A Challenging Case of Hypokalaemic Cushing's Crisis 
Mary Dunne, Andrew Solomon, Francesca Swords
P170
Comparison of HbA1c and oral glucose tolerance testing for the diagnosis of patients with and at risk of diabetes among long term bone marrow transplant survivors.
Sowmya Gururaj, Victoria Cartwright, Samiul Mostafa, Ann Hunter, Helena Gleeson
P171
Neuroendocrine biomarkers change with treatment in small cell lung cancer
Suzanne Meredith, Jennifer Bryant, Muhammad Babur, Philip Riddell, Kaye Williams, Anne White
P172
Late Presentation Predicts Endocrine Dysfunction in Patients with Langerhans Cell Histiocytosis. A Retrospective Analysis of the West Of Scotland LCH Service 1998-2012.
Aishah Coyte, Dermot Murphy, Milind Dattatraya Ronghe, Jairam Sastry, Faisal Ahmed, Mohamad Guftar Shaikh
P173
The first reported mutations in the pituitary tumor-transforming gene (PTTG) binding factor (PBF)
Waraporn Imruetaicharoenchoke, Martin Read, Joel Smith, Vicki Smith, Bhavika Modasia, Vikki Poole, Rachel Watkins, Franklyn Jayne, Kristien Boelaert, Christopher McCabe
P174
Bromodomain inhibitors reduce proliferation and increase apoptosis of human neuroendocrine tumour cells
Kate E Lines, Mark Stevenson, Katherine U Gaynor, Paul J Newey, Sian E Piret, Hannah Lingard, Panagis Filippakopoulos, Susanne Muller, Simona Grozinsky-Glasberg, Ashley Grossman, Stefan Knapp, Chris Schofield, Chas Bountra, Rajesh V Thakker
P175
Adrenocortical cancer - rare but gloomy cause of adrenal lesions
Agnieszka Falinska, Tanaz Vakilgilani, David Woods, Yong Yong Ling, Raj Tanday, Jeannie F Todd
P176
Metastatic paraganglioma with unknown genetics - to screen or not to screen the family?
Agnieszka Falinska, Tanaz Vakilgilani, David Woods, Raj Tanday, Yong Yong Ling, Jeannie F Todd
P177
Clinical dilemmas in diagnosing pheochromocytoma
Agnieszka Falinska, Tanaz Vakilgilani, Raj Tanday, Yong Yong Ling, Jeannie F Todd
P178
Inhibition of radioiodine uptake by PBF in breast cells is consistent with sodium iodide symporter repression in the thyroid
Vikki Louise Poole, Martin Read, Rachel Watkins, Bhavika Modasia, Gavin Ryan, Kristien Boelaert, Jayne Franklyn, Vicki Smith, Christopher McCabe
P179
Expression Modulation of Tumour Necrosis Factor-alpha and Tumour Necrosis Factor Receptor-1 genes in Breast Cancer Cell Lines (MCF-7) by some selected Indigenous Cytotoxic Plants
TITILOLA ADERONKE SAMUEL, BABATUNDE JAMES, OLUBUNMI ABIOLA MAGBAGBEOLA
P180
Characteristics of "foregut" carcinoid tumours occurring in multiple endocrine neoplasia type 1 (MEN1)
Lisa Yang, Kirsty Mann, Julian Winceslaus, Roaid Khan, Scott Akker, Mona Waterhouse, William Drake, Maralyn Druce
P181
Inherited mutations in the SDH complex may increase metastatic malignant potential of paragnglioma and phaeochromocytoma tumours
Bahram Jafar-Mohammadi, Louise Izatt, Klaus-Martin Schulte, Paul v Carroll, Barbara M McGowan, Jake K Powrie, Benjamin C Whitelaw, Debashis Sarker, Salvador Diaz-Cano, Simon JB Aylwin
P182
Pre-clinical assessment of the impact of Erlotinib on adrenocortical cancer cells proliferation
Dorota Dworakowska, Dorota Dudka, Gregory Weitsman, Peter King, Harshini Katugampola, Márta Korbonits, Klaus-Martin Schulte, Salvador Diaz-Cano, Alan McGregor, Ashley B. Grossman, Simon Aylwin, Krzysztof Sworczak, Tony Ng
P183
Long-term negative effects in young cancer survivors: metabolic disorders in the patients after complex treatment for brain tumors and acute lymphoblastic leukemia in childhood and adolescence
Tatiana Tselovalnikova, Maria Pavlova, Alexey Zilov, Nadezhda Mazerkina, Olga Zheludkova
P184
Diagnosis of adrenocortical carcinoma; Urinary steroid profiles measured by GC:MS
Frances McManus, Jonathan Hannay, Patrick O'Dwyer, David Shapiro, Marie Freel
P185
A rare Adrenal Lieomyosarcome in a subject with lupus and the antiphospholipid syndrome
IN Khan, A Guha, M A Adlan, M Stetchman, LD Premawardhana
P186
RET Genetic Screening in Patients with Multiple Endocrine Neoplasia type 2 and Medullary Thyroid Carcinoma: Experience of the Exeter Molecular Genetics Laboratory
Martina Owens, Bijay Vaidya, Sian Ellard
P187
MIBG-Avidity in Genetically Distinct Phaeochromocytoma and Paraganglioma Populations
Ross Jack, Robert Lindsay, Nicola Bradshaw, Marie Freel, Colin Perry
P188
SDHB surveillance regime - a single UK institution experience
Umasuthan Srirangalingam, Fazia Khan, Kirun Gunganah, Anju Sahdev, Mona Waterhouse, Maralyn R Druce, William M Drake, Scott A Akker
P189
Multiple endocrine neoplasia type 2A in a large family with a C620G mutation of the RET proto-oncogene: Diagnostic, treatment and ethical challenges.
Rajeev Raghavan, Venkata Katreddy, L Leiw, A Garnham, R Gama, P Strouhal, H Buch, A Viswanath, BM Singh
P190
An incidental diagnosis...
Irfan Khan, Paul Lambert
P191
ATR kinase function is modulated by the proto-oncogene PBF
Hanna Fan, Teresa Gagliano, Martin L Read, Jayne A Franklyn, Kristien Boelaert, Andrew S Turnell, Christofer J McCabe
Nursing practice
P192
Steroid Group Education: Developing a Curriculum Ensures Good Nursing Practice is maintained.
Jean Munday
P193
Time taken for Growth Hormone (GH) -treated adolescent patients transitioning to adult services, to reach IGF-1 levels within the upper normal range. Do we need to monitor more frequently?
Kerrie Grounds, Mohammed Didi, Pamela Corlett, Pauline Whittingham, Aftab Ahmad
P194
Life, death and modern technology - an update
Fiona Anthonypillai
P195
Introduction of a protocol and endocrine specialist nurse ward visits in the management of hyponatraemia.
Rhianne Mason, Charlotte Forbes, Seren Williams, Timothy McDonald, Antonia Brooke
P196
Optimal Vitamin D treatments in Coeliac patients
Nicci Komlosy, Caroline Jagger
P197
Integration of a new drug into clinical Practice and enhancing the patient experience
Caroline Jagger
P198
Emergency hydrocortisone kits - Assessment of knowledge & skills of patients & family.
Lisa Shepherd, Sadaf Ulnasah, Asad Rahim, Jayadave Shakher, Andrew Bates
Obesity, diabetes, metabolism and cardiovascular
P199
The effect of L-cysteine on appetite in humans
Anjali Amin, Amy Agahi, Niamh Martin, Mohamed Ghatei, Steve Bloom, Kevin Murphy
P200
Analysis of serum FTO level and related factors in obese and T2DM patients
Jianjin Guo, Wei Ren, Jie Liu, Weiping Jia
P201
Associations between regional body fat distribution and homocysteine levels in type 2 diabetes with coronary atherosclerosis patients
Wei Ren, Jianjin Guo, Jie Liu
P202
An opinion survey in Eastern Ghana: health behaviours and knowledge of diabetes in diagnosed diabetes mellitus type 2 patients.
Gemma Buston
P203
EFFECTS OF TRANSDERMALLY DELIVERED INSULIN ON SOME SELECTED METABOLIC PARAMETERS OF STREPTOZOTOCIN-INDUCED DIABETIC MALE SPRAGUE-DAWLEY RATS
Silindile I Hadebe, Phikelelani S Ngubane, Metse R Serumula, Cephas T Musabayane
P204
"EARLY INSULIN THERAPY-A NEW TREATMENT APPROACH FOR TYPE-2 DIABETES MELLITUS WITH GLYCOSYLATED HAEMOGLOBIN MORE THAN 7% (HbA1c > 7 %)"
Harshitbhai patel
P205
Cross-sectional survey of depression and anxiety in a clinical diabetes population: prevalence and role in blood sugar control
Hammad Lakhani, Isobel Cane, Michelle Taylor, Paul Chadwick, Miranda Rosenthal
P206
Dark chocolate rich in polyphenols improves insulin sensitivity in the adult non diabetic population
Grace Farhat
P207
Effect of H.gordonii on regulatory peptides under short term calorie restriction
Swati Jain, SomNath Singh
P208
Abnormal glucocorticoid metabolism in horses with metabolic syndrome.
Ruth Morgan, Patrick Hadoke, Brian Walker, John Keen
P209
An Audit of patients with Diabetes attending Accident and Emergency with Severe Hypoglycaemia
Tolulope Shonibare, Khyatisha Seejore, Robert Moisey
P210
Predictive clinical variables for periodontitis in Type 2 diabetic subjects with poor glycemic control.
Jai karthik, Shajithanoop Selva kumar, Suresh kumar, M.V Usha rani
P211
Impacts of the serum testosterone on the metabolic syndrome in Chinese young and middle-agd men with type 2 diabetes mellitus
Xin Li, Miao Yang, Su-xing Sun, Yu-wen Wu, Jia-zhong Sun
P212
Metabolic improvement after bariatric surgery: An overview from a single tertiary centre
Abigail Barrett, Saloni Bakhshi, Ananth Nayak, George Varughese, Chandra Cheruvu, Lakshminarayanan Varadhan
P213
Renal function variation after bariatric surgery: Which measurement do we rely on?
Saloni Bakhshi, Abigail Barrett, Ananth Nayak, George Varughese, Chandra Cheruvu, Lakshminarayanan Varadhan
P214
Chemerin as a potential screening marker for sub-clinical diabetes?
Syeda Sadia Fatima, Najeeha Talat Iqbal
P215
The Salt-Inducible Kinases: Gatekeeper of Hepatic Gluconeogenesis
Kashyap Patel, Marc Foretz, David Campbell, Calum Sutherland, Kei Sakamoto
P216
Maturity Onset Diabetes of Young type 5
Ahmed Imran Siddiqi
P217
Obstructive Sleep Apnoea Syndrome (OSAS) and Type 2 Diabetes (T2D)
Katy Talbot, Peter Evans, Melissa Hack
P218
Young women with polycystic ovary syndrome have increased concentrations of circulating annexin V-positive microparticles derived predominantly from platelets
Gareth Willis, Katherine Connolly, Kristin Ladell, Kelly Miners, David Price, Irina Guschina, Aled Clayton, Philip James, Aled Rees
P219
Quality improvement for patients with type 2 diabetes
Finn Edler von Eyben
P220
Central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS but are associated with insulin resistance and abdominal obesity
Rosie Coulson, Emma Rees, Frank Dunstan, Julian Halcox, Alan Fraser, Aled Rees
P221
An Evaluation of Knowledge and Understanding of HbA1c in Diabetes Patients in a Secondary Care setting
Caroline Bowler, Ruth Erde, Parijat De
P222
Joint Predictability of Physical Activity and Bodyweight on Health-Related Quality of Life among Nigerian Type 2 Diabetes
Kolade Idowu
P223
A 3 month low fat diet leads to significant lipid profile improvement in obese T2DM Saudi subjects, without substantial weight loss, and the capacity to manage a damaging high fat meal challenge more appropriately post intervention
Dara Al-Disi, Nasser Al-Daghri, Nasiruddin Khan, Mohammad Alsaif, Assim Alfadda, Shaun Sabico, Gyanendra Tripathi, Philip McTernan
P225
Outcomes of bariatric surgery in men versus women: a matched observational cohort analysis
Andrew Kennedy-Dalby, Basil Ammori, Akheel Syed
P226
Meal size and frequency influences metabolic endotoxaemia and inflammatory risk but has no effect on diet induced thermogenesis in either lean or obese subjects
Milan Piya, Narendra Reddy, Alison Campbell, John Hattersley, Louise Halder, Gyanendra Tripathi, Abd Tahrani, Thomas Barber, Sudhesh Kumar, Philip McTernan
P227
Screening and diagnosis of gestational diabetes: impact of  age,  BMI and adipokines
Rym-Ikram MEHAOUDI, Hanane OUSSEKHRI, Yacine SOLTANI, Djouhra TAMDRARI, Hafida BENDAOUD, Zohra HAMOULI, Zohra NIBOUCHA, Fatima HADJ BEKKOUCHE
P229
The effects of treatment with Liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
Hassan Kahal, Ahmed Aburima, Tamas Ungvari, Alan Rigby, Anne-Marie Coady, Rebecca Vince, Ramzi Ajjan, Eric Kilpatrick, Khalid Naseem, Stephen Atkin
P230
MINERAL NUTRIENTS AND METABOLIC HEALTH: DATA ON NIGERIAN LOCAL DISHES.
AYODELE MORAKINYO, TITILOLA SAMUEL, OLUFEYI ADEGOKE
P231
EZH2 regulates responses of endothelial cells under hypoxia and during tissue regeneration following limb ischemia
Tijana Mitić, Micol Marchetti, Marco Meloni, Andrea Caporali, Costanza Emanueli
P232
High Incidence of Cardiac Involvement in Patients Diagnosed with Phaeochromocytoma: A Clinical Study Using Cardiovascular Magnetic Resonance Imaging
Vanessa Ferreira, Mafalda Rodrigues, Stefan Piechnik, Claudia Marini, Theodoros Karamitsos, Jane Francis, Ranjit Arnold, Radu Mihai, Julia Thomas, Maria Herincs, Marta Korbonits, Zaki Hassan-Smith, Wiebke Arlt, Niki Karavitaki, Ashley Grossman, Stefan Neubauer, John Wass
P233
Microparticle profile in patients with type 2 diabetes
Judit Konya, Leigh A Madden, Thozhukat Sathyapalan, Eric S Kilpatrick, Stephen L Atkin
P234
Expression of GLP-1 receptors throughout the mouse brain using a novel transgenic mouse model
Simon C Cork, Frank Reimann, Fiona M Gribble, Stefan Trapp
P235
Novel syndromes of hypoinsulinaemic, hypoketotic hypoglycaemia
Sarah Leiter, Marina Minic, Victoria Parker, Julie Harris, Julian Hamilton-Shield, Rachel Williams, Eckhard Korsch, Khalid Hussain, Robert Semple
P236
The characteristics of a patient population with extreme and complex obesity attending a specialist weight management service
Wen Bun Leong, Peymane Adab, Neil G Thomas, Shahrad Taheri
P237
COFFEE ATTENUATES INDUCTION OF INSULIN RESISTANCE IN HIGH SUCROSE-DIET  FED RATS.
Ayodele Morakinyo, Daniel Adekunbi, Kayode Dada, Olufeyi Adegoke
P238
Systemic triglycerides as a key determinant of TLR regulated inflammatory risk in human adipose tissue post bariatric surgical intervention and weight loss.
Warunee Kumsaiyai, Nasser Al-Daghri, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Thomas Barber, Sudhesh Kumar, Gyanendra Tripathi, Philip McTernan
P239
Upregulation of AKR1C3 expression by insulin in a human differentiated preadipocyte cell line
Philip House, Michael O'Reilly, Laura Gathercole, Jeremy Tomlinson
P240
The outcome results in patients with type 2 diabetes mellitus and obesity after either adjustable gastric banding (AGB) or Roux-en-Y (RNY) gastric bypass
Andrzej Rys, Tabinda Dugal
P241
Diabetes in pregnancy and birth weight (BW): Differential effects due to ethnicity in a real-life observational study
James Wilson, Hema Venkataraman, Jessica Cheong, Nithya Sukumar, Kamlesh Khunti, Ponnusamy Saravanan
P242
Evolutionary conserved novel targets of NGN3, located on the short arm of chromosome 20, may have a role in the development of the endocrine pancreas.
Oluwafikunayo Orekoya, Andrew Berry, Neil Hanley
P243
Decreased brain 11β-HSD1 expression following inflammation; a role in regulating brain energy homeostasis ?
Manu Verma, Zhenguang Zhang, Annie Mackellar, Jonathan Seckl, Megan Holmes, Karen Chapman
P244
Capillary blood glucose monitoring and ambulatory peritoneal dialysis: reassuring the patient
Waiel Bashari, Samson Oyibo
P245
Case report - the role of somatostatin analogue therapy in nesidioblastosis following Roux-en-Y bypass surgery.
Rajamani Manikandan, Shiva Mongolu, Azraai Nasruddin
P246
Impact of chronic heart failure on adipose tissue functional plasticity: a role for fatty acids?
Andrew Yale, Malcolm Cobb, Alexander Lyon, Alison Mostyn
P247
Maternal metabolic adaptations in pregnancy are associated with altered circadian rhythmicity
Georgia Papacleovoulou, Vanya Nikolova, Olayiwola Oduwole, Malcolm Parker, Catherine Williamson
P249
Derivatisation of estrogens enhances specificity and sensitivity of analysis by liquid chromatography tandem mass spectrometry
Abdullah MM Faqehi, Diego F Cobice, Gregorio Naredo, Tracy CS Mak, Brian R Walker, Natalie ZM Homer, Ruth Andrew
P250
Virally delivered target-specific optogenetic stimulation of PPG neurons in the nucleus of the solitary tract
James E Richards, Simon C Cork, Marie Holt, Frank Reimann, Fiona M Gribble, Stefan Trapp
P251
METFORMIN AND ACUTE KIDNEY INJURY (AKI): IS IT THE CULPRIT?
Phey Shen Lee, Jonathan Donald Mackay
P252
The role of glucocorticoid metabolism in bile acid homeostasis
Monica Naomi Opiyo, Geneviève Escher, Christopher Kenyon, Jonathan Seckl, Ruth Andrew, Karen Chapman
P253
Gitelman Syndrome
Veneranda Lorelei Salazar, Komal Imtiaz, Tamsin Rimmer, Arwa Amijee
P255
Serum ferritin levels are correlated with total adiposity, but not BMI in obese males
M.Gulrez Zariwala, Ania Kosicka, Richard Mackenzie, Derek Renshaw
P256
Ventricular dysfunction in the new born Secondary to Maternal Vitamin D Deficiency
Sampath Satish Kumar, Akshatha Taranath Kamath
P257
Contribution of Hepatic Liver X Receptor to the Adaptations in Maternal Lipid Metabolism During Pregnancy
Vanya Nikolova, Shadi Abu-Hayyeh, Georgia Papacleovoulou, Malcolm Parker, Catherine Williamson
P258
High serum amylase a contraindication to GLP1 analogue treatment?
Karolina Stepien, Anne-Marie Kelly, Graham Horsman, Naveed Younis
P259
Decrums disease; an unusual case of bilateral adrenal lipomas
Anne marie Hannon, Lisa Owens, Domhnall O'Halloran
P260
Longitudinal changes in glucocorticoid metabolism predict the development of metabolic phenotype
Rachel Crowley, Beverly Hughes, Joanna Gray, Theresa McCarthy, Susan Hughes, Cedric Shackleton, Nicola Crabtree, Peter Nightingale, Paul Stewart, Jeremy Tomlinson
P262
Elevated cord leptin from low B12 mothers predicts birth weight
Adaikala Antonysunil, Manu Vatish, Alexander Lawson, Catherine Wood, Kavitha Sivakumar, Craig Webster, Neil Anderson, Philip McTernan, Gyanendra Tripathi, Ponnusamy Saravanan
P263
Renalase a key regulator of Brown Adipose Tissue Activity.
Manjunath Ramanjaneya, Bee Tan, Vanlata Patel, Jiamiao Hu, Hendrik Lehnert, Edward Hillhouse, Jing Chen, Harpal Randeva
P264
Bariatric surgery for hypothalamic obesity: Case Series Report
Ye Kyaw, Robert Mayo, Gul Bano
P265
Depletion of glucose-6-phosphate transporter impacts SR calcium homeostasis in muscle.
Craig Doig, Agnieszka Zielinska, Rachel Fletcher, Emma McCabe, Gareth Lavery
P266
Breaking NAD+: Investigating NMRK2 as a regulator of muscle adaptation through NAD+ salvage
Craig Doig, Agnieszka Zielinska, Rachel Fletcher, Emma McCabe, Andrew Philp, Gareth Lavery
P267
11beta HSD1KO mice resist aged associated decline in markers of brown adipose tissue function
Emma McCabe, Craig Doig, Stuart Morgan, Dean Larner, Jeremy Tomlinson, Paul Stewart, Gareth Lavery
P268
H6PDH deficiency in muscle impacts amino acid metabolism
Agnieszka Zielinska, Craig Doig, Paul Stewart, Jerzy Adamski, Gareth Lavery
P269
Unfolded protein response in adipose tissue of obese diabetic women significantly improved six months post bariatric surgery, irrespective of malabsorptive or bypass operation type and correlates with plasma glucose concentration
Philip Voyias, Adaikala Antonysunil, Warunee Kumasaiyai, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Ponnusamy Saravanan, Sudhesh Kumar, Philip McTernan, Gyanendra Tripathi
P270
Does TCF7L2 Polymorphisms increase the risk of Gestational Diabetes Mellitus in South Indian population?
NIHAL THOMAS, MAHESH D.M., AARON CHAPLA, JOHAN PAUL, SHWETHA N, FLORY CHRISTINA, ASHA HS
P271
Evaluating beta-hydroxybutyrate (BOHB) as indicator for early termination of 72 hours fast for spontaneous hypoglycaemia
Octavian-Ionut Cozar, Sondra Gorick, Anupam Brahma, Francesca Swords
P272
Liver fibrosis is common in Alstrom Syndrome and can be identified using non-invasive tests
Jonathan Hazlehurst, Matthew Armstrong, Jayne Hodgkiss, Rachel Crowley, Tarekegn Geberhiwot, Phillip Newsome, Jeremy Tomlinson
P273
Familial Adult Hyperinsulinism due to Genetic Glucokinase Activation:Implications for Therapeutic Use of Glucokinase Activators
B.G. Challis, J. Harris, A. Sleigh, S.M. Orme, N. Seevaratnam, K. Dhatariya, H.L. Simpson, R.K. Semple
P274
Metabolic Pathway Analysis in Choline and Methionine Deficient Mice: New Insights into the Mechanism of Steatosis and Insulin Resistance.
Marcus Lyall, Jonathan Manning, Jennifer Hunter, Steve Anderton, Richard Meehan, Amanda Drake
P275
Evaluation of a crude extract administration of Cnidoscolus chayamansa in normal and diabetic Wistar rats
Francis Echeverría-Bobadilla, Andrea Ceballos-Arana, Daniel Sanchez-Ruz, Elda Pacheco-Pantoja
P276
A pathway to investigate and manage patients complaining of symptoms suggestive of hypoglycaemia post Roux-en-Y Gastric Bypass Surgery (RYGB)
George Tharakan, Harvinder Chahal, Alex Miras, Preeshila Behary, Sanjay Purkayastha, Sherif Hakky, Jo Boyle, Candace Bovril-Taylor, Asta Julnaite, Sarah Allen, Jonathan Cousins, Krishna Moorthy, Ahmed Ahmed, Tricia Tan
P277
Proliferative Retinopathy in Pregnancy after Bariatric Surgery.
Helen Dobson, Chitra Raj, Alia Munir
P278
Therapeutic durability of the GLP1-based therapy Liraglutide in patients with Type 2 Diabetes Mellitus
Daniel Border, Puja Thadani, Joseph Reed, Harpal Randeva, Thomas Barber
Pituitary
P279
An unusual cause of pituitary apoplexy
Preeshila Behary, Gareth Townsey, Amrish Mehta, Karim Meeran
P280
Pituitary metastasis from CLL - an extremely rare case
Kirthika Jeyaraman, Rashmi Kaushal
P281
Painful Third Nerve Palsy Caused by Primary Pituitary Lymphoma Associated with Apoplectic Pituitary Adenoma
Luke Pickup, Adrian Jennings
P282
Lack of Fpr2/Fpr3 receptors alters the structure and function of pituitary corticotrophs 
Maria Mahmood, Helen Christian
P283
A Deficit of Dystrophin 71 leads to disorder in vasopressin and oxytocin production in the magnocellular neurons
Roza Benabdesselam, Latifa Dorbani-Mamine, Alvaro Rendon, Hélène Hardin-Pouzet
P284
The Effect of Pregnancy on Hyperprolactinaemia:  A 5-year retrospective observational study.
Vani Shankaran, Emma Ward
P285
Diabetes insipidus in Erdheim-Chester disease
Nishant Ranjan, V P Sumathi, Zayd Merza
P286
The gonadotroph natriuretic peptide system is sensitive to pulsatile GnRH stimulation: Insights into CNP/GC-B signalling in gonadotroph function
Samantha Mirczuk, Alice Catterick, Andrew Lessey, Rebecca Perrett, Craig McArdle, Imelda McGonnell, Robert Fowkes
P287
An evolution of clinical practice: the impact of new management strategies for non-functioning pituitary adenomas on long-term outcomes and pituitary function
Michael O'Reilly, Harriet Pearce, Gabriella Bugg, Rosalind Mitchell, Andy Toogood, Neil Gittoes, John Ayuk
P288
A case of Pancytopenia due to isolated ACTH deficiency successfully treated with Hydrocortisone
Shiva Mongolu, Rajamani Manikandan, Jana Bujanova, Azraai Nasruddin
P289
Comparison of acute and subacute pituitary tumour apoplexy
IOANNIS DIMITROPOULOS, LOUIS POBERESKIN, DANIEL FLANAGAN
P290
Newer Dopaminergic Agents Cause Minimal Endocrine Effects In Subjects With Idiopathic Parkinson's Disease
J Daniel, J Govindan, C Kamath, C De souza, M A Adlan, LD Premawardhana
P291
Chronic glucocorticoid exposure inhibits expression of the pomc activator, tpit, by inducing de-novo DNA methylation.
Georgia Bakirtzi, John Newell-Price
P292
Follow-up, surgery and proton beam therapy for a pituitary sella chondrosarcoma
Yasir Mohamed Elhassan, Bernie Foran, Tim Hodgson, Paul Ince, Saurabh Sinha, John Newell-Price
P293
Growth hormone excess of unknown origin
Agnieszka Falinska, Yong Yong Ling, Raj Tanday, Tanaz Vakilgilani, Jeannie F Todd
P294
Hypopituitarism from Hyderabad.
Raj Tanday, Agnieszka Falinska, David Woods, YongYong Ling, Tannaz Vakilgilani, Jeannie Todd
P295
Can 9am serum cortisol levels be used to predict patient’s response to the insulin tolerance test? N Kyriakakis, E Appleton, J Andrew, RD Murray. Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Nikolaos Kyriakakis, Elizabeth Appleton, Julie Andrew, Robert Murray
P296
The challenge of diagnosing Langerhan cell histiocytosis as the cause of a hypothalamic lesion presenting with diabetes insipidus  
Muditha Weerakkody, Saurabh Sinha, Richard Ross
P297
Just another ‘incidental finding'?
Sumithra Giritharan, Tara Kearney, Helen Doran, Kanna Gnanalingham
P298
Could GH deficiency exacerbate Insulinoma?
TANNAZ VAKILGILANI, RAJ TANDAY, DAVID WOODS, AGNIESZKA JEANNIE, YOUNGYOUNG LING, JEANNIE F TODD
P299
Pituitary Tuberculosis
Darshi Sivakumaran, Gideon Mlawa, Gul Bano
P300
Immunohistochemical features of PANCH tumour, a mixed pituitary adenoma/gangliocytoma - a rare cause of acromegaly. 
Leong Quah, Ute Pohl, Jonathan Pollock, James Ahlquist
P301
Sheehan’s syndrome – end of 15 years of hardship
Akshatha Taranath Kamath, Sampath Satish Kumar
P302
Primary Polydipsia in a family with a known mutation in the AVP gene
Ruth Casey, Anne marie Hannon, Caroline Joyce, Susan O'Connell, Domhnall O'Halloran
P303
Differential p120 isoform distribution and splicing regulator ESRP1 expression distinguishes sparsely and densely granulated somatotroph adenomas
Sarah Larkin, Olaf Ansorge
P304
Disordered sleep architecture is a common finding in acromegaly
Andrew S Powlson, Laksha Bala, Anand K Annamalai, Olympia Koulouri, Alison Webb, Samantha Moir, John M Shneerson, Mark Gurnell
P305
The effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women
Shakunthala Narayanaswamy, Channa Jayasena, Alexander Comninos, Sanjana Bhalla, Ali Abbara, Zainab Gainyu-Dada, Mark Busbridge, Mohammad Ghatei, Stephen Bloom, Waljit Dhillo
P306
One year Pituitary function follow-up in survivors of severe brain injury presenting at a regional neurosurgical centre.
Zaka Haq, Ioana Onac, Suad Elyas, Sarah Leeder, Trever Wheatley
P307
The incidence of Hypopituitarism in post interventional Subarachnoid Haemorrhage (SAH) survivors in a tertiary neurosurgical unit
Stephen J McGlynn, Joanna Cox, Sumi Giritharan, Kanna Gnanalingham, David Hughes, Russell Sheldrick, Tara M Kearney
P308
Inhibition of lipolysis improves peripheral and hepatic insulin sensitivity and restores first phase insulin response in patients with acromegaly
Stephen J McGlynn, Les Bluck, Burak Salgin, Peter J Trainer, Steve Williams, Claire E Higham
P309
Acromegaly in a treated prolactinoma
Funke Akiboye, Adam Nicholls, Triston Richardson
P310
The effect of somatostatin analogues on the hypothalamo-pituitary-thyroid axis and peripheral thyroid hormone dependent tissues in patients with thyrotropin secreting pituitary tumours.
Olympia Koulouri, Carla Moran, Andrew Powlson, Nagui Antoun, Heok Cheow, Andrew Hoole, David Halsall, Krishna Chatterjee, Mark Gurnell
P311
A medically managed pituitary tumour and ovarian tumours in a young female
Muditha Weerakkody, Prasad Katulanda
P312
Isolated 6th nerve palsy, a surprising complication of acromegaly.
Sriranaganath Akavarapu, Anna Pouncey, Ali Alexandra de Juniac, Jeremy Cox
P313
Optochiasmal cavernoma presenting with secondary hypogonadism- A case report
Rupa Ahluwalia, Muhammad Khan, Kumar Das, Ajay Sinha, Jiten Vora
P314
Analysis of the AIP gene promoter
Serban Radian, Peter King, Márta Korbonits
Reproduction
P315
Protective Role of Nigerian Honey on Sperm indices and Testis in Sucrose-fed rats
OLUWAKEMI OYELOWO, DANIEL ADEKUNBI, KAYODE DADA
P316
Effect of Bovine Somatotropin on Libido, Serum Testosterone, Hematology and Certain Biochemical Metabolites of Sahiwal Bulls
Ghulam Hussain Dilbar, Nazir Ahmad, Maqbool Ahmad, Ijaz Ahmad, Salman Waqas, Muhammad Younis
P317
Gestational Diabetes and Polycystic Ovary Syndrome
Christiana Georgiou, Helen Mason, Gul Bano
P318
PLANT MOLECULES QUERCETIN AND RESVERATROL CAN AFFECT OVARIAN CELLS AND INVERT FSH ACTION
Aneta Stochmalova, Attila Kadasi, Richard Alexa, Alexander Sirotkin
P319
Fetal glucocorticoid overexposure impacts on germline epigenetic reprogramming in the rat
Catherine M Rose, Sander van den Driesche, Ashley K Boyle, Thomas Chambers, Richard M Sharpe, Richard R Meehan, Amanda J Drake
P320
Post-endocytic sorting of the luteinizing hormone receptor is mediated by a novel APPL1 dependent mechanism
Silvia Sposini, Frederic Jean-Alphonse, Ashley Newcombe, Aylin Hanyaloglu
P321
Fertility and pregnancy outcomes for patients with polycystic ovary syndrome in the UK: a retrospective observational study
Christopher Morgan, Sara Jenkins-Jones, Aled Rees
P322
In the mouse ovary, AMH expression is independent of androgen physiology.
Marie Lebbe, Teresa Woodruff
P323
Interaction of androgen with insulin like growth factor signalling in preantral follicle development in the mouse ovary
Hina Jamall, Mhairi Laird, Kate Hardy, Stephen Franks
P324
Regulation of implantation by interaction between the IGF receptor (IGF1R) and miR-145
Miranda Lees, Youn-Jung Kang, Karen Forbes, John Aplin
P325
Renal anomalies in Kallmann syndrome, an uncommon association.
Preeti Chiran
P326
miR-145 is associated with placental growth in mice
Lisa Jones, Jayne Charnock, Karen Forbes
P327
Glial Cells Missing 1 (GCM1) transactivates the equine chorionic gonadotrophin beta (CGβ) promoter.
Victoria Cabrera-Sharp, Jordan Read, Phoebe Kitscha, Amelie Geddis, Judith Cartwright, Amanda de Mestre
P328
Hypoxia induces terminal differentiation of primary trophoblast cells in vitro.
Victoria Cabrera-Sharp, Jordan Read, Abir Mukherjee, Amanda de Mestre
P329
A rare cause of male infertility
Ahmed Imran Siddiqi, Ravi Menon
P330
Transforming Growth Factor-β (TGF-β) superfamily signalling and its role in the pathogenesis of heavy menstrual bleeding (HMB)
Jacqueline Maybin, Lyndsey Boswell, Colin Duncan, Hilary Critchley
P331
Effect of endometrial thickness on pregnancy outcome after intracytoplasmic sperm injection
Rehana Rehman, Syeda Sadia Fatima, Taseer Khan, Mehwish Hussain, Rakhshaan Khan
P332
Regulation of the LH/CG receptor signalling in human endometrium
Camilla West, Aylin Hanyaloglu, Jan Brosens, Stuart Lavery, Nick Panay
P333
Steroid Hormones Regulate Cyclical Expression of Osteopontin and CD44 in the Ovine Endometrium
Tina Tremaine, Mohammed Khalid, Claire Wathes, Ali Fouladi-Nashta
P334
Oestrogen Implant improves symptoms of hypogonadism and lipid profile in transwomen.
Ye Kyaw, Maricel Espina, Leighton Seal
P335
Testosterone implant therapy: efficacy and safety in transmen and native men with hypogondism
Ye Kyaw, Maricel Espina, Leighton Seal
P336
Elevation of HRPE773 (ZG16B) expression in amnion at term and in human ectocervical cell lines treated with inflammatory mediators is consistent with a function in innate immunity
Rachel Rachel Hayhurst, Nanette Hibbert, Lorraine Frew, Sarah Stock, Simon Riley, Steven Morley
P337
Maternal and cord blood serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3), in asymmetrically small for gestational age neonates
Amrit Gupta, Nisha Singh, Swasti Tiwari
P338
The melanocortin system in the male reproductive axis.
Monika Dowejko, Caroline Smith, Stephen Getting, Paul, R. Le Tissier, Joanne, F. Murray
P339
Hyperandrogenism secondary to ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor- A case report
Muhammad Khan, Rupa Ahluwalia, Susannah Shore, Alison Waghorn, Jiten Vora
P340
Two rare conditions in one patient: CAH and Fragile X
Ahmed Imran Siddiqi
Steroids
P341
Defining Contralateral Adrenal Suppression in Primary Aldosteronism: Implications for Diagnosis and Outcome
Gregory Kline, Valerian Dias, Benny So, Adrian Harvey, Janice Pasieka
P342
Monitoring outcomes in Congenital Adrenal Hyperplasia: have we been neglecting testosterone?
Naomi Sakai, Carlo Acerini
P343
A large retrospective audit of Adrenal Incidentalomas
Sviatlana Zhyzhneuskaya, Nora Wuerdemann, Sath Nag, Vijayaraman Arutchelvam, Simon Ashwell
P344
Biophenols-rich Pomegranate extract intake inhibits salivary cortisol and 11βHSD1 activity and improves overall quality of life scores in healthy volunteers
Angela Stockton, Emad Al-Dujaili
P345
Role of estrogen hormone in lipopolysaccharide – induced Alzheimer's disease in female rats; possible underlying mechanisms and modulation by progesterone hormone
O.M. Abdelwahed, M. Gamal, Z. Abdelwahab, M. Zickri, W. El Eraky, D.O. Saleh
P346
A rapid and sensitive LC-MS/MS method for the simultaneous analysis of testosterone, androstenedione, 17 OHP and DHEAS
Brian Keevil
P347
A case of recurrent, re-admissions with Severe Hyperemesis Gravidarum.
Pushpa Jinadev, Koshy Jacob
P348
The effect of green tea extracts on steroidogenesis, proliferation and apoptosis in ovarian granulosa cells.
Attila Kadasi, Nora Maruniakova, Adriana Kolesarova, Aneta Stochmalova, Richard Alexa, Roland Grossmann, Alexander, V. Sirotkin
P349
Hyperandrogenaemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
Michael O'Reilly, Angela Taylor, Nicola Crabtree, Beverly Hughes, Farfia Capper, Rachel Crowley, Paul Stewart, Jeremy Tomlinson, Wiebke Arlt
P350
Increased adipose AKR1C3 expression drives adipose androgen generation in women
Michael O'Reilly, Laura Gathercole, Wiebke Arlt, Jeremy Tomlinson
P351
High 11β-HSD1 activity is associated with progression to rheumatoid arthritis in patients first presenting with inflammatory arthritis.
Dominika Nanus, Andrew D. Filer, Lorraine Yeo, Dagmar Scheel-Toellner, Rowan Hardy, Gareth L. Lavery, Paul M. Stewart, Christopher D. Buckley, Mark S. Cooper, Karim Raza
P352
Urinary steroid profiling by Gas-Chromatography Mass-Spectrometry (GC-MS) is not helpful in the diagnosis of Cushing's Syndrome
Emma Johns, David Shapiro, Frances McManus, Marie Freel
P353
A novel UPLC-MS/MS method to extract and quantify sulphated and non-sulphated oestrogens automatically optimised using MUSCLE software  
Lorna Gilligan, James Bradbury, Angela Taylor, Shan He, Donna O'Neil, Mark Viant, Paul Foster
P354
Dexamethasone-related adrenal insufficiency in patients with solid brain tumours
Helen Currie, Muzzammil Ali
P355
Patient Education and Steroid Replacement Regimens in Adrenal Insufficiency.
Zana Ameen, Sadaf Ulnasah, Jo Rees, Lisa Shepherd, Andrew Bates, Asad Rahim
P356
Evaluating progesterone as a novel neuroprotective drug after ocular injury
ELEANOR MCCANCE, RICHARD BLANCH
P357
Steroid sulfatase contributes to systemic androgen activation in pre-pubertal boys – lessons from steroid sulfatase deficiency
Jan Idkowiak, Angela E Taylor, Donna M O'Neil, Sandra Subtil, Raymon Vijzelaar, Renuka P Dias, Rakesh Amin, Timothy G Barrett, Jeremy W Kirk, Cedric H L Shackleton, Celia Moss, Wiebke Arlt
P358
Glucocorticoid Receptor Interactome
Emyr Bakker, Kun Tian, James Andrews, Constantinos Demonacos, Jean-Marc Schwartz, Marija Krstic-Demonacos
P359
Does recurrent hypoglycaemia, a known activator of the HPA axis, alter the diurnal pattern of cortisol release?
Priya George, Alasdair Mackie, John Connell, Rory McCrimmon
P360
Systemic availability of placental growth factor correlates with urinary tetrahydroaldosterone excretion in normal and preeclamptic pregnancy.
Gemma Currie, Nicole Eisele, Heather Small, Genevieve Escher, Carine Gennari-Moser, David Carty, Markus Mohaupt, Delles Christian
P361
Endogenous androgen-mediated modulation of neointima formation is independent of the vascular androgen receptor
Junxi Wu, Patrick Hadoke, Iris Mair, Win Gel Lim, Eileen Millar, Laura Milne, Martin Denvir, Lee Smith
P362
An audit on the outcomes of bloodspot 17-OHP results on the management of patients with CAH
Erin Mozley, Simon Salter, Justin Davies, Annie Armston
P363
Androgen receptor over expression drives lipid accumulation in human hepatocytes.
Nikolaos Nikolaou, Maryam Nasiri, Laura Gathercole, Silvia Parajes Castro, Nils Krone, George Valsamakis, George Mastorakos, Jeremy Tomlinson
P364
Bioinformatic analysis of altered microRNA production in normal adrenal tissue and aldosterone-producing adenoma
Nur Izah Ab Razak, Louise Diver, Samantha Alvarez-Madrazo, Stacy Robertson, Martin McBride, Paul Stewart, John Connell, Scott MacKenzie, Eleanor Davies
P365
11C-metomidate PET-CT in primary hyperaldosteronism - a valuable alternative to AVS
Andrew S Powlson, Olympia Koulouri, Benjamin G Challis, HK Cheow, John Buscombe, Brendan Koo, Morris J Brown, Mark Gurnell
P366
Testosterone regulates glucose control in liver and muscle of Tfm mice as a mechanism to improve type 2 diabetes
Daniel Kelly, Samia Akhtar, Vakkat Muraleedharan, Donna Sellers, Johnathan Brooke, David McLaren, Hugh Jones
P367
The Endocrine Response to Severe Trauma: the Steroids and Immunity from injury to Rehabilitation (SIR) study
Mark Foster, Angela Taylor, Neil Hill, Rob Staruch, Donna O’Neil, Julian Bion, Stephen Young, Mark Midwinter, Janet Lord, Wiebka Arlt
P368
Glucocorticoid Activation in Muscle by 11β-Hydroxysteroid Dehydrogenase Type 1: Contributions to Inflammatory Muscle Wasting
Rowan Hardy, Gareth Lavery, Mark Pierson, Craig Doug, Andrew Filer, Christopher Buckley, Janet Lord, Paul Stewart, Mark Cooper, Karim Raza
P370
A very late and unusual presentation of congenital adrenal hyperplasia
Ahmad Abou-Saleh, Dennis Barnes, Masud Haq
P371
Enhanced expression of hepatic inflammatory markers in 11β-hydroxysteroid dehydrogenase type 1 knockout mice fed a steatogenic diet
Dean Larner, Stuart Morgan, Laura Gathercole, Maryam Nasiri, Philip Guest, Matthew Chapman, Jeremy Tomlinson, Paul Stewart, Gareth Lavery
P372
Cushing`s syndrome, missed in Pregnancy.
Koshy Jacob, Pushpa Jinadev
P373
Dutasteride and 5α-reductase type 1 activity: for androgens only?
Charles West, Royce Vincent, Norman Taylor
P374
Differential impact of PAPS synthases on human sulfation pathways
Jonathan W Mueller, Jan Idkowiak, Philip J House, Joane McNelis, Ian I Rose, Johannes van den Boom, Florian Schlereth, Vivek Dhir, Wiebke Arlt
P375
Increased lipopolysaccharide-induced neutrophilia in mice lacking the glucocorticoid receptor in bronchial epithelial (Clara) cells
Louise Kearney, Julie Gibbs, Stuart Farrow, David Ray, Andrew Loudon
P376
Blocking local glucocorticoid activation improves skin thinning and impaired healing in Cushingoid mice
Ana Tiganescu, Yoshikazu Uchida, Peter Elias, Walter Holleran
P377
Increased 11β-hydroxysteroid dehydrogenase type 1 activity in UVB-irradiated mice
Ana Tiganescu, Yoshikazu Uchida, Peter Elias, Walter Holleran
P378
The Prevention of Adrenal Crisis in Stress (PACS) Study: Serum cortisol during elective surgery and acute trauma in comparison to stress dose hydrocortisone in adrenal insufficiency.
Angela Taylor, Niki Karavitaki, Mark Foster, Sibylle Meier, Donna O'Neil, John Komninos, Dimitra Vassiliadi, Christopher Mowatt, Janet Lord, John Wass, Wiebke Arlt
Thyroid
P380
Suspected DVT after thyrotoxicosis
Rakhi Kakad, Munirul Haque, John Milles
P381
Post - operative thyroiditis:  An under recognised clinical phenomenon
Rashmi Manjunatha, DH Markham, Rajni Mahto
P382
Prevalence and Clinical Associations of Calcium-Sensing Receptor Autoantibodies in Finnish APECED Patients
Mahmoud Habibullah, Elizabeth H Kemp, Nicolas Kluger, Annamari Ranki, Harpreet K Sandhu, Kai J E Krohn, Anthony P Weetman
P383
Incidence of Sunitinib induced Thyroid dysfunction in renal cell carcinoma - a pilot retrospective audit
Sviatlana Zhyzhneuskaya, Leanna Erete, Justyna Czechowska, Wendy Anderson, Alison Humphreys, Sath Nag
P384
Mis-management of medullary thyroid carcinoma leads to investigation of a non existent phaechromocytoma
Christian Hariman, Lavanya Pelluri, Martin Weickert
P385
Investigating and treating Thyrotoxicosis.
Momin Shah, Simon Saunders
P386
Prevalence of thyroid dysfunction in patients with Rheumatoid Arthritis  
Loai Shakerdi, Wadah Haj Naema, Saied Hamdon
P387
Is there a need to change how we approach a patient with hyperthyroidism?
Lakshminarayanan Varadhan, Anney Altaf, George Varughese, Sailesh Sankar
P388
A rare cause of clinical hypothyroidism: Thyroid hormone resistance
Ram Prakash Narayanan, Preeti Chiran, Mohammad Al-Jubouri, Steven McNulty, Niall Furlong
P389
Radioiodine therapy for thyrotoxicosis over a 2 year period: an audit
Jennifer Clark, Ranganatha Rao, Prabir Bandyopadhyay, Parijat De
P390
Factors Contributing To High Levothyroxine Doses In Primary Hypothyroidism; An Interventional Audit Of A Large Community Database.
Hannah Robertson, Anil Narayanaswamy, Olivia Pereira, Shirley Copland, Richard Herriot, Alastair McKinlay, John Bevan, Prakash Abraham
P391
Anti-thyroid drugs as treatment for neutropenia in Graves' thyrotoxicosis
N Aggarwal, W Saqib, T Fretwell, G Summerfield, S Razvi
P392
A CASE OF NEWLY DIAGNOSED HYPERTHYROIDISM IN THE 25TH GESTATIONAL WEEK OF PREGNANCY PRESENTED WITH DIVERGENT ARTERIAL HYPERTENSION
Mateja Legan, Janez Zaveljcina, Simona Gaberscek
P393
Deafness and Goitre - Think Pendred
Jasvir Virdee, Russell Warwick, Ranganatha Rao, Robert Ryder, Parijat De
P394
PBF is a component of the molecular signalling pathways that drive hyperplastic and neoplastic thyroid growth
Vicki Smith, Martin Read, Rachel Watkins, Vikki Poole, Bhavika Modasia, Waraporn Imruetaicharoenchoke, Kristien Boelaert, Jayne Franklyn, Christopher McCabe
P395
Clinical outcome of radioiodine treatment for Graves’ disease at a tertiary care centre
Ali Rathore, Rammya Mathew, Anukul Garg, Mark Vanderpump
P396
A highly exaggerated response to Warfarin Therapy in a patient with Thyrotoxicosis
Tolulope Shonibare, Elizabeth Berkin, Bernard Chang, Ramzi Ajjan
P397
Examination of PTTG-Binding Factor (PBF) mRNA reveals functional miRNA target sites and exon-skipping splice variants in thyroid cells
Martin Read, Jo Longman, Alice Fletcher, Vicki Smith, Rachel Watkins, Bhavika Modasia, Vikki Poole, Waraporn Imruetaicharoenchoke, Jayne Franklyn, Kristien Boelaert, Christopher McCabe
P398
Neurocognitive and CNS abnormalities in humans with defective thyroid receptor alpha
Carla Moran, Edward Visser, Nadia Schoenmakers, Francesco Muntoni, Chris Clark, David Gadian, Kling Chong, Adam Kuczynski, Mehul Dattani, Faraneh Vargha-Khadem, Krishna Chatterjee
P399
Thyrotoxicosis: a district general hospital experience compared to guidelines
Emily Brown, Momin Shah, Pallavi Hegde, Simon Saunders
P400
A case of Hashimoto Encephalitis in a patient with severe autoimmune hypothyroidism
Jana Bujanova, Shiva Mongolu, Azraai Nasruddin
P401
The Diagnosis of Graves' disease: Diagnostic and management dilemmas
Lakshminarayanan Pichaipillai, Biswa Mishra
P402
Severe Transient Hyperthyroidism and Wernicke’s Encephalopathy in a Lady with Hyperemesis Gravidarum
Mehjabeen Beebeejaun, Susanna Meade, Emma Bingham, Frances Coyle, Jennifer Tringham
P403
Can a Radiological Scoring System for Assessing the Malignant Potential of Thyroid Nodules be Safely Applied in Clinical Practice?
Mark Lewis, Sunethra Ghattamaneni, Annice Mukherjee, Helen Doran
P404
Thyroid Nodules: Is one robust Thy2 result sufficient?
Jalini Joharatnam, Rose Ngu, Ash Chandra, Jake Powrie
P405
Scalp metastasis in follicular thyroid cancer; an atypical consequence
Anne marie Hannon, Frank O'Brien, Deirdre Fitzgerald, Antoinette Tuthill
P406
Hypoxic incubation favours the development and growth of primary human parathyroid adenoma cells
Kate E Lines, Mark Stevenson, Radu Mihai, Irina V Grigorieva, Dilair Baban, Katherine U Gaynor, Jeshmi Jeyabalan, Mahsa Javid, Rajesh V Thakker
P407
A mediastinal mass in a patient with thyrotoxicosis-recognising the association between Thymic hyperplasia and Graves' Disease.
David Bishop, Vikram Lal, Joanne Fletcher, Wael Elsaify, Satyajit Nag
P408
Thyrotoxic Cardiomyopathy
Haval Surchi, Usha Ayyagari
P409
Not to worry PET, it's not cancer!
Raj Tanday, Agnieszka Falinska, Tannaz Vakilgilani, YongYong Ling, Jeannie Todd
P410
PTEN Hamartoma Syndrome – Unravelling the Complexities of Childhood Surveillance
Harshini Katugampola, Sasha Howard, Jeremy Allgrove
P411
A rare case of papillary thyroid cancer arising from the ovary
venkata Katreddy, Harit Buch, Laura Pettit, Victor Oguntolu
P412
Are patients aware of the risk of agranulocytosis when taking antithyroid drugs?
Vincent Chau, Julie Andrew, Emma Ward, Ramzi Ajjan, Robert Murray
P413
Myxoedema Coma in a patient with Bipolar disorder   Jahagirdar VR, May CJ, Boelaert K 
Vidhya Jahagirdar, Christine May, Kristien Boelaert
P414
Audit of Thyroid Surgery Outcomes for Benign Thyroid Disease at West Hertfordshire Hospitals NHS Trust 2010-12
Sajini Wijetilleka, Edouard Mills, Ana Pokrajac, Julia Ostberg
P415
Correlation between thyrotoxicosis and hepatic dysfunction in out-patient's endocrine clinic- A single centre experience
victor oguntolu, Umaira Aziz, Rolli Allain, Rosseau gama
P416
A case of severe Hypothyroidism presenting with multi-organ failure
Eswari Chinnasamy, Andrew Rodin
P417
Alemtuzumab and Thyroid dysfunction in patients with Multiple Sclerosis - Experience in a University Hospital
Maneesh Udiawar, Hemanth Bolusani
P418
Consequences of an inadvertent iodine-rich diet, in previously definitively treated Graves' disease.  
Rebecca Shankland
P419
A Case of Myxoedema Coma and Malnutrition
Alexander Tattersall, Rajni Mahto, Rashmi Manjunatha, Jack Storrow
P420
Is there a difference in observed bone mineral density at diagnosis between overt and subclinical thyrotoxicosis.
Cathy McHugh, Paul Hession
P421
Treatment with a TRα1 antagonist increases bone mineral content
Julian A Waung, J H Duncan Bassett, Graham R Williams
P422
Neutrophil phagocytic capacity is lower in patients with abnormal thyroid function in critical illness
Emma Browne, John Simpson, Salman Razvi
P423
Autoimmune thyroid disease in the presence of Resistance to Thyroid Hormone or TSH-secreting pituitary tumour – a diagnostic challenge
Carla Moran, Olympia Koulouri, Fleur Talbot, Catherine Mitchell, Nadia Schoenmakers, Greta Lyons, Mark Gurnell, V.K.K Chatterjee
P424
Evaluation of calcitonin as a screening tool for medullary thyroid carcinoma in patients with nodular thyroid disease
Sivasujan Sivasubramaniyam, Roy Sherwood, Jackie Gilbert
P425
RET Mutation Negative Familial Medullary Thyroid Carcinoma: Four Families and Literature Review
Donato Iacovazzo, Patrick Morrison, William Foulkes, Douglas Ross, Francesca Lugli, Plamena Gabrovska, Emanuela Lucci-Cordisco, Giovanni Neri, Laura De Marinis, Marta Korbonits
P426
Small papillary thyroid carcinoma: a "benign" condition?
Ruxandra Dobrescu, Dumitru Ioachim, Anca Simioniuc, Corin Badiu, Andrei Goldstein
P427
Renal Function In Goitrous Patients Attending Endocrinology Clinic In A South Western Nigerian Hospital
Olubukola Ojo, Olalekan Ojo, Rosemary Ikem
P428
The influence of thyrotoxicosis on circulating cortisol and response to synacthen
Alex Chowdhury, Aziza Khanom, Tomas Agustsson, Sunita Sandhu, Arun Sankaralingam, Louise Breen, Jake Powrie, Stephen Thomas, Barbara McGowan
P429
Frequency of biochemical thyroid dysfunction in hospitalised patients: analysis of 280,000 admissions to a large centre.
Barbara Torlinska, Jamie Coleman, Mariam Afzal, Jayne Franklyn, Kristien Boelaert
P430
Pre-operative cytology vs post-operative histology in Thyroid nodules
Gurmit Gill, Paul Wilson, Karthik Kalyanasundaram, George Varughese, Lakshminarayanan Varadhan
Abstract Code Title Authors Affiliations Category
P1 Primary Hyperparathroidism in pregnancy Jehangir Abbas, Rudy Bilous Bone
P2 Primary hyperparathyroidism in pregnancy presenting as hyperemesis Rashmi Manjunatha, Jyothi Nippani, Deborah Markham, Rajni Mahto Bone
P3 The Utility of Bone Turnover Markers in Paget’s Disease of Bone Mark J Hannon, Isolda M Frizelle, Mark Kilbane, Malachi J McKenna Bone
P4 An audit of the clinical indications for initiating  Denosumab as a treatment for Osteoporosis in a secondary care clinic. Angela Collie, Khun Phyomaung, Menai Shahim, Stephen Gallacher, Andrew Gallagher, Fergus McLean, John Ahukannah, John Hinnie Bone
P5 Value of sequential 25-hydroxyvitamin D measurements prior to denosumab and zoledronic acid treatment Pushpa Singh, Neil Gittoes Bone
P6 Impact of vitamin D replacement in patients with primary hyperparathyroidism and co-existing vitamin D deficiency Gautam Das, Vinay Eligar, Jyothish Govindan, Stephen Davies Bone
P7 Monitoring the Bisphosphonate Treatment Holiday Clare Mumby, Shazli Azmi, Peter Selby, Katharine Hayden, Judith Adams Bone
P8 Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice Marie Pereira, Jeshmi Jeyabalan, Camilla Sofie Jørgensen, Mark Cleasby, Mark Hopkinson, Chantal Chenu Bone
P9 Pre-operative localisation studies in primary hyperparathyroidism: concordance with surgical findings and histology Edward McKeever, Robert Kennedy, Stephen Kirk, Roy Harper, Darren McLaughlin, C Mulligan, Tom Lynch, Clive Majury, CM McHenry Bone
P11 Unusual cause of Hypocalcemia Lavanya Pelluri, Christian Hariman, Narasimha Murthy Bone
P12 The influence of gender on the bone health of adolescent patients with hormonal deficiencies   Kerrie Grounds, Pamela Corlett, Aftab Ahmad, Pauline Whittingham Bone
P13 Mutational Analysis of the Adaptor Protein 2 Sigma Subunit (AP2S1) gene: Search for Autosomal Dominant Hypocalcaemia Type 3 (ADH3). Angela Rogers, M. Andrew Nesbit, Fadil M. Hannan, Sarah A. Howles, Treena Cranston, Jeremy Allgrove, John S. Bevan, Gul Bano, Caroline Brain, Vipan Datta, Shirley V. Hodgson, Louise Izatt, Lynne Millar-Jones, Simon H. Pearce, Lisa Robertson, Peter L. Selby, Brian Shine, Katie Snape, Justin Warner, Rajesh V. Thakker Bone
P14 Clinical studies of adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 reveal genotype-phenotype correlations and effectiveness of cinacalcet Fadil Hannan, Angela Rogers, Sarah Howles, Treena Cranston, Malachi McKenna, Tristan Richardson, Valerie Babinsky, Anita Reed, Clare Thakker, Detlef Bockenhauer, Rosalind Brown, Jacqueline Cook, Ken Darzy, Sarah Ehtisham, Una Graham, Tony Hulse, Steven Hunter, Dhavendra Kumar, John McKnight, Patrick Morrison Bone
P15 Identification of twelve Adaptor Protein-2 Sigma 2 Subunit (AP2σ) mutations in Familial Hypocalciuric Hypercalcaemia type 3 (FHH3) and expansion of phenotypic spectrum. Angela Rogers, Fadil M. Hannan, Sarah A. Howles, Treena Cranston, Clare E. Thakker, Detlef Bockenhauer, Rosalind Brown, Jacqueline A. Cook, Ken Darzy, Sarah Ehtisham, Tony Hulse, Dhavendra Kumar, Malachi McKenna, John McKnight, Zulf Mughal, Simon H. Pearce, Tristan Richardson, Isabelle Scheers, Timothy Wang, M. Andrew Nesbit Bone
P16 Role of cortisol in the pathogenesis of postmenopausal osteoporosis: relationship to bone structure Miguel Debono, Selina Bratherton, Margaret Paggiosi, Fatima Gossiel, Brian Keevil, Richard Ross, Richard Eastell Bone
P17 The calcilytic NPS2143 rectifies the gain-of-function associated with G-protein alpha 11 mutations causing autosomal dominant hypocalcaemia type 2 (ADH2) Valerie Babinsky, Fadil Hannan, M. Andrew Nesbit, Sarah Howles, Jianxin Hu, Allen Spiegel, Rajesh Thakker Bone
P18 Baseline Characteristics of Patients Presenting with Primary Hyperparathyroidism (PHPT) Alice Blackwell, Zana Ameen, Sarah Goellner, Abd Tahrani, Andrew Bates, Asad Rahim Heart of England NHS Foundation Trust, Birmingham Bone
P19 Treatment of Vitamin D Deficiency in Primary Hyperparathyroidism (PHPT) with Different Vitamin D Preparations Sarah Goellner, Zana Ameen, Alice Blackwell, Abd Tahrani, Andrew Bates, Asad Rahim Bone
P20 Is parathyroid hormone venous sampling useful? Correlation of parathyroid hormone selective venous sampling (PTHSVS) and histopathological results in patients who underwent parathyroidectomy between 2006-2013 Andrzej Rys, Robert Dyer, David Cunliffe, Simon Hickey, Richard Seymour Bone
P21 Predictors of postoperative hypocalcaemia in parathyroidectomy patients: Local audit. Venkata Katreddy, David Blundell, Harit Buch Bone
P22 A rare germline Leu63Pro missense mutation in CDC73 resulting in familial primary hyperparathyroidism with variable phenotype Khyatisha Seejore, Robert Murray, Stephen Orme, Afroze Abbas Bone
P23 HYPOGONADISM MASQUERADING AS METABOLIC BONE DISEASE IN AN YOUNG MALE Mallikarjuna Jeeragi, Arpandev Bhattacharyya, S Vidhyadhara, Karthik Prabhakar Bone
P24 Unusual parathyroid location- A case of primary hyperparathyroidism(PTHP) with failed right parathyroidectomy TANNAZ VAKILGILANI, YOUNGYOUNG LING, DAVID WOODS, AGNIESZKA FALINSKA, JEANNIE F TODD Bone
P25 Is the Response to high dose oral Vitamin D replacement predictable? Deepak Chandrajay, Marina Milic, Gwen Al-Khaili, Afroze Abbas, Stephen Orme Bone
P26 Functional read out of defective osteoclast function in an in vitro model of Gaucher's disease. Sarbjit Nijjar, Neil Gittoes, Tarekegn Geberhiwot Bone
P27 The diagnosis of osteoporosis among South Indian male and female subjects with low impact hip fracture and comparison between Indian Council of Medical Research (ICMR) and Caucasian Bone Mineral Density Databases NIHAL THOMAS, SAHANA SHETTY, NITIN KAPOOR, ASHA HS, DUKHABANDHU NAIK, VISALAKSHI P, THOMAS PAUL Bone
P28 Evaluation of a glucocorticoid-induced osteoporosis model using ImageJ Elda Pacheco-Pantoja, Francisco Arias-Garcia, Ximena Montes-de-Oca, Sergio Hernandez-Rosado, Luis Cab-Cesar, Brahim Rojano-Carrillo, Gustavo Rico-Toro Bone
P29 The worlds of Primary and Secondary Hyperparathyroidism often collide; What effect do variable regimens of supplementing Vitamin D have in primary hyperparathyroidism? Antonia Ugur, Emma Ward Bone
P30 An ectopic parathyroid adenoma presenting with reduced conscious level and severe hypertension Rediet Wiebel, Kimberley Lambert, Azraai Nasruddin Bone
P31 Effects of light at night and rotating shift on circadian pattern of neuroendocrine chronomolecules B Anjum, Narsingh Verma, Sandeep Tiwari, Ranjana Singh, Abbas Mahdi Clinical biochemistry
P32 Limitations of dexamethasone suppression tests for Cushing’s disease – a reminder! Emanuela Bejinariu, Shiu-Ching Soo, Ritwik Banerjee Clinical biochemistry
P33 Are we investigating and managing Hyponatremia in hospitalised patients properly: a re-audit Laura Pearson, Ranganatha Rao, Parijat De Clinical biochemistry
P34 A routine combined LC-MS/MS assay for male androgens Laura Owen, Brian Keevil Clinical biochemistry
P35 URINARY KISSPEPTIN AS A NOVEL MARKER OF PREGNANCY Alexander Comninos, Channa Jayasena, Shakunthala Narayanaswamy, Ali Abbara, Gurjinder Nijher, Mansimran Cheema, Zainab Malik, Mohammad Ghatei, Stephen Bloom, Waljit Dhillo Clinical biochemistry
P36 'The effects of climate on the incidence of thiazide diuretic induced hyponatraemia (TIH) in the UK'. Christopher Redford, Thomas Skinner, Andrzej Rys, Jamie Smith Clinical biochemistry
P37 Title: Generation of a long acting GCSF for treatment of neutropenia and stem cell harvest Abdulrahman Alshehri, Richard Ross, Ian Wilkinson Clinical biochemistry
P38 Hypercalcaemia referrals from primary care: A retrospective audit Negar Maghsoodi, Caje Moniz, Royce Vincent Clinical biochemistry
P39 Development of a LC-MS/MS method for the measurement of serum 17-hydroxyprogesterone during the follicular and luteal phases of the menstrual cycle Charlotte Hill, Andrew Davison Clinical biochemistry
P40 Audit on short synacthen test- are 30and 60 min samples necessary? Yasmeen Khalid, Edward Kearney, Stonny Joseph Clinical biochemistry
P41 A Comparison Of Calculated Bioavailable Testosterone With Calculated Free Testosterone In Males With Hypogonadism David Tesh, Timothy Davies, Miles Levy, Trevor Howlett Clinical biochemistry
P42 Urinary 3-Methoxytyramine as a biomarker of Phaeochromocytoma and Paraganglioma tumours Christina Neophytou, Sarah Darch, Jasdeep Singh Gill, Maggie Hancock, Karim Meeran, Fausto Palazzo, Tricia Tan Clinical biochemistry
P43 EVALUATION THE OF EFFICACY OF TRANSDERMAL DELIVERY OF CHLOROQUINE ON PLASMODIUM BERGHEI-INFECTED MALE SPRAGUE-DAWLEY RATS: EFFECTS ON BLOOD GLUCOSE AND RENAL ELECTROLYTE HANDLING Happiness Sibiya, Metse Serumula, Cephas T Musabayane Clinical biochemistry
P44 Measurement of dexamethasone by LC-MS/MS after a 1mg overnight dexamethasone suppression test. Miguel Debono, John Newell-Price, James Hawley, Brian Keevil Clinical biochemistry
P45 Serum 5HIAA: a better biomarker than urine for detecting and monitoring neuroendocrine tumours? Joanne Adaway, Rebecca Dobson, Jennifer Walsh, Daniel Cuthbertson, Philip Monaghan, Juan Valle, Brian Keevil Clinical biochemistry
P46 High testosterone? Look again! Tarig Babiker, Mandy Perry, Timothy McDonald, Antonia Brooke, John O'Connor Clinical biochemistry
P47 Vitamin D status in patients visiting a large teaching hospital Shaina Hirany, Mihail Firan, Ibrahim Hashim Clinical biochemistry
P48 Development of a whole blood assay for the LC-MS/MS measurement of 5-hydroxyindole acetic acid Suzanne Armitage, Joanne Adaway, Brian Keevil Clinical biochemistry
P49 Do we need method specific cortisol cut off limits for dynamic function tests? Kate Braha, Suzannah Phillips, John Dutton, Anna Milan Clinical biochemistry
P50 Reference ranges for salivary steroid measurement during short synacthen tests Rohan Shotton, Ilias Perogamvros, Brian Keevil, Philip Monaghan, Peter Trainer, Claire Higham Clinical biochemistry
P51 Hyponatraemia prior to discharge from hospital after a general medical admission is associated with a significantly increased risk of readmission within 28 days. Pratik Solanki, Benjamin Whitelaw, Christine Leong, John Miell, Simon Aylwin Clinical biochemistry
P52 Clinical Application of the Levothyroxine Absorption Test Muhammad Butt, Nidhi Gupta, Fiona Greenfield, Najeeb Waheed Clinical practice/governance and case reports
P53 Recurrent Hypomagnesaemia, tackling modifiable risk factors Moayed Alhelfi, Yared N Demssie Clinical practice/governance and case reports
P54 Thyrotoxicosis After Severe Hypothyroidism in a Patient With a History of Hodgkin’s Lymphoma And Neck Irradiation. Krzysztof Lewandowski, Katarzyna Dabrowska, Jacek Makarewicz, Andrzej Lewinski Clinical practice/governance and case reports
P55 Large testicular adrenal rest tumours in a patient with congenital adrenal hyperplasia: a consequence of poor drug compliance. JEYANTHY RAJKANNA, SO OYIBO Clinical practice/governance and case reports
P56 A case of precocious puberty in a 4 year old boy: differential diagnosis and treatment goals Ella-Grace Kirton Clinical practice/governance and case reports
P57 Fixed dose radioactive iodine treatment for hyperthyroidism - Experience of a district general hospital Rashmi Manjunatha, Katherine Harris, Sarfraz Nawaz, Rajni Mahto, Peter Horrocks Clinical practice/governance and case reports
P58 Investigation of inpatient hyponatraemia in a teaching hospital Ploutarchos Tzoulis, Devaki Nair, Rebecca Leyland, Emma Woolman, Nick Martin, Pierre Marc Bouloux Clinical practice/governance and case reports
P59 Unexpected  Adrenocortical Carcinoma 8yrs after Diagnosis of Adrenal Incidentaloma Mahender Yadagiri, David Barton Clinical practice/governance and case reports
P60 Characteristics, comorbidities and aetiology of hospitalised patients with hyponatraemia Ploutarchos Tzoulis, Pierre Marc Bouloux Clinical practice/governance and case reports
P61 Endocrine complications of Thalassemia and its treatment: a local experience Serena Deller, Radhika Mistry, Wyn Burbridge, Shivan Pancham, Christine Wright, Parijat De Clinical practice/governance and case reports
P62 Juvenile Granulosa Cell Tumour of the Ovary presenting with hyperprolactinaemic amenorrhoea and galactorrhoea. Ahmed Iqbal, Alexandra Lubina-Solomon, Jonathan Webster Clinical practice/governance and case reports
P63 Analysis of hyponatraemic inpatients who died in a teaching hospital Ploutarchos Tzoulis, Pierre Marc Bouloux Clinical practice/governance and case reports
P64 Elevated Hounsfield units and Large Tumour size on Radiological Imaging are both suggestive of Functionality in Incidental Adrenal Tumours. Dilip Abraham, Jadwiga Raasz, Edward Kearney, Stonny Joseph Clinical practice/governance and case reports
P65 Spontaneous Hypoglycaemia in a Non-Diabetic Patient with Insulin Antibodies Una Graham, Laura McQuillan, John Lindsay Clinical practice/governance and case reports
P66 Severe hypercalcaemia requiring emergency haemodialysis due to postpartum hypophysitis and thyroiditis Jing Mia Gao, Benjamin Whitelaw, Omar Mustafa, Salim Cheeroth Clinical practice/governance and case reports
P67 Parathyroid adenoma presenting solely as acute necrotising pancreatitis in an adolescent girl Mallikarjuna Jeeragi, Shabber Zaveri, Nagaraj Palankar, Karthik Prabhakar Clinical practice/governance and case reports
P68 Pseudo-secondary hyperparathyroidism due to vitamin D deficiency and coexisting familial hypocalciuric hypercalcaemia. Anna Louise Mitchell, Richard Bliss, Simon H S Pearce Clinical practice/governance and case reports
P69 An unusual cause and an unusual complication of Cushing’s Syndrome Zana Ameen, Rakhi Kakad, John Watkinson, Kristien Boelaert Clinical practice/governance and case reports
P70 Not every Gestational Diabetes is Mellitus! Zana Ameen Clinical practice/governance and case reports
P71 A rare endocrine cause of severe resistant hypoglycaemia Zana Ameen Clinical practice/governance and case reports
P72 Enigma of an 18 year Acromegalic Window: what your mind knows but eyes may still miss? Danielle Foucault, Parijat De Clinical practice/governance and case reports
P73 ADRENAL MASSES-A BLEEDING PROBLEM You-Jin Chang, Angela Alina Khan, Sobia Arshad, Ian Scobie Clinical practice/governance and case reports
P75 Stuttering Priapism Ahmed Imran Siddiqi Clinical practice/governance and case reports
P76 Recovery of adrenal function in confirmed Addison's Disease Mark Baxter, Sondra Gorick, Francesca Swords Clinical practice/governance and case reports
P77 Hypercalcaemia - a mixed family picture Leanne Hunt, Robert Robinson, Pallia Shillo, Treena Cranston, Rajesh Thakker Clinical practice/governance and case reports
P78 Severe Hypercalcaemia and Acute Kidney Injury secondary to Graves' thyrotoxicosis Thinzar Min, Lawrance Cozma, Silas Benjamin Clinical practice/governance and case reports
P79 Patient feedback on receiving copies of clinic correspondence Ram Prakash Narayanan, Preeti Chiran, Steven J McNulty, Upendram Srinivas Shankar, Niall Furlong Clinical practice/governance and case reports
P80 Carbimazole induced agranulocytosis: A case report in the setting of a young female, on low dose and duration of treatment of more than one year Hiang Leng Tan, Isy Douek Clinical practice/governance and case reports
P81 The patient with broken Heart. Alexandra Lubina Solomon, Ahmed Iqbal, Barney Harrison, Jonathan Webster, William Bennet Clinical practice/governance and case reports
P82 Do you know where the hypo box on the ward is? A revealing audit... Michelle Willmott Clinical practice/governance and case reports
P83 Plasma 25-hydroxycholecalciferol before and after supplementation in paediatric oncology patients from Scotland: a time-series cross-sectional study Raquel Revuelta Iniesta, Ilenia Paciarotti, Jane McKenzie, Mark Brougham, David Wilson Clinical practice/governance and case reports
P84 Long-term follow up of Patients Treated with Tolvaptan for resistant hyponatraemia Malik Asif Humayun, Rosina Elliot, Michael Cummings, Partha Kar, Darryl Meeking, Iain Cranston Clinical practice/governance and case reports
P85 A Rare Cause of Primary Adrenal Insufficiency Bethany Watt, Catrin Barwick, Catrin Searell, Tony Wilton Clinical practice/governance and case reports
P86 A Feminising Adrenocortical Carcinoma Bethany Watt, Sarah Wenham, Kakali Mitra, Avril Wayte, Tony Wilton Clinical practice/governance and case reports
P87 Look Before You Leap...  An Adrenal Mass and Elevated Metadrenalines May Not Be Phaeochromocytoma. Iona Galloway, Vincent McAulay, Stewart Ferguson Clinical practice/governance and case reports
P88 Is Demeclocycline safe and effective in the treatment of SIADH ? Shiva Mongolu, Azraai Nasruddin Clinical practice/governance and case reports
P89 Low dose tolvpatan (7.5 mg) is effective in the management of SIADH in oncology patients (results from a retrospective audit at The Christie Hospital and Wythenshawe Pulmonary Oncology Unit) Jennifer King, Angelos Kyriacou, Basil Issa, Paul Taylor, Claire Higham Clinical practice/governance and case reports
P90 Teriparatide infusion for post-thyroidectomy hypocalcaemia: a case report Khaliq Hamdan, Jawad Bashir, Ishrat Khan, Onyebuchi Okosieme, Neera Agarwal, Andrew Aldridge Clinical practice/governance and case reports
P91 KALLMANN SYNDROME, GENDER DYSPHORIA, THROMBOPHILIA AND MULTIPLE SCLEROSIS: A COMPLEX CASE REPORT Aniruthan Renukanthan, Richard Quinton, Ben Turner, Marta Korbonits Clinical practice/governance and case reports
P92 An audit of clinical follow up and management of adult patients with Turner's Syndrome at the Royal Devon & Exeter. Elizabeth Whittle, Mollie Donohoe, Antonia Brooke Clinical practice/governance and case reports
P93 Can a random cortisol predict outcome of Short Synacthen test in non-acute patients with low pre-test probability? Rajendran Bellan Kannan, Senthil Krishnasamy, Ananth Nayak, Biju Jose, Laks Varadhan Clinical practice/governance and case reports
P94 An unusual case of recurrent hypercalcaemia. Sleeping parathyroid hyperplasia? Una Graham, Fiona Eatock, Brew Atkinson Clinical practice/governance and case reports
P95 Hypokalaemia attributed to liquorice use - not Allsorted! Louise Hunter, Shailesh Agarwal, James Tymms, Sushmita Pearce Clinical practice/governance and case reports
P96 Pre clinic tests accelerate decision making, reduce delays in treatment and are highly popular with endocrinology patients and staff. Vidya Srinivas, Javier Gomez, Susan Kerry, Francesca Swords Clinical practice/governance and case reports
P97 Carbimazole-induced Antineutrophil Cytoplasmic Antibody (ANCA) positive vasculitis: A case report Kah Fai Wong, Harit Buch Clinical practice/governance and case reports
P98 Outcomes following pituitary surgery - a single centre audit Konstantinos Manolopoulos, Andrew S Bates, Amjad Shad, Assad Rahim Clinical practice/governance and case reports
P99 Hyperparathyroidism in early pregnancy: a case report Yong Yong Ling, Agnieszka Falinska, David Woods, Tannaz Vakilgilani, Raj Tanday, Jeannie Todd Clinical practice/governance and case reports
P100 Distinguishing between primary hyperparathyroidism and familial hypocalciuric hypercalcaemia - the role of genetic testing in patient with equivocal results Yong Yong Ling, Agnieszka Falinska, Tannaz Vakilgilani, Raj Tanday, Jeannie Todd Clinical practice/governance and case reports
P101 Efficacy and safety of  doxazosin in perioperative management of phaeochromocytoma . Gautam Das, James Clark, Benjamin Field, Sunil Zachariah Clinical practice/governance and case reports
P102 Are we appropriately referring patients for Short Synacthen Testing? Danielle Foucault, Sara Guthrie, Parijat De Clinical practice/governance and case reports
P103 The use of subcutaneous denosumab for cases of hypercalcaemia refractory to intravenous bisphosphonate therapy Muhammad Khan, Karen Perkins, Franklin Joseph Clinical practice/governance and case reports
P104 Localised Charcot of the Hallux Andrzej Rys, Tania Woodrow, Harvey Chant, Kim Farmer, Michael Butler, Duncan Browne Clinical practice/governance and case reports
P105 Phaeochromocytomas and Paragangliomas - A 20 year experience Anand Velusamy, Vanitha Karunakaran, David Kirtchuk, John Quin Clinical practice/governance and case reports
P106 Autoimmune adrenal insufficiency presenting as severe hypercalcaemia Matthew Carroll, Angelos Kyriacou, Tim Cooksley, Stephen McGlynn Clinical practice/governance and case reports
P107 Somatostatin analogue therapy with good biochemical response in a patient with Ectopic ACTH secretion due to high grade metastatic neuroendocrine tumour. Nidhi Choudhary, Tabinda Dugal, Steven Creely, Benjamin Hopwood, Duncan Browne Clinical practice/governance and case reports
P108 Improving the quality of endocrinology teaching to clinical medical students    Philippa Vega, Faye Gishen, Andrew Solomon Clinical practice/governance and case reports
P109 An audit into the screening tests used for Cushing’s Syndrome Mark Platt Clinical practice/governance and case reports
P110 testicular adrenal axis lymphoma Madhurima Vidyarthi, Awad Awad-Elkarim, Khalid Saja, Alison Brownell, Frederick Nkonge Clinical practice/governance and case reports
P111 A Rare Case of Cushing's Syndrome caused by ‘cyclical' Ectopic ACTH secretion Preeshila Behary, Raghunath Kadiyala, Agnieszka Falinska, Hannah Beckwith, James Jackson, Catherine Mitchell, Jeannie F Todd Clinical practice/governance and case reports
P112 Management of hyponatremia in secondary care Sophie Mescall, Amataullah Hashi, Polly Begum, Muhammad Ali Karamat Clinical practice/governance and case reports
P113 A case of severe hypercalcaemia Vilashini Arul Devah, Xiang Lee, Paul Turner, Vinutha Shetty, Komal Imtiaz, Simon Howell, Kalpana Kaushal Clinical practice/governance and case reports
P114 Baseline assessment of patients referred for ‘Metabolic surgery' : Managing the myriad of metabolic abnormalities Hafsa Imran, George Varughese, Chandra Cheruvu, Ananth Nayak, Emily Cooper, Lakshminarayanan Varadhan Clinical practice/governance and case reports
P115 Detecting Vitamin D Deficiency in South Asians: is a population or targeted method better? Samiul Mostafa, Kamlesh Khunti, Danielle Bodicoat, David Webb, Melanie Davies Clinical practice/governance and case reports
P116 Endocrinology in a District General Hospital; it’s not all thyroid disease. Emily Brown, Momin Shah, Simon Saunders Clinical practice/governance and case reports
P117 Polycythaemia is a common side-effect of testosterone therapy, regardless of treatment mode, and careful monitoring of haematological indices is required Rahila Bhatti, Belinda Grimmett, Maeve McCarthy, Tomas Agusttson, Barbara McGowan, Jake Powrie, Paul Carroll Clinical practice/governance and case reports
P118 Gastrinoma: Difficult to Diagnose Difficult to Treat Ahmed Imran Siddiqi Clinical practice/governance and case reports
P119 Severe hyponatraemia, hypokalaemia and associated seizure following the administration of sodium picosulfate/magnesium citrate (picolax) - a case report John Storrow, Urmar Raja Clinical practice/governance and case reports
P120 Bilateral Adrenal Hyperplasia - A Rare cause of Cushing's Syndrome in Children Akshatha Taranath Kamath, Shiny Goyal Mandliya, Sanjay Rao, Sampath Satish Kumar Clinical practice/governance and case reports
P121 Micrometastases in a paraganglioma Fareeda Tabassum, Belayat Hossain Clinical practice/governance and case reports
P122 Mitotane ameliorates testostoxicosis due to metastatic Leydig cell tumour Nicholas Johal, Michael Cullen, Peter Guest, Emilio Porfiri, Wiebke Arlt Clinical practice/governance and case reports
P123 Hypomagnesaemia during proton pump inhibitor therapy causing functional hypoparathyroidism Senthilkumar Krishnasamy, Vineet Abbott, Rajendran Bellan Kannan, George Varughese, Ananth Nayak, Laks Varadhan, Biju Jose Clinical practice/governance and case reports
P124 Anti-GAD ANTIBODY ENCEPHALITIS: A potentially treatable syndrome Senthilkumar Krishnasamy, George Varughese, Adnan Al-araji, Laks Varadhan, Ananth Nayak, Indira Natarajan, Biju Jose Clinical practice/governance and case reports
P125 Intravascular pituitary invasion by large B cell lymphoma is a rare cause of SIADH and hypopituitarism; a case report. Marc Aitken, Simeen Akhtar, Edward Jude Clinical practice/governance and case reports
P126 Double trouble - Pseudo-phaeochromocytoma in a patient with Adrenocortical Cancer Christine May, Vidhya Jahagirdar, Vasileios Chortis, David Jenkins, Wiebke Arlt, John Ayuk Clinical practice/governance and case reports
P127 Audit on investigations and diagnosis of hyponatremia in in-patients at a district general hospital NIRUTHIKA SITHAMPARNATHAN, REBECCA DOOLEY, ISHA MALIK Clinical practice/governance and case reports
P128 Three cases of octogenarians with Cushing's syndrome Jodie Sabin, Urvi Popli, John Gibson, Alex Kraus, Catrin Searell, Tony Wilton Clinical practice/governance and case reports
P129 Spontaneous hypoglycaemia induced by ACE-inhibitor: A case report Kah Fai Wong, Varadarajan Baskar, Rajeev Raghavan Clinical practice/governance and case reports
P130 The role of genetic analysis in the diagnosis of Familial Hypocalciuric Hypercalcaemia (FHH) Zana Ameen, Jayadave Shakher Clinical practice/governance and case reports
P131 Epidural abscess as a complication of infected diabetic foot ulcers: a case report. Marc Aitken, Abdelaziz Marzoug, Edward Jude Clinical practice/governance and case reports
P132 Alternating high and low TSH levels post subacute thyroiditis Marie-France Kong, Rafik Karmali Clinical practice/governance and case reports
P133 Pituitary apoplexy during a second pregnancy in a woman with prolactinoma Monica Livia Gheorghiu, Andra Caragheorgheopol, Anda Dumitrascu, Virgil Ionescu Clinical practice/governance and case reports
P134 Endocrine considerations in ever-improving HIV-related mortality outcomes - a clinical perspective Sarah Mensforth, Biju Jose, George Varughese, Neena Bodasing, Gurdeep Singh, Kieran Fernando Clinical practice/governance and case reports
P135 Next Generation Sequencing Approach for Molecular Genetic Diagnosis of Familial Partial Lipodystrophy NIHAL THOMAS, ASHA HS, AARON CHAPLA, MANIKA V., SHRINATH SHETTY Clinical practice/governance and case reports
P136 THE H SYNDROME & Next Generation Sequencing for Molecular Genetic Diagnosis NIHAL THOMAS, MAHESH D.M., AARON CHAPLA, ASHA HS, SHRINATH SHETTY, SAHANA SHETTY, LYDIA M, RENU GEORGE Clinical practice/governance and case reports
P137 Adrenal Incidentalomas, a district general hospital perspective. Brian Mtemererwa, Anne de Bray, Anne- Marie O'neill, Alice Webster, Halimah Alazzani, Priyo Sada, Diana Raskauskiene Clinical practice/governance and case reports
P138 Acute confusional state in the thyroid clinic - autoimmunity as a multi-edge knife Vasileios Chortis, Matthew Edmunds, Edward Littleton, Kristien Boelaert Clinical practice/governance and case reports
P139 Jumping the gun - an audit of adrenal biopsies in a tertiary referral centre  Vasileios Chortis, Kassiani Scordilis, Wiebke Arlt, Rachel Crowley Clinical practice/governance and case reports
P140 Is levothyroxine availability enhanced by grapes? Ishrat Khan, Andrew Aldridge, Ruhina Ahmed, Onyebuchi OE Clinical practice/governance and case reports
P141 Granulomatosis with Polyangiitis (GPA) presenting as a pituitary lesion Louise Christou, Mahesh Katreddy, Shouma Dutta, Sanjeet Kamath, Simon Shaw, Biju Jose Clinical practice/governance and case reports
P142 A case of hypoadrenalism Funke Akiboye, Adam Nicholls, Triston Richardson Clinical practice/governance and case reports
P143 Mayer-Rokitansky-Kuster-Hauser syndrome and Pituitary adenoma - a co-incidence? Rajendran Bellan Kannan, Ananth Nayak, Laks Varadhan, George Varughese, Biju Jose Clinical practice/governance and case reports
P144 Madness on the medical ward: ectopic ACTH producing tumour Amar Puttanna, Viraj Patel, Diana Raskauskiene, Richard Clayton Clinical practice/governance and case reports
P145 Training Needs in Adolescent Health and Transition in Paediatric and Adult trainees in Diabetes & Endocrinology in the UK Helena Gleeson, Rohana Wright, Rachel Besser, Kelly Cheer, Paul Dimitri, Simon Chapman, on behalf of AYASIG Clinical practice/governance and case reports
P146 Delayed hypocalcaemia following treatment of malignant hypercalcaemia with denosumab Amar Puttanna, Ahsan Khan, Noushad Padinjakara Clinical practice/governance and case reports
P147 Non Islet Cell Tumour Hypoglycaemia: management strategies for a rare and challenging condition Dhanya Kalathil, Simon Roughneen, Momin Shah, Ali Akram, Reza Zaidi, Tejpal Purewal, Aftab Ahmad, Philip Weston Clinical practice/governance and case reports
P148 Diabetes: The forgotten complication of parathyroidectomy Nantia Othonos, Vinod Patel, Rajiv Nair, Stephen Ayre, Ponnusamy Saravanan Clinical practice/governance and case reports
P149 Adrenocortical Carcinoma, where’s the delay? Aftab Aziz, Rob Dyer, Julie Dunn, Andy Goodman, Antonia Brooke Clinical practice/governance and case reports
P150 Tertiary hyperparathyroidism. A long term complication of pseudohypoparathyroidism type 1b? Justyna Witczak, Penelope Owen, Mike Page Clinical practice/governance and case reports
P151 Liraglutide as an effective therapeutic agent in a patient with Prader Willi Syndrome and type 2 diabetes. Justyna Witczak, Penelope Owen Clinical practice/governance and case reports
P152 Cushing's Disease with Hepatic Adrenal Rests Daniel Border, Saboor Aftab, Lavanya Pelluri, Thomas Barber, Harpal Randeva Clinical practice/governance and case reports
P153 The prevalence and mortality in Hospitalised Patients with Mild, Moderate and Severe Hyponatremia Jayadave Shakher, Nirav Gandhi, Lisa Shepherd, Christopher Pitt, Kamaljit Chatha Clinical practice/governance and case reports
P154 Profound hyponatraemia secondary to indapamide Julia Prague, Ben Zalin Clinical practice/governance and case reports
P155 Modelling hepatic encephalopathy in vitro: molecular and functional consequences of hyperammonaemia and C-type natriuretic peptide signalling in C6 glioma cells Samantha Mirczuk, Camille Robson, Emily Stacey, Robert Fowkes, Victoria Lipscomb Cytokines and growth factors
P156 Spatial Expression Profiling Reveals Tissue-Specific Sexual Dimorphism of the Natriuretic Peptide System in mice Samantha Mirczuk, Camille Robson, Benjamin Robinson, Andrew Lessey, Victoria Lipscomb, Imelda McGonnell, Robert Fowkes Cytokines and growth factors
P157 The remote organ effects of acute kidney injury in a porcine model Louise Dunford, David Gardner, Benjamin Duckworth, Saoirse O'Sullivan, Mark Devonald Cytokines and growth factors
P158 Novel Genes Influencing The Timing of Puberty Sasha Howard, Leo Guasti, Helen Storr, Lou Metherell, Anna Cariboni, Michael Barnes, Claudia Cabrera, Karoliina Wehkalampi, Leo Dunkel Growth and development
P159 Identification and characterisation of human foetal adrenocortical progenitor cells Jessica Sampson, David Wilson, Ita O'Kelly Growth and development
P160 Relationships between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) Thang Han, Roland Stimson, Aled Rees, Nils Krone, Debbie Willis, Gerard Conway, Wiebke Arlt, Brian Walker, Richard Ross Growth and development
P161 CUL7, OBSL1 and CCDC8 modulate alternative splicing of exon 11 of the insulin receptor gene Daniel Hanson, Graeme Black, Peter Clayton Growth and development
P163 C-type natriuretic peptide regulates growth and pituitary development in the zebrafish (Danio rerio) Andrew Lessey, Samantha Mirczuk, Imelda McGonnell, Robert Fowkes Growth and development
P164 Distinct gene expression is associated with epigenetic and growth related network modules in relation to gender differences in the timing of the pubertal growth spurt Chiara De Leonibus, Pierre Chatelain, Peter Clayton, Adam Stevens Growth and development
P165 Altered Frequency of Sequence Variants in Growth Related Genes in Children with Short Stature Philip Murray, Adam Stevens, Daniel Hanson, Andrew Whatmore, Mireille Bonnemarie, Laurent Naudin, Pascale Dutailly, Patrice Denefle, Peter Clayton Growth and development
P166 Differential effects of grazing and meal feeding on skeletal growth and femoral strength in male rats Thomas W Tilston, Anna L Hopkins, Richard C Brown, Bradley Arms-Williams, Sam L Evans, Timothy Wells Growth and development
P167 Calycosin suppresses breast cancer cell growth via ERβ-mediated inhibition of IGF-1R pathway jian chen, jing tian Neoplasia, cancer and late effects
P168 A Challenging Case of Hypokalaemic Cushing's Crisis  Mary Dunne, Andrew Solomon, Francesca Swords Neoplasia, cancer and late effects
P170 Comparison of HbA1c and oral glucose tolerance testing for the diagnosis of patients with and at risk of diabetes among long term bone marrow transplant survivors. Sowmya Gururaj, Victoria Cartwright, Samiul Mostafa, Ann Hunter, Helena Gleeson Neoplasia, cancer and late effects
P171 Neuroendocrine biomarkers change with treatment in small cell lung cancer Suzanne Meredith, Jennifer Bryant, Muhammad Babur, Philip Riddell, Kaye Williams, Anne White Neoplasia, cancer and late effects
P172 Late Presentation Predicts Endocrine Dysfunction in Patients with Langerhans Cell Histiocytosis. A Retrospective Analysis of the West Of Scotland LCH Service 1998-2012. Aishah Coyte, Dermot Murphy, Milind Dattatraya Ronghe, Jairam Sastry, Faisal Ahmed, Mohamad Guftar Shaikh Neoplasia, cancer and late effects
P173 The first reported mutations in the pituitary tumor-transforming gene (PTTG) binding factor (PBF) Waraporn Imruetaicharoenchoke, Martin Read, Joel Smith, Vicki Smith, Bhavika Modasia, Vikki Poole, Rachel Watkins, Franklyn Jayne, Kristien Boelaert, Christopher McCabe Neoplasia, cancer and late effects
P174 Bromodomain inhibitors reduce proliferation and increase apoptosis of human neuroendocrine tumour cells Kate E Lines, Mark Stevenson, Katherine U Gaynor, Paul J Newey, Sian E Piret, Hannah Lingard, Panagis Filippakopoulos, Susanne Muller, Simona Grozinsky-Glasberg, Ashley Grossman, Stefan Knapp, Chris Schofield, Chas Bountra, Rajesh V Thakker Neoplasia, cancer and late effects
P175 Adrenocortical cancer - rare but gloomy cause of adrenal lesions Agnieszka Falinska, Tanaz Vakilgilani, David Woods, Yong Yong Ling, Raj Tanday, Jeannie F Todd Neoplasia, cancer and late effects
P176 Metastatic paraganglioma with unknown genetics - to screen or not to screen the family? Agnieszka Falinska, Tanaz Vakilgilani, David Woods, Raj Tanday, Yong Yong Ling, Jeannie F Todd Neoplasia, cancer and late effects
P177 Clinical dilemmas in diagnosing pheochromocytoma Agnieszka Falinska, Tanaz Vakilgilani, Raj Tanday, Yong Yong Ling, Jeannie F Todd Neoplasia, cancer and late effects
P178 Inhibition of radioiodine uptake by PBF in breast cells is consistent with sodium iodide symporter repression in the thyroid Vikki Louise Poole, Martin Read, Rachel Watkins, Bhavika Modasia, Gavin Ryan, Kristien Boelaert, Jayne Franklyn, Vicki Smith, Christopher McCabe Neoplasia, cancer and late effects
P179 Expression Modulation of Tumour Necrosis Factor-alpha and Tumour Necrosis Factor Receptor-1 genes in Breast Cancer Cell Lines (MCF-7) by some selected Indigenous Cytotoxic Plants TITILOLA ADERONKE SAMUEL, BABATUNDE JAMES, OLUBUNMI ABIOLA MAGBAGBEOLA Neoplasia, cancer and late effects
P180 Characteristics of "foregut" carcinoid tumours occurring in multiple endocrine neoplasia type 1 (MEN1) Lisa Yang, Kirsty Mann, Julian Winceslaus, Roaid Khan, Scott Akker, Mona Waterhouse, William Drake, Maralyn Druce Neoplasia, cancer and late effects
P181 Inherited mutations in the SDH complex may increase metastatic malignant potential of paragnglioma and phaeochromocytoma tumours Bahram Jafar-Mohammadi, Louise Izatt, Klaus-Martin Schulte, Paul v Carroll, Barbara M McGowan, Jake K Powrie, Benjamin C Whitelaw, Debashis Sarker, Salvador Diaz-Cano, Simon JB Aylwin Neoplasia, cancer and late effects
P182 Pre-clinical assessment of the impact of Erlotinib on adrenocortical cancer cells proliferation Dorota Dworakowska, Dorota Dudka, Gregory Weitsman, Peter King, Harshini Katugampola, Márta Korbonits, Klaus-Martin Schulte, Salvador Diaz-Cano, Alan McGregor, Ashley B. Grossman, Simon Aylwin, Krzysztof Sworczak, Tony Ng Neoplasia, cancer and late effects
P183 Long-term negative effects in young cancer survivors: metabolic disorders in the patients after complex treatment for brain tumors and acute lymphoblastic leukemia in childhood and adolescence Tatiana Tselovalnikova, Maria Pavlova, Alexey Zilov, Nadezhda Mazerkina, Olga Zheludkova Neoplasia, cancer and late effects
P184 Diagnosis of adrenocortical carcinoma; Urinary steroid profiles measured by GC:MS Frances McManus, Jonathan Hannay, Patrick O'Dwyer, David Shapiro, Marie Freel Neoplasia, cancer and late effects
P185 A rare Adrenal Lieomyosarcome in a subject with lupus and the antiphospholipid syndrome IN Khan, A Guha, M A Adlan, M Stetchman, LD Premawardhana Neoplasia, cancer and late effects
P186 RET Genetic Screening in Patients with Multiple Endocrine Neoplasia type 2 and Medullary Thyroid Carcinoma: Experience of the Exeter Molecular Genetics Laboratory Martina Owens, Bijay Vaidya, Sian Ellard Neoplasia, cancer and late effects
P187 MIBG-Avidity in Genetically Distinct Phaeochromocytoma and Paraganglioma Populations Ross Jack, Robert Lindsay, Nicola Bradshaw, Marie Freel, Colin Perry Neoplasia, cancer and late effects
P188 SDHB surveillance regime - a single UK institution experience Umasuthan Srirangalingam, Fazia Khan, Kirun Gunganah, Anju Sahdev, Mona Waterhouse, Maralyn R Druce, William M Drake, Scott A Akker Neoplasia, cancer and late effects
P189 Multiple endocrine neoplasia type 2A in a large family with a C620G mutation of the RET proto-oncogene: Diagnostic, treatment and ethical challenges. Rajeev Raghavan, Venkata Katreddy, L Leiw, A Garnham, R Gama, P Strouhal, H Buch, A Viswanath, BM Singh Neoplasia, cancer and late effects
P190 An incidental diagnosis... Irfan Khan, Paul Lambert Neoplasia, cancer and late effects
P191 ATR kinase function is modulated by the proto-oncogene PBF Hanna Fan, Teresa Gagliano, Martin L Read, Jayne A Franklyn, Kristien Boelaert, Andrew S Turnell, Christofer J McCabe Neoplasia, cancer and late effects
P192 Steroid Group Education: Developing a Curriculum Ensures Good Nursing Practice is maintained. Jean Munday Nursing practice
P193 Time taken for Growth Hormone (GH) -treated adolescent patients transitioning to adult services, to reach IGF-1 levels within the upper normal range. Do we need to monitor more frequently? Kerrie Grounds, Mohammed Didi, Pamela Corlett, Pauline Whittingham, Aftab Ahmad Nursing practice
P194 Life, death and modern technology - an update Fiona Anthonypillai Nursing practice
P195 Introduction of a protocol and endocrine specialist nurse ward visits in the management of hyponatraemia. Rhianne Mason, Charlotte Forbes, Seren Williams, Timothy McDonald, Antonia Brooke Nursing practice
P196 Optimal Vitamin D treatments in Coeliac patients Nicci Komlosy, Caroline Jagger Nursing practice
P197 Integration of a new drug into clinical Practice and enhancing the patient experience Caroline Jagger Nursing practice
P198 Emergency hydrocortisone kits - Assessment of knowledge & skills of patients & family. Lisa Shepherd, Sadaf Ulnasah, Asad Rahim, Jayadave Shakher, Andrew Bates Nursing practice
P199 The effect of L-cysteine on appetite in humans Anjali Amin, Amy Agahi, Niamh Martin, Mohamed Ghatei, Steve Bloom, Kevin Murphy Obesity, diabetes, metabolism and cardiovascular
P200 Analysis of serum FTO level and related factors in obese and T2DM patients Jianjin Guo, Wei Ren, Jie Liu, Weiping Jia Obesity, diabetes, metabolism and cardiovascular
P201 Associations between regional body fat distribution and homocysteine levels in type 2 diabetes with coronary atherosclerosis patients Wei Ren, Jianjin Guo, Jie Liu Obesity, diabetes, metabolism and cardiovascular
P202 An opinion survey in Eastern Ghana: health behaviours and knowledge of diabetes in diagnosed diabetes mellitus type 2 patients. Gemma Buston Obesity, diabetes, metabolism and cardiovascular
P203 EFFECTS OF TRANSDERMALLY DELIVERED INSULIN ON SOME SELECTED METABOLIC PARAMETERS OF STREPTOZOTOCIN-INDUCED DIABETIC MALE SPRAGUE-DAWLEY RATS Silindile I Hadebe, Phikelelani S Ngubane, Metse R Serumula, Cephas T Musabayane Obesity, diabetes, metabolism and cardiovascular
P204 "EARLY INSULIN THERAPY-A NEW TREATMENT APPROACH FOR TYPE-2 DIABETES MELLITUS WITH GLYCOSYLATED HAEMOGLOBIN MORE THAN 7% (HbA1c > 7 %)" Harshitbhai patel Obesity, diabetes, metabolism and cardiovascular
P205 Cross-sectional survey of depression and anxiety in a clinical diabetes population: prevalence and role in blood sugar control Hammad Lakhani, Isobel Cane, Michelle Taylor, Paul Chadwick, Miranda Rosenthal Obesity, diabetes, metabolism and cardiovascular
P206 Dark chocolate rich in polyphenols improves insulin sensitivity in the adult non diabetic population Grace Farhat Obesity, diabetes, metabolism and cardiovascular
P207 Effect of H.gordonii on regulatory peptides under short term calorie restriction Swati Jain, SomNath Singh Obesity, diabetes, metabolism and cardiovascular
P208 Abnormal glucocorticoid metabolism in horses with metabolic syndrome. Ruth Morgan, Patrick Hadoke, Brian Walker, John Keen Obesity, diabetes, metabolism and cardiovascular
P209 An Audit of patients with Diabetes attending Accident and Emergency with Severe Hypoglycaemia Tolulope Shonibare, Khyatisha Seejore, Robert Moisey Obesity, diabetes, metabolism and cardiovascular
P210 Predictive clinical variables for periodontitis in Type 2 diabetic subjects with poor glycemic control. Jai karthik, Shajithanoop Selva kumar, Suresh kumar, M.V Usha rani Obesity, diabetes, metabolism and cardiovascular
P211 Impacts of the serum testosterone on the metabolic syndrome in Chinese young and middle-agd men with type 2 diabetes mellitus Xin Li, Miao Yang, Su-xing Sun, Yu-wen Wu, Jia-zhong Sun Obesity, diabetes, metabolism and cardiovascular
P212 Metabolic improvement after bariatric surgery: An overview from a single tertiary centre Abigail Barrett, Saloni Bakhshi, Ananth Nayak, George Varughese, Chandra Cheruvu, Lakshminarayanan Varadhan Obesity, diabetes, metabolism and cardiovascular
P213 Renal function variation after bariatric surgery: Which measurement do we rely on? Saloni Bakhshi, Abigail Barrett, Ananth Nayak, George Varughese, Chandra Cheruvu, Lakshminarayanan Varadhan Obesity, diabetes, metabolism and cardiovascular
P214 Chemerin as a potential screening marker for sub-clinical diabetes? Syeda Sadia Fatima, Najeeha Talat Iqbal Obesity, diabetes, metabolism and cardiovascular
P215 The Salt-Inducible Kinases: Gatekeeper of Hepatic Gluconeogenesis Kashyap Patel, Marc Foretz, David Campbell, Calum Sutherland, Kei Sakamoto Obesity, diabetes, metabolism and cardiovascular
P216 Maturity Onset Diabetes of Young type 5 Ahmed Imran Siddiqi Obesity, diabetes, metabolism and cardiovascular
P217 Obstructive Sleep Apnoea Syndrome (OSAS) and Type 2 Diabetes (T2D) Katy Talbot, Peter Evans, Melissa Hack Obesity, diabetes, metabolism and cardiovascular
P218 Young women with polycystic ovary syndrome have increased concentrations of circulating annexin V-positive microparticles derived predominantly from platelets Gareth Willis, Katherine Connolly, Kristin Ladell, Kelly Miners, David Price, Irina Guschina, Aled Clayton, Philip James, Aled Rees Obesity, diabetes, metabolism and cardiovascular
P219 Quality improvement for patients with type 2 diabetes Finn Edler von Eyben Obesity, diabetes, metabolism and cardiovascular
P220 Central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS but are associated with insulin resistance and abdominal obesity Rosie Coulson, Emma Rees, Frank Dunstan, Julian Halcox, Alan Fraser, Aled Rees Obesity, diabetes, metabolism and cardiovascular
P221 An Evaluation of Knowledge and Understanding of HbA1c in Diabetes Patients in a Secondary Care setting Caroline Bowler, Ruth Erde, Parijat De Obesity, diabetes, metabolism and cardiovascular
P222 Joint Predictability of Physical Activity and Bodyweight on Health-Related Quality of Life among Nigerian Type 2 Diabetes Kolade Idowu Obesity, diabetes, metabolism and cardiovascular
P223 A 3 month low fat diet leads to significant lipid profile improvement in obese T2DM Saudi subjects, without substantial weight loss, and the capacity to manage a damaging high fat meal challenge more appropriately post intervention Dara Al-Disi, Nasser Al-Daghri, Nasiruddin Khan, Mohammad Alsaif, Assim Alfadda, Shaun Sabico, Gyanendra Tripathi, Philip McTernan Obesity, diabetes, metabolism and cardiovascular
P225 Outcomes of bariatric surgery in men versus women: a matched observational cohort analysis Andrew Kennedy-Dalby, Basil Ammori, Akheel Syed Obesity, diabetes, metabolism and cardiovascular
P226 Meal size and frequency influences metabolic endotoxaemia and inflammatory risk but has no effect on diet induced thermogenesis in either lean or obese subjects Milan Piya, Narendra Reddy, Alison Campbell, John Hattersley, Louise Halder, Gyanendra Tripathi, Abd Tahrani, Thomas Barber, Sudhesh Kumar, Philip McTernan Obesity, diabetes, metabolism and cardiovascular
P227 Screening and diagnosis of gestational diabetes: impact of  age,  BMI and adipokines Rym-Ikram MEHAOUDI, Hanane OUSSEKHRI, Yacine SOLTANI, Djouhra TAMDRARI, Hafida BENDAOUD, Zohra HAMOULI, Zohra NIBOUCHA, Fatima HADJ BEKKOUCHE Obesity, diabetes, metabolism and cardiovascular
P229 The effects of treatment with Liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls Hassan Kahal, Ahmed Aburima, Tamas Ungvari, Alan Rigby, Anne-Marie Coady, Rebecca Vince, Ramzi Ajjan, Eric Kilpatrick, Khalid Naseem, Stephen Atkin Obesity, diabetes, metabolism and cardiovascular
P230 MINERAL NUTRIENTS AND METABOLIC HEALTH: DATA ON NIGERIAN LOCAL DISHES. AYODELE MORAKINYO, TITILOLA SAMUEL, OLUFEYI ADEGOKE Obesity, diabetes, metabolism and cardiovascular
P231 EZH2 regulates responses of endothelial cells under hypoxia and during tissue regeneration following limb ischemia Tijana Mitić, Micol Marchetti, Marco Meloni, Andrea Caporali, Costanza Emanueli Obesity, diabetes, metabolism and cardiovascular
P232 High Incidence of Cardiac Involvement in Patients Diagnosed with Phaeochromocytoma: A Clinical Study Using Cardiovascular Magnetic Resonance Imaging Vanessa Ferreira, Mafalda Rodrigues, Stefan Piechnik, Claudia Marini, Theodoros Karamitsos, Jane Francis, Ranjit Arnold, Radu Mihai, Julia Thomas, Maria Herincs, Marta Korbonits, Zaki Hassan-Smith, Wiebke Arlt, Niki Karavitaki, Ashley Grossman, Stefan Neubauer, John Wass Obesity, diabetes, metabolism and cardiovascular
P233 Microparticle profile in patients with type 2 diabetes Judit Konya, Leigh A Madden, Thozhukat Sathyapalan, Eric S Kilpatrick, Stephen L Atkin Obesity, diabetes, metabolism and cardiovascular
P234 Expression of GLP-1 receptors throughout the mouse brain using a novel transgenic mouse model Simon C Cork, Frank Reimann, Fiona M Gribble, Stefan Trapp Obesity, diabetes, metabolism and cardiovascular
P235 Novel syndromes of hypoinsulinaemic, hypoketotic hypoglycaemia Sarah Leiter, Marina Minic, Victoria Parker, Julie Harris, Julian Hamilton-Shield, Rachel Williams, Eckhard Korsch, Khalid Hussain, Robert Semple Obesity, diabetes, metabolism and cardiovascular
P236 The characteristics of a patient population with extreme and complex obesity attending a specialist weight management service Wen Bun Leong, Peymane Adab, Neil G Thomas, Shahrad Taheri Obesity, diabetes, metabolism and cardiovascular
P237 COFFEE ATTENUATES INDUCTION OF INSULIN RESISTANCE IN HIGH SUCROSE-DIET  FED RATS. Ayodele Morakinyo, Daniel Adekunbi, Kayode Dada, Olufeyi Adegoke Obesity, diabetes, metabolism and cardiovascular
P238 Systemic triglycerides as a key determinant of TLR regulated inflammatory risk in human adipose tissue post bariatric surgical intervention and weight loss. Warunee Kumsaiyai, Nasser Al-Daghri, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Thomas Barber, Sudhesh Kumar, Gyanendra Tripathi, Philip McTernan Obesity, diabetes, metabolism and cardiovascular
P239 Upregulation of AKR1C3 expression by insulin in a human differentiated preadipocyte cell line Philip House, Michael O'Reilly, Laura Gathercole, Jeremy Tomlinson Obesity, diabetes, metabolism and cardiovascular
P240 The outcome results in patients with type 2 diabetes mellitus and obesity after either adjustable gastric banding (AGB) or Roux-en-Y (RNY) gastric bypass Andrzej Rys, Tabinda Dugal Obesity, diabetes, metabolism and cardiovascular
P241 Diabetes in pregnancy and birth weight (BW): Differential effects due to ethnicity in a real-life observational study James Wilson, Hema Venkataraman, Jessica Cheong, Nithya Sukumar, Kamlesh Khunti, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P242 Evolutionary conserved novel targets of NGN3, located on the short arm of chromosome 20, may have a role in the development of the endocrine pancreas. Oluwafikunayo Orekoya, Andrew Berry, Neil Hanley Obesity, diabetes, metabolism and cardiovascular
P243 Decreased brain 11β-HSD1 expression following inflammation; a role in regulating brain energy homeostasis ? Manu Verma, Zhenguang Zhang, Annie Mackellar, Jonathan Seckl, Megan Holmes, Karen Chapman Obesity, diabetes, metabolism and cardiovascular
P244 Capillary blood glucose monitoring and ambulatory peritoneal dialysis: reassuring the patient Waiel Bashari, Samson Oyibo Obesity, diabetes, metabolism and cardiovascular
P245 Case report - the role of somatostatin analogue therapy in nesidioblastosis following Roux-en-Y bypass surgery. Rajamani Manikandan, Shiva Mongolu, Azraai Nasruddin Obesity, diabetes, metabolism and cardiovascular
P246 Impact of chronic heart failure on adipose tissue functional plasticity: a role for fatty acids? Andrew Yale, Malcolm Cobb, Alexander Lyon, Alison Mostyn Obesity, diabetes, metabolism and cardiovascular
P247 Maternal metabolic adaptations in pregnancy are associated with altered circadian rhythmicity Georgia Papacleovoulou, Vanya Nikolova, Olayiwola Oduwole, Malcolm Parker, Catherine Williamson Obesity, diabetes, metabolism and cardiovascular
P249 Derivatisation of estrogens enhances specificity and sensitivity of analysis by liquid chromatography tandem mass spectrometry Abdullah MM Faqehi, Diego F Cobice, Gregorio Naredo, Tracy CS Mak, Brian R Walker, Natalie ZM Homer, Ruth Andrew Obesity, diabetes, metabolism and cardiovascular
P250 Virally delivered target-specific optogenetic stimulation of PPG neurons in the nucleus of the solitary tract James E Richards, Simon C Cork, Marie Holt, Frank Reimann, Fiona M Gribble, Stefan Trapp Obesity, diabetes, metabolism and cardiovascular
P251 METFORMIN AND ACUTE KIDNEY INJURY (AKI): IS IT THE CULPRIT? Phey Shen Lee, Jonathan Donald Mackay Obesity, diabetes, metabolism and cardiovascular
P252 The role of glucocorticoid metabolism in bile acid homeostasis Monica Naomi Opiyo, Geneviève Escher, Christopher Kenyon, Jonathan Seckl, Ruth Andrew, Karen Chapman Obesity, diabetes, metabolism and cardiovascular
P253 Gitelman Syndrome Veneranda Lorelei Salazar, Komal Imtiaz, Tamsin Rimmer, Arwa Amijee Obesity, diabetes, metabolism and cardiovascular
P255 Serum ferritin levels are correlated with total adiposity, but not BMI in obese males M.Gulrez Zariwala, Ania Kosicka, Richard Mackenzie, Derek Renshaw Obesity, diabetes, metabolism and cardiovascular
P256 Ventricular dysfunction in the new born Secondary to Maternal Vitamin D Deficiency Sampath Satish Kumar, Akshatha Taranath Kamath Obesity, diabetes, metabolism and cardiovascular
P257 Contribution of Hepatic Liver X Receptor to the Adaptations in Maternal Lipid Metabolism During Pregnancy Vanya Nikolova, Shadi Abu-Hayyeh, Georgia Papacleovoulou, Malcolm Parker, Catherine Williamson Obesity, diabetes, metabolism and cardiovascular
P258 High serum amylase a contraindication to GLP1 analogue treatment? Karolina Stepien, Anne-Marie Kelly, Graham Horsman, Naveed Younis Obesity, diabetes, metabolism and cardiovascular
P259 Decrums disease; an unusual case of bilateral adrenal lipomas Anne marie Hannon, Lisa Owens, Domhnall O'Halloran Obesity, diabetes, metabolism and cardiovascular
P260 Longitudinal changes in glucocorticoid metabolism predict the development of metabolic phenotype Rachel Crowley, Beverly Hughes, Joanna Gray, Theresa McCarthy, Susan Hughes, Cedric Shackleton, Nicola Crabtree, Peter Nightingale, Paul Stewart, Jeremy Tomlinson Obesity, diabetes, metabolism and cardiovascular
P262 Elevated cord leptin from low B12 mothers predicts birth weight Adaikala Antonysunil, Manu Vatish, Alexander Lawson, Catherine Wood, Kavitha Sivakumar, Craig Webster, Neil Anderson, Philip McTernan, Gyanendra Tripathi, Ponnusamy Saravanan Obesity, diabetes, metabolism and cardiovascular
P263 Renalase a key regulator of Brown Adipose Tissue Activity. Manjunath Ramanjaneya, Bee Tan, Vanlata Patel, Jiamiao Hu, Hendrik Lehnert, Edward Hillhouse, Jing Chen, Harpal Randeva Obesity, diabetes, metabolism and cardiovascular
P264 Bariatric surgery for hypothalamic obesity: Case Series Report Ye Kyaw, Robert Mayo, Gul Bano Obesity, diabetes, metabolism and cardiovascular
P265 Depletion of glucose-6-phosphate transporter impacts SR calcium homeostasis in muscle. Craig Doig, Agnieszka Zielinska, Rachel Fletcher, Emma McCabe, Gareth Lavery Obesity, diabetes, metabolism and cardiovascular
P266 Breaking NAD+: Investigating NMRK2 as a regulator of muscle adaptation through NAD+ salvage Craig Doig, Agnieszka Zielinska, Rachel Fletcher, Emma McCabe, Andrew Philp, Gareth Lavery Obesity, diabetes, metabolism and cardiovascular
P267 11beta HSD1KO mice resist aged associated decline in markers of brown adipose tissue function Emma McCabe, Craig Doig, Stuart Morgan, Dean Larner, Jeremy Tomlinson, Paul Stewart, Gareth Lavery Obesity, diabetes, metabolism and cardiovascular
P268 H6PDH deficiency in muscle impacts amino acid metabolism Agnieszka Zielinska, Craig Doig, Paul Stewart, Jerzy Adamski, Gareth Lavery Obesity, diabetes, metabolism and cardiovascular
P269 Unfolded protein response in adipose tissue of obese diabetic women significantly improved six months post bariatric surgery, irrespective of malabsorptive or bypass operation type and correlates with plasma glucose concentration Philip Voyias, Adaikala Antonysunil, Warunee Kumasaiyai, Ioannis Kyrou, Jana Vrbikova, Vojtech Hainer, Martin Fried, Petra Sramkova, Ponnusamy Saravanan, Sudhesh Kumar, Philip McTernan, Gyanendra Tripathi Obesity, diabetes, metabolism and cardiovascular
P270 Does TCF7L2 Polymorphisms increase the risk of Gestational Diabetes Mellitus in South Indian population? NIHAL THOMAS, MAHESH D.M., AARON CHAPLA, JOHAN PAUL, SHWETHA N, FLORY CHRISTINA, ASHA HS Obesity, diabetes, metabolism and cardiovascular
P271 Evaluating beta-hydroxybutyrate (BOHB) as indicator for early termination of 72 hours fast for spontaneous hypoglycaemia Octavian-Ionut Cozar, Sondra Gorick, Anupam Brahma, Francesca Swords Obesity, diabetes, metabolism and cardiovascular
P272 Liver fibrosis is common in Alstrom Syndrome and can be identified using non-invasive tests Jonathan Hazlehurst, Matthew Armstrong, Jayne Hodgkiss, Rachel Crowley, Tarekegn Geberhiwot, Phillip Newsome, Jeremy Tomlinson Obesity, diabetes, metabolism and cardiovascular
P273 Familial Adult Hyperinsulinism due to Genetic Glucokinase Activation:Implications for Therapeutic Use of Glucokinase Activators B.G. Challis, J. Harris, A. Sleigh, S.M. Orme, N. Seevaratnam, K. Dhatariya, H.L. Simpson, R.K. Semple Obesity, diabetes, metabolism and cardiovascular
P274 Metabolic Pathway Analysis in Choline and Methionine Deficient Mice: New Insights into the Mechanism of Steatosis and Insulin Resistance. Marcus Lyall, Jonathan Manning, Jennifer Hunter, Steve Anderton, Richard Meehan, Amanda Drake Obesity, diabetes, metabolism and cardiovascular
P275 Evaluation of a crude extract administration of Cnidoscolus chayamansa in normal and diabetic Wistar rats Francis Echeverría-Bobadilla, Andrea Ceballos-Arana, Daniel Sanchez-Ruz, Elda Pacheco-Pantoja Obesity, diabetes, metabolism and cardiovascular
P276 A pathway to investigate and manage patients complaining of symptoms suggestive of hypoglycaemia post Roux-en-Y Gastric Bypass Surgery (RYGB) George Tharakan, Harvinder Chahal, Alex Miras, Preeshila Behary, Sanjay Purkayastha, Sherif Hakky, Jo Boyle, Candace Bovril-Taylor, Asta Julnaite, Sarah Allen, Jonathan Cousins, Krishna Moorthy, Ahmed Ahmed, Tricia Tan Obesity, diabetes, metabolism and cardiovascular
P277 Proliferative Retinopathy in Pregnancy after Bariatric Surgery. Helen Dobson, Chitra Raj, Alia Munir Obesity, diabetes, metabolism and cardiovascular
P278 Therapeutic durability of the GLP1-based therapy Liraglutide in patients with Type 2 Diabetes Mellitus Daniel Border, Puja Thadani, Joseph Reed, Harpal Randeva, Thomas Barber Obesity, diabetes, metabolism and cardiovascular
P279 An unusual cause of pituitary apoplexy Preeshila Behary, Gareth Townsey, Amrish Mehta, Karim Meeran Pituitary
P280 Pituitary metastasis from CLL - an extremely rare case Kirthika Jeyaraman, Rashmi Kaushal Pituitary
P281 Painful Third Nerve Palsy Caused by Primary Pituitary Lymphoma Associated with Apoplectic Pituitary Adenoma Luke Pickup, Adrian Jennings Pituitary
P282 Lack of Fpr2/Fpr3 receptors alters the structure and function of pituitary corticotrophs  Maria Mahmood, Helen Christian Pituitary
P283 A Deficit of Dystrophin 71 leads to disorder in vasopressin and oxytocin production in the magnocellular neurons Roza Benabdesselam, Latifa Dorbani-Mamine, Alvaro Rendon, Hélène Hardin-Pouzet Pituitary
P284 The Effect of Pregnancy on Hyperprolactinaemia:  A 5-year retrospective observational study. Vani Shankaran, Emma Ward Pituitary
P285 Diabetes insipidus in Erdheim-Chester disease Nishant Ranjan, V P Sumathi, Zayd Merza Pituitary
P286 The gonadotroph natriuretic peptide system is sensitive to pulsatile GnRH stimulation: Insights into CNP/GC-B signalling in gonadotroph function Samantha Mirczuk, Alice Catterick, Andrew Lessey, Rebecca Perrett, Craig McArdle, Imelda McGonnell, Robert Fowkes Pituitary
P287 An evolution of clinical practice: the impact of new management strategies for non-functioning pituitary adenomas on long-term outcomes and pituitary function Michael O'Reilly, Harriet Pearce, Gabriella Bugg, Rosalind Mitchell, Andy Toogood, Neil Gittoes, John Ayuk Pituitary
P288 A case of Pancytopenia due to isolated ACTH deficiency successfully treated with Hydrocortisone Shiva Mongolu, Rajamani Manikandan, Jana Bujanova, Azraai Nasruddin Pituitary
P289 Comparison of acute and subacute pituitary tumour apoplexy IOANNIS DIMITROPOULOS, LOUIS POBERESKIN, DANIEL FLANAGAN Pituitary
P290 Newer Dopaminergic Agents Cause Minimal Endocrine Effects In Subjects With Idiopathic Parkinson's Disease J Daniel, J Govindan, C Kamath, C De souza, M A Adlan, LD Premawardhana Pituitary
P291 Chronic glucocorticoid exposure inhibits expression of the pomc activator, tpit, by inducing de-novo DNA methylation. Georgia Bakirtzi, John Newell-Price Pituitary
P292 Follow-up, surgery and proton beam therapy for a pituitary sella chondrosarcoma Yasir Mohamed Elhassan, Bernie Foran, Tim Hodgson, Paul Ince, Saurabh Sinha, John Newell-Price Pituitary
P293 Growth hormone excess of unknown origin Agnieszka Falinska, Yong Yong Ling, Raj Tanday, Tanaz Vakilgilani, Jeannie F Todd Pituitary
P294 Hypopituitarism from Hyderabad. Raj Tanday, Agnieszka Falinska, David Woods, YongYong Ling, Tannaz Vakilgilani, Jeannie Todd Pituitary
P295 Can 9am serum cortisol levels be used to predict patient’s response to the insulin tolerance test? N Kyriakakis, E Appleton, J Andrew, RD Murray. Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Nikolaos Kyriakakis, Elizabeth Appleton, Julie Andrew, Robert Murray Pituitary
P296 The challenge of diagnosing Langerhan cell histiocytosis as the cause of a hypothalamic lesion presenting with diabetes insipidus   Muditha Weerakkody, Saurabh Sinha, Richard Ross Pituitary
P297 Just another ‘incidental finding'? Sumithra Giritharan, Tara Kearney, Helen Doran, Kanna Gnanalingham Pituitary
P298 Could GH deficiency exacerbate Insulinoma? TANNAZ VAKILGILANI, RAJ TANDAY, DAVID WOODS, AGNIESZKA JEANNIE, YOUNGYOUNG LING, JEANNIE F TODD Pituitary
P299 Pituitary Tuberculosis Darshi Sivakumaran, Gideon Mlawa, Gul Bano Pituitary
P300 Immunohistochemical features of PANCH tumour, a mixed pituitary adenoma/gangliocytoma - a rare cause of acromegaly.  Leong Quah, Ute Pohl, Jonathan Pollock, James Ahlquist Pituitary
P301 Sheehan’s syndrome – end of 15 years of hardship Akshatha Taranath Kamath, Sampath Satish Kumar Pituitary
P302 Primary Polydipsia in a family with a known mutation in the AVP gene Ruth Casey, Anne marie Hannon, Caroline Joyce, Susan O'Connell, Domhnall O'Halloran Pituitary
P303 Differential p120 isoform distribution and splicing regulator ESRP1 expression distinguishes sparsely and densely granulated somatotroph adenomas Sarah Larkin, Olaf Ansorge Pituitary
P304 Disordered sleep architecture is a common finding in acromegaly Andrew S Powlson, Laksha Bala, Anand K Annamalai, Olympia Koulouri, Alison Webb, Samantha Moir, John M Shneerson, Mark Gurnell Pituitary
P305 The effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women Shakunthala Narayanaswamy, Channa Jayasena, Alexander Comninos, Sanjana Bhalla, Ali Abbara, Zainab Gainyu-Dada, Mark Busbridge, Mohammad Ghatei, Stephen Bloom, Waljit Dhillo Pituitary
P306 One year Pituitary function follow-up in survivors of severe brain injury presenting at a regional neurosurgical centre. Zaka Haq, Ioana Onac, Suad Elyas, Sarah Leeder, Trever Wheatley Pituitary
P307 The incidence of Hypopituitarism in post interventional Subarachnoid Haemorrhage (SAH) survivors in a tertiary neurosurgical unit Stephen J McGlynn, Joanna Cox, Sumi Giritharan, Kanna Gnanalingham, David Hughes, Russell Sheldrick, Tara M Kearney Pituitary
P308 Inhibition of lipolysis improves peripheral and hepatic insulin sensitivity and restores first phase insulin response in patients with acromegaly Stephen J McGlynn, Les Bluck, Burak Salgin, Peter J Trainer, Steve Williams, Claire E Higham Pituitary
P309 Acromegaly in a treated prolactinoma Funke Akiboye, Adam Nicholls, Triston Richardson Pituitary
P310 The effect of somatostatin analogues on the hypothalamo-pituitary-thyroid axis and peripheral thyroid hormone dependent tissues in patients with thyrotropin secreting pituitary tumours. Olympia Koulouri, Carla Moran, Andrew Powlson, Nagui Antoun, Heok Cheow, Andrew Hoole, David Halsall, Krishna Chatterjee, Mark Gurnell Pituitary
P311 A medically managed pituitary tumour and ovarian tumours in a young female Muditha Weerakkody, Prasad Katulanda Pituitary
P312 Isolated 6th nerve palsy, a surprising complication of acromegaly. Sriranaganath Akavarapu, Anna Pouncey, Ali Alexandra de Juniac, Jeremy Cox Pituitary
P313 Optochiasmal cavernoma presenting with secondary hypogonadism- A case report Rupa Ahluwalia, Muhammad Khan, Kumar Das, Ajay Sinha, Jiten Vora Pituitary
P314 Analysis of the AIP gene promoter Serban Radian, Peter King, Márta Korbonits Pituitary
P315 Protective Role of Nigerian Honey on Sperm indices and Testis in Sucrose-fed rats OLUWAKEMI OYELOWO, DANIEL ADEKUNBI, KAYODE DADA Reproduction
P316 Effect of Bovine Somatotropin on Libido, Serum Testosterone, Hematology and Certain Biochemical Metabolites of Sahiwal Bulls Ghulam Hussain Dilbar, Nazir Ahmad, Maqbool Ahmad, Ijaz Ahmad, Salman Waqas, Muhammad Younis Reproduction
P317 Gestational Diabetes and Polycystic Ovary Syndrome Christiana Georgiou, Helen Mason, Gul Bano Reproduction
P318 PLANT MOLECULES QUERCETIN AND RESVERATROL CAN AFFECT OVARIAN CELLS AND INVERT FSH ACTION Aneta Stochmalova, Attila Kadasi, Richard Alexa, Alexander Sirotkin Reproduction
P319 Fetal glucocorticoid overexposure impacts on germline epigenetic reprogramming in the rat Catherine M Rose, Sander van den Driesche, Ashley K Boyle, Thomas Chambers, Richard M Sharpe, Richard R Meehan, Amanda J Drake Reproduction
P320 Post-endocytic sorting of the luteinizing hormone receptor is mediated by a novel APPL1 dependent mechanism Silvia Sposini, Frederic Jean-Alphonse, Ashley Newcombe, Aylin Hanyaloglu Reproduction
P321 Fertility and pregnancy outcomes for patients with polycystic ovary syndrome in the UK: a retrospective observational study Christopher Morgan, Sara Jenkins-Jones, Aled Rees Reproduction
P322 In the mouse ovary, AMH expression is independent of androgen physiology. Marie Lebbe, Teresa Woodruff Reproduction
P323 Interaction of androgen with insulin like growth factor signalling in preantral follicle development in the mouse ovary Hina Jamall, Mhairi Laird, Kate Hardy, Stephen Franks Reproduction
P324 Regulation of implantation by interaction between the IGF receptor (IGF1R) and miR-145 Miranda Lees, Youn-Jung Kang, Karen Forbes, John Aplin Reproduction
P325 Renal anomalies in Kallmann syndrome, an uncommon association. Preeti Chiran Reproduction
P326 miR-145 is associated with placental growth in mice Lisa Jones, Jayne Charnock, Karen Forbes Reproduction
P327 Glial Cells Missing 1 (GCM1) transactivates the equine chorionic gonadotrophin beta (CGβ) promoter. Victoria Cabrera-Sharp, Jordan Read, Phoebe Kitscha, Amelie Geddis, Judith Cartwright, Amanda de Mestre Reproduction
P328 Hypoxia induces terminal differentiation of primary trophoblast cells in vitro. Victoria Cabrera-Sharp, Jordan Read, Abir Mukherjee, Amanda de Mestre Reproduction
P329 A rare cause of male infertility Ahmed Imran Siddiqi, Ravi Menon Reproduction
P330 Transforming Growth Factor-β (TGF-β) superfamily signalling and its role in the pathogenesis of heavy menstrual bleeding (HMB) Jacqueline Maybin, Lyndsey Boswell, Colin Duncan, Hilary Critchley Reproduction
P331 Effect of endometrial thickness on pregnancy outcome after intracytoplasmic sperm injection Rehana Rehman, Syeda Sadia Fatima, Taseer Khan, Mehwish Hussain, Rakhshaan Khan Reproduction
P332 Regulation of the LH/CG receptor signalling in human endometrium Camilla West, Aylin Hanyaloglu, Jan Brosens, Stuart Lavery, Nick Panay Reproduction
P333 Steroid Hormones Regulate Cyclical Expression of Osteopontin and CD44 in the Ovine Endometrium Tina Tremaine, Mohammed Khalid, Claire Wathes, Ali Fouladi-Nashta Reproduction
P334 Oestrogen Implant improves symptoms of hypogonadism and lipid profile in transwomen. Ye Kyaw, Maricel Espina, Leighton Seal Reproduction
P335 Testosterone implant therapy: efficacy and safety in transmen and native men with hypogondism Ye Kyaw, Maricel Espina, Leighton Seal Reproduction
P336 Elevation of HRPE773 (ZG16B) expression in amnion at term and in human ectocervical cell lines treated with inflammatory mediators is consistent with a function in innate immunity Rachel Rachel Hayhurst, Nanette Hibbert, Lorraine Frew, Sarah Stock, Simon Riley, Steven Morley Reproduction
P337 Maternal and cord blood serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3), in asymmetrically small for gestational age neonates Amrit Gupta, Nisha Singh, Swasti Tiwari Reproduction
P338 The melanocortin system in the male reproductive axis. Monika Dowejko, Caroline Smith, Stephen Getting, Paul, R. Le Tissier, Joanne, F. Murray Reproduction
P339 Hyperandrogenism secondary to ovarian hyperthecosis masked by concurrent use of an aromatase inhibitor- A case report Muhammad Khan, Rupa Ahluwalia, Susannah Shore, Alison Waghorn, Jiten Vora Reproduction
P340 Two rare conditions in one patient: CAH and Fragile X Ahmed Imran Siddiqi Reproduction
P341 Defining Contralateral Adrenal Suppression in Primary Aldosteronism: Implications for Diagnosis and Outcome Gregory Kline, Valerian Dias, Benny So, Adrian Harvey, Janice Pasieka Steroids
P342 Monitoring outcomes in Congenital Adrenal Hyperplasia: have we been neglecting testosterone? Naomi Sakai, Carlo Acerini Steroids
P343 A large retrospective audit of Adrenal Incidentalomas Sviatlana Zhyzhneuskaya, Nora Wuerdemann, Sath Nag, Vijayaraman Arutchelvam, Simon Ashwell Steroids
P344 Biophenols-rich Pomegranate extract intake inhibits salivary cortisol and 11βHSD1 activity and improves overall quality of life scores in healthy volunteers Angela Stockton, Emad Al-Dujaili Steroids
P345 Role of estrogen hormone in lipopolysaccharide – induced Alzheimer's disease in female rats; possible underlying mechanisms and modulation by progesterone hormone O.M. Abdelwahed, M. Gamal, Z. Abdelwahab, M. Zickri, W. El Eraky, D.O. Saleh Steroids
P346 A rapid and sensitive LC-MS/MS method for the simultaneous analysis of testosterone, androstenedione, 17 OHP and DHEAS Brian Keevil Steroids
P347 A case of recurrent, re-admissions with Severe Hyperemesis Gravidarum. Pushpa Jinadev, Koshy Jacob Steroids
P348 The effect of green tea extracts on steroidogenesis, proliferation and apoptosis in ovarian granulosa cells. Attila Kadasi, Nora Maruniakova, Adriana Kolesarova, Aneta Stochmalova, Richard Alexa, Roland Grossmann, Alexander, V. Sirotkin Steroids
P349 Hyperandrogenaemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. Michael O'Reilly, Angela Taylor, Nicola Crabtree, Beverly Hughes, Farfia Capper, Rachel Crowley, Paul Stewart, Jeremy Tomlinson, Wiebke Arlt Steroids
P350 Increased adipose AKR1C3 expression drives adipose androgen generation in women Michael O'Reilly, Laura Gathercole, Wiebke Arlt, Jeremy Tomlinson Steroids
P351 High 11β-HSD1 activity is associated with progression to rheumatoid arthritis in patients first presenting with inflammatory arthritis. Dominika Nanus, Andrew D. Filer, Lorraine Yeo, Dagmar Scheel-Toellner, Rowan Hardy, Gareth L. Lavery, Paul M. Stewart, Christopher D. Buckley, Mark S. Cooper, Karim Raza Steroids
P352 Urinary steroid profiling by Gas-Chromatography Mass-Spectrometry (GC-MS) is not helpful in the diagnosis of Cushing's Syndrome Emma Johns, David Shapiro, Frances McManus, Marie Freel Steroids
P353 A novel UPLC-MS/MS method to extract and quantify sulphated and non-sulphated oestrogens automatically optimised using MUSCLE software   Lorna Gilligan, James Bradbury, Angela Taylor, Shan He, Donna O'Neil, Mark Viant, Paul Foster Steroids
P354 Dexamethasone-related adrenal insufficiency in patients with solid brain tumours Helen Currie, Muzzammil Ali Steroids
P355 Patient Education and Steroid Replacement Regimens in Adrenal Insufficiency. Zana Ameen, Sadaf Ulnasah, Jo Rees, Lisa Shepherd, Andrew Bates, Asad Rahim Steroids
P356 Evaluating progesterone as a novel neuroprotective drug after ocular injury ELEANOR MCCANCE, RICHARD BLANCH Steroids
P357 Steroid sulfatase contributes to systemic androgen activation in pre-pubertal boys – lessons from steroid sulfatase deficiency Jan Idkowiak, Angela E Taylor, Donna M O'Neil, Sandra Subtil, Raymon Vijzelaar, Renuka P Dias, Rakesh Amin, Timothy G Barrett, Jeremy W Kirk, Cedric H L Shackleton, Celia Moss, Wiebke Arlt Steroids
P358 Glucocorticoid Receptor Interactome Emyr Bakker, Kun Tian, James Andrews, Constantinos Demonacos, Jean-Marc Schwartz, Marija Krstic-Demonacos Steroids
P359 Does recurrent hypoglycaemia, a known activator of the HPA axis, alter the diurnal pattern of cortisol release? Priya George, Alasdair Mackie, John Connell, Rory McCrimmon Steroids
P360 Systemic availability of placental growth factor correlates with urinary tetrahydroaldosterone excretion in normal and preeclamptic pregnancy. Gemma Currie, Nicole Eisele, Heather Small, Genevieve Escher, Carine Gennari-Moser, David Carty, Markus Mohaupt, Delles Christian Steroids
P361 Endogenous androgen-mediated modulation of neointima formation is independent of the vascular androgen receptor Junxi Wu, Patrick Hadoke, Iris Mair, Win Gel Lim, Eileen Millar, Laura Milne, Martin Denvir, Lee Smith Steroids
P362 An audit on the outcomes of bloodspot 17-OHP results on the management of patients with CAH Erin Mozley, Simon Salter, Justin Davies, Annie Armston Steroids
P363 Androgen receptor over expression drives lipid accumulation in human hepatocytes. Nikolaos Nikolaou, Maryam Nasiri, Laura Gathercole, Silvia Parajes Castro, Nils Krone, George Valsamakis, George Mastorakos, Jeremy Tomlinson Steroids
P364 Bioinformatic analysis of altered microRNA production in normal adrenal tissue and aldosterone-producing adenoma Nur Izah Ab Razak, Louise Diver, Samantha Alvarez-Madrazo, Stacy Robertson, Martin McBride, Paul Stewart, John Connell, Scott MacKenzie, Eleanor Davies Steroids
P365 11C-metomidate PET-CT in primary hyperaldosteronism - a valuable alternative to AVS Andrew S Powlson, Olympia Koulouri, Benjamin G Challis, HK Cheow, John Buscombe, Brendan Koo, Morris J Brown, Mark Gurnell Steroids
P366 Testosterone regulates glucose control in liver and muscle of Tfm mice as a mechanism to improve type 2 diabetes Daniel Kelly, Samia Akhtar, Vakkat Muraleedharan, Donna Sellers, Johnathan Brooke, David McLaren, Hugh Jones Steroids
P367 The Endocrine Response to Severe Trauma: the Steroids and Immunity from injury to Rehabilitation (SIR) study Mark Foster, Angela Taylor, Neil Hill, Rob Staruch, Donna O’Neil, Julian Bion, Stephen Young, Mark Midwinter, Janet Lord, Wiebka Arlt Steroids
P368 Glucocorticoid Activation in Muscle by 11β-Hydroxysteroid Dehydrogenase Type 1: Contributions to Inflammatory Muscle Wasting Rowan Hardy, Gareth Lavery, Mark Pierson, Craig Doug, Andrew Filer, Christopher Buckley, Janet Lord, Paul Stewart, Mark Cooper, Karim Raza Steroids
P370 A very late and unusual presentation of congenital adrenal hyperplasia Ahmad Abou-Saleh, Dennis Barnes, Masud Haq Steroids
P371 Enhanced expression of hepatic inflammatory markers in 11β-hydroxysteroid dehydrogenase type 1 knockout mice fed a steatogenic diet Dean Larner, Stuart Morgan, Laura Gathercole, Maryam Nasiri, Philip Guest, Matthew Chapman, Jeremy Tomlinson, Paul Stewart, Gareth Lavery Steroids
P372 Cushing`s syndrome, missed in Pregnancy. Koshy Jacob, Pushpa Jinadev Steroids
P373 Dutasteride and 5α-reductase type 1 activity: for androgens only? Charles West, Royce Vincent, Norman Taylor Steroids
P374 Differential impact of PAPS synthases on human sulfation pathways Jonathan W Mueller, Jan Idkowiak, Philip J House, Joane McNelis, Ian I Rose, Johannes van den Boom, Florian Schlereth, Vivek Dhir, Wiebke Arlt Steroids
P375 Increased lipopolysaccharide-induced neutrophilia in mice lacking the glucocorticoid receptor in bronchial epithelial (Clara) cells Louise Kearney, Julie Gibbs, Stuart Farrow, David Ray, Andrew Loudon Steroids
P376 Blocking local glucocorticoid activation improves skin thinning and impaired healing in Cushingoid mice Ana Tiganescu, Yoshikazu Uchida, Peter Elias, Walter Holleran Steroids
P377 Increased 11β-hydroxysteroid dehydrogenase type 1 activity in UVB-irradiated mice Ana Tiganescu, Yoshikazu Uchida, Peter Elias, Walter Holleran Steroids
P378 The Prevention of Adrenal Crisis in Stress (PACS) Study: Serum cortisol during elective surgery and acute trauma in comparison to stress dose hydrocortisone in adrenal insufficiency. Angela Taylor, Niki Karavitaki, Mark Foster, Sibylle Meier, Donna O'Neil, John Komninos, Dimitra Vassiliadi, Christopher Mowatt, Janet Lord, John Wass, Wiebke Arlt Steroids
P380 Suspected DVT after thyrotoxicosis Rakhi Kakad, Munirul Haque, John Milles Thyroid
P381 Post - operative thyroiditis:  An under recognised clinical phenomenon Rashmi Manjunatha, DH Markham, Rajni Mahto Thyroid
P382 Prevalence and Clinical Associations of Calcium-Sensing Receptor Autoantibodies in Finnish APECED Patients Mahmoud Habibullah, Elizabeth H Kemp, Nicolas Kluger, Annamari Ranki, Harpreet K Sandhu, Kai J E Krohn, Anthony P Weetman Thyroid
P383 Incidence of Sunitinib induced Thyroid dysfunction in renal cell carcinoma - a pilot retrospective audit Sviatlana Zhyzhneuskaya, Leanna Erete, Justyna Czechowska, Wendy Anderson, Alison Humphreys, Sath Nag Thyroid
P384 Mis-management of medullary thyroid carcinoma leads to investigation of a non existent phaechromocytoma Christian Hariman, Lavanya Pelluri, Martin Weickert Thyroid
P385 Investigating and treating Thyrotoxicosis. Momin Shah, Simon Saunders Thyroid
P386 Prevalence of thyroid dysfunction in patients with Rheumatoid Arthritis   Loai Shakerdi, Wadah Haj Naema, Saied Hamdon Thyroid
P387 Is there a need to change how we approach a patient with hyperthyroidism? Lakshminarayanan Varadhan, Anney Altaf, George Varughese, Sailesh Sankar Thyroid
P388 A rare cause of clinical hypothyroidism: Thyroid hormone resistance Ram Prakash Narayanan, Preeti Chiran, Mohammad Al-Jubouri, Steven McNulty, Niall Furlong Thyroid
P389 Radioiodine therapy for thyrotoxicosis over a 2 year period: an audit Jennifer Clark, Ranganatha Rao, Prabir Bandyopadhyay, Parijat De Thyroid
P390 Factors Contributing To High Levothyroxine Doses In Primary Hypothyroidism; An Interventional Audit Of A Large Community Database. Hannah Robertson, Anil Narayanaswamy, Olivia Pereira, Shirley Copland, Richard Herriot, Alastair McKinlay, John Bevan, Prakash Abraham Thyroid
P391 Anti-thyroid drugs as treatment for neutropenia in Graves' thyrotoxicosis N Aggarwal, W Saqib, T Fretwell, G Summerfield, S Razvi Thyroid
P392 A CASE OF NEWLY DIAGNOSED HYPERTHYROIDISM IN THE 25TH GESTATIONAL WEEK OF PREGNANCY PRESENTED WITH DIVERGENT ARTERIAL HYPERTENSION Mateja Legan, Janez Zaveljcina, Simona Gaberscek Thyroid
P393 Deafness and Goitre - Think Pendred Jasvir Virdee, Russell Warwick, Ranganatha Rao, Robert Ryder, Parijat De Thyroid
P394 PBF is a component of the molecular signalling pathways that drive hyperplastic and neoplastic thyroid growth Vicki Smith, Martin Read, Rachel Watkins, Vikki Poole, Bhavika Modasia, Waraporn Imruetaicharoenchoke, Kristien Boelaert, Jayne Franklyn, Christopher McCabe Thyroid
P395 Clinical outcome of radioiodine treatment for Graves’ disease at a tertiary care centre Ali Rathore, Rammya Mathew, Anukul Garg, Mark Vanderpump Thyroid
P396 A highly exaggerated response to Warfarin Therapy in a patient with Thyrotoxicosis Tolulope Shonibare, Elizabeth Berkin, Bernard Chang, Ramzi Ajjan Thyroid
P397 Examination of PTTG-Binding Factor (PBF) mRNA reveals functional miRNA target sites and exon-skipping splice variants in thyroid cells Martin Read, Jo Longman, Alice Fletcher, Vicki Smith, Rachel Watkins, Bhavika Modasia, Vikki Poole, Waraporn Imruetaicharoenchoke, Jayne Franklyn, Kristien Boelaert, Christopher McCabe Thyroid
P398 Neurocognitive and CNS abnormalities in humans with defective thyroid receptor alpha Carla Moran, Edward Visser, Nadia Schoenmakers, Francesco Muntoni, Chris Clark, David Gadian, Kling Chong, Adam Kuczynski, Mehul Dattani, Faraneh Vargha-Khadem, Krishna Chatterjee Thyroid
P399 Thyrotoxicosis: a district general hospital experience compared to guidelines Emily Brown, Momin Shah, Pallavi Hegde, Simon Saunders Thyroid
P400 A case of Hashimoto Encephalitis in a patient with severe autoimmune hypothyroidism Jana Bujanova, Shiva Mongolu, Azraai Nasruddin Thyroid
P401 The Diagnosis of Graves' disease: Diagnostic and management dilemmas Lakshminarayanan Pichaipillai, Biswa Mishra Thyroid
P402 Severe Transient Hyperthyroidism and Wernicke’s Encephalopathy in a Lady with Hyperemesis Gravidarum Mehjabeen Beebeejaun, Susanna Meade, Emma Bingham, Frances Coyle, Jennifer Tringham Thyroid
P403 Can a Radiological Scoring System for Assessing the Malignant Potential of Thyroid Nodules be Safely Applied in Clinical Practice? Mark Lewis, Sunethra Ghattamaneni, Annice Mukherjee, Helen Doran Thyroid
P404 Thyroid Nodules: Is one robust Thy2 result sufficient? Jalini Joharatnam, Rose Ngu, Ash Chandra, Jake Powrie Thyroid
P405 Scalp metastasis in follicular thyroid cancer; an atypical consequence Anne marie Hannon, Frank O'Brien, Deirdre Fitzgerald, Antoinette Tuthill Thyroid
P406 Hypoxic incubation favours the development and growth of primary human parathyroid adenoma cells Kate E Lines, Mark Stevenson, Radu Mihai, Irina V Grigorieva, Dilair Baban, Katherine U Gaynor, Jeshmi Jeyabalan, Mahsa Javid, Rajesh V Thakker Thyroid
P407 A mediastinal mass in a patient with thyrotoxicosis-recognising the association between Thymic hyperplasia and Graves' Disease. David Bishop, Vikram Lal, Joanne Fletcher, Wael Elsaify, Satyajit Nag Thyroid
P408 Thyrotoxic Cardiomyopathy Haval Surchi, Usha Ayyagari Thyroid
P409 Not to worry PET, it's not cancer! Raj Tanday, Agnieszka Falinska, Tannaz Vakilgilani, YongYong Ling, Jeannie Todd Thyroid
P410 PTEN Hamartoma Syndrome – Unravelling the Complexities of Childhood Surveillance Harshini Katugampola, Sasha Howard, Jeremy Allgrove Thyroid
P411 A rare case of papillary thyroid cancer arising from the ovary venkata Katreddy, Harit Buch, Laura Pettit, Victor Oguntolu Thyroid
P412 Are patients aware of the risk of agranulocytosis when taking antithyroid drugs? Vincent Chau, Julie Andrew, Emma Ward, Ramzi Ajjan, Robert Murray Thyroid
P413 Myxoedema Coma in a patient with Bipolar disorder   Jahagirdar VR, May CJ, Boelaert K  Vidhya Jahagirdar, Christine May, Kristien Boelaert Thyroid
P414 Audit of Thyroid Surgery Outcomes for Benign Thyroid Disease at West Hertfordshire Hospitals NHS Trust 2010-12 Sajini Wijetilleka, Edouard Mills, Ana Pokrajac, Julia Ostberg Thyroid
P415 Correlation between thyrotoxicosis and hepatic dysfunction in out-patient's endocrine clinic- A single centre experience victor oguntolu, Umaira Aziz, Rolli Allain, Rosseau gama Thyroid
P416 A case of severe Hypothyroidism presenting with multi-organ failure Eswari Chinnasamy, Andrew Rodin Thyroid
P417 Alemtuzumab and Thyroid dysfunction in patients with Multiple Sclerosis - Experience in a University Hospital Maneesh Udiawar, Hemanth Bolusani Thyroid
P418 Consequences of an inadvertent iodine-rich diet, in previously definitively treated Graves' disease.   Rebecca Shankland Thyroid
P419 A Case of Myxoedema Coma and Malnutrition Alexander Tattersall, Rajni Mahto, Rashmi Manjunatha, Jack Storrow Thyroid
P420 Is there a difference in observed bone mineral density at diagnosis between overt and subclinical thyrotoxicosis. Cathy McHugh, Paul Hession Thyroid
P421 Treatment with a TRα1 antagonist increases bone mineral content Julian A Waung, J H Duncan Bassett, Graham R Williams Thyroid
P422 Neutrophil phagocytic capacity is lower in patients with abnormal thyroid function in critical illness Emma Browne, John Simpson, Salman Razvi Thyroid
P423 Autoimmune thyroid disease in the presence of Resistance to Thyroid Hormone or TSH-secreting pituitary tumour – a diagnostic challenge Carla Moran, Olympia Koulouri, Fleur Talbot, Catherine Mitchell, Nadia Schoenmakers, Greta Lyons, Mark Gurnell, V.K.K Chatterjee Thyroid
P424 Evaluation of calcitonin as a screening tool for medullary thyroid carcinoma in patients with nodular thyroid disease Sivasujan Sivasubramaniyam, Roy Sherwood, Jackie Gilbert Thyroid
P425 RET Mutation Negative Familial Medullary Thyroid Carcinoma: Four Families and Literature Review Donato Iacovazzo, Patrick Morrison, William Foulkes, Douglas Ross, Francesca Lugli, Plamena Gabrovska, Emanuela Lucci-Cordisco, Giovanni Neri, Laura De Marinis, Marta Korbonits Thyroid
P426 Small papillary thyroid carcinoma: a "benign" condition? Ruxandra Dobrescu, Dumitru Ioachim, Anca Simioniuc, Corin Badiu, Andrei Goldstein Thyroid
P427 Renal Function In Goitrous Patients Attending Endocrinology Clinic In A South Western Nigerian Hospital Olubukola Ojo, Olalekan Ojo, Rosemary Ikem Thyroid
P428 The influence of thyrotoxicosis on circulating cortisol and response to synacthen Alex Chowdhury, Aziza Khanom, Tomas Agustsson, Sunita Sandhu, Arun Sankaralingam, Louise Breen, Jake Powrie, Stephen Thomas, Barbara McGowan Thyroid
P429 Frequency of biochemical thyroid dysfunction in hospitalised patients: analysis of 280,000 admissions to a large centre. Barbara Torlinska, Jamie Coleman, Mariam Afzal, Jayne Franklyn, Kristien Boelaert Thyroid
P430 Pre-operative cytology vs post-operative histology in Thyroid nodules Gurmit Gill, Paul Wilson, Karthik Kalyanasundaram, George Varughese, Lakshminarayanan Varadhan Thyroid
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 193
Mon 24 09:00
Registration
Mon 24 11:00
Symposium 1: GnRH biology - from pulses to longevity
Supported by Journal of Molecular Endocrinology
1B
Chairs: H Christian (Oxford) & R Perrett (Bristol)
From novel insights into GnRH timing and central control of reproduction to new discoveries in hypothalamic inflammatory change and ageing
Mon 24 11:30
S1.2
Symposium 1: GnRH biology - from pulses to longevity
Biological insights from genetically tagged gonadotropes
Mon 24 12:00
S1.3
Symposium 1: GnRH biology - from pulses to longevity
GnRH and inflammatory signalling in the ageing hypothalamus
Bronx, USA
Mon 24 11:00
Symposium 2: The upside of glucocorticoids in metabolism
Supported by Journal of Endocrinology
1C
Chairs: R Stimson (Edinburgh) & S Morgan (Birmingham)
Amending our thinking of the way GCs work
Mon 24 11:00
S2.1
Symposium 2: The upside of glucocorticoids in metabolism
Insulin sensitisation of adipose tissue by glucocorticoids
Mon 24 11:30
S2.2
Symposium 2: The upside of glucocorticoids in metabolism
Maintaining the anti-inflammatory action of glucocorticoid without the metabolic side effects
Toronto, Canada
Mon 24 12:00
S2.3
Symposium 2: The upside of glucocorticoids in metabolism
Glucocorticoids and protection from pancreatic beta cell failure
Mon 24 11:00
Symposium 3: Emerging Clinical importance of iodine
Supported by Endocrine-Related Cancer and the British Thyroid Foundation
3B
Chairs: M Vanderpump (London) & J Waung (London)
New clinical applications in iodine biology
Mon 24 11:00
S3.1
Symposium 3: Emerging Clinical importance of iodine
Iodine nutrition and neurodevelopment
Mon 24 11:30
S3.2
Symposium 3: Emerging Clinical importance of iodine
Regulation of NIS function in thyroid and breast cancer
Los Angeles, USA
Mon 24 12:00
S3.3
Symposium 3: Emerging Clinical importance of iodine
Use of radioiodine in the imaging and therapy of non-thyroidal tumours
Munich, Germany
Mon 24 12:30
Lunch
Hall 2A
Mon 24 12:45
Internis Industry Sponsored Satellite Symposia
Vitamin D – the Dark Truth
1C
Chair: A Grosso (London)
Mon 24 12:45 - 13:05
Internis Industry Sponsored Satellite Symposia
Clinical Update on Vitamin D
Mon 24 13:05 - 13:25
Internis Industry Sponsored Satellite Symposia
Shedding light on the Health Economics of Vitamin D
Mon 24 13:25 - 13:45
Internis Industry Sponsored Satellite Symposia
The Dark Truth of Prescribing Unlicensed Vitamin D
Mon 24 12:45
HRA Pharma Industry Sponsored Satellite Symposia
Cushing’s syndrome and adrenocortical carcinoma management: are we making progress?
1B
Chair: R Feelders (Rotterdam, Netherlands)
Mon 24 12:45 - 12:50
HRA Pharma Industry Sponsored Satellite Symposia
Welcome and introduction
Rotterdam, Netherlands
Mon 24 12:50 - 13:00
HRA Pharma Industry Sponsored Satellite Symposia
Current challenges in the management of Cushing’s syndrome
Mon 24 13:00 - 13:20
HRA Pharma Industry Sponsored Satellite Symposia
Use of Steroidogenesis inhibitors for Cushing’s syndrome. Audit of 13 UK tertiary centres
Sheffield, UK
Mon 24 13:20 - 13:35
HRA Pharma Industry Sponsored Satellite Symposia
Multimodal therapy in the management of advanced ACC
Mon 24 13:35 - 13:45
HRA Pharma Industry Sponsored Satellite Symposia
Questions and Answers
Mon 24 13:45
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Supported by Journal of Endocrinology
1B
Chairs: G Lavery (Birmingham) & D Macfarlane (Dundee)
How to assess and quantitate energy usage and interpret the data
Mon 24 13:45
APW1.1
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Assessing energy demand in living organisms
Stockholm, Sweden
Mon 24 14:15
APW1.2
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Lipid metabolism: from mice to men?
Mon 24 14:45
APW1.3
Applied Physiology Workshop: A guide to the analysis of energy metabolism
Tracking lipid energy partitioning in human liver
Mon 24 13:45
Oral Communications 1: Young Endocrinologists' Prize Session
1A
Chairs: C McCabe (Birmingham) & S Mirczuk (London)
Mon 24 13:45
OC1.1
Oral Communications 1: Young Endocrinologists' Prize Session
The Thr92Ala substitution in deiodonase-2 is associated with increased odds of a sub-optimal IQ score in children with low-normal thyroid function
Mon 24 14:00
OC1.2
Oral Communications 1: Young Endocrinologists' Prize Session
Characterisation of adrenocortical progenitor cells: isolation of mesenchymal stem cell-like cell populations from human adrenal cortex
Mon 24 14:15
OC1.3
Oral Communications 1: Young Endocrinologists' Prize Session
Angiogenic factors sFlt1 and PlGF are novel determinants of newborn thyroid (dys)function: the Generation R study
Mon 24 14:30
OC1.4
Oral Communications 1: Young Endocrinologists' Prize Session
Single molecule analysis of GPCR transactivation reveals oligomeric complexes that regulate signal sensitivity
London, UK
Mon 24 14:45
OC1.5
Oral Communications 1: Young Endocrinologists' Prize Session
Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment
Mon 24 15:00
OC1.6
Oral Communications 1: Young Endocrinologists' Prize Session
A loss-of-function mutation in the prolactin receptor (PRLR) causes familial hyperprolactinaemia
Birmingham, UK
Mon 24 13:45
Symposium 4: Putting flesh on the bones
3B
Chairs: N Shaw (Birmingham) & S Howles (Oxford)
Genetic disorders of bone and mineral metabolism
Mon 24 13:45
S4.1
Symposium 4: Putting flesh on the bones
Assessment of abnormalities of skeletal development
Mon 24 14:15
S4.2
Symposium 4: Putting flesh on the bones
Osteogenesis imperfecta - management beyond childhood
Mon 24 14:45
S4.3
Symposium 4: Putting flesh on the bones
Management of hypophosphatemic rickets
New Haven, USA
Mon 24 15:15
Tea & Coffee
Hall 2A
Mon 24 15:45
Education Workshop 1: Teaching and learning in Endocrinology
3B
Chairs: A Crown (Brighton) & H Christian (Oxford)
Mon 24 15:45
EW1.1
Education Workshop 1: Teaching and learning in Endocrinology
Endocrinologists as teachers: integrating teaching and practice in the real world
Mon 24 16:05
EW1.2
Education Workshop 1: Teaching and learning in Endocrinology
Using technology to enhance your teaching in endocrinology
Mon 24 16:25
EW1.3
Education Workshop 1: Teaching and learning in Endocrinology
Exams, and the future of assessment in medicine. A view from the MRCP(UK)
Mon 24 16:45
EW1.4
Education Workshop 1: Teaching and learning in Endocrinology
Interprofessional learning through and for multidisciplinary working
Mon 24 17:05
Education Workshop 1: Teaching and learning in Endocrinology
Questions and discussion
Mon 24 15:45
Clinical Management Workshop 1: Management of complex obesity
Supported by Clinical Endocrinology
1A
Chairs: B McGowan (London) & K McCullough (London)
Mon 24 15:45
CMW1.1
Clinical Management Workshop 1: Management of complex obesity
Have the new commissioning guidelines for bariatric surgery improved patient's pathways?
Mon 24 16:15
CMW1.2
Clinical Management Workshop 1: Management of complex obesity
Medical management of severe obesity

Unknown speaker

Liverpool, United Kingdom
Mon 24 16:45
CMW1.3
Clinical Management Workshop 1: Management of complex obesity
Endocrine and metabolic complications post-bariatric surgery
London, United Kingdom
Mon 24 15:45
Oral Communications 2: Endocrine regulation of cell behaviour
1B
Chairs: G Lavery (Birmingham) & G WIllis (Cardiff)
Mon 24 15:45
OC2.1
Oral Communications 2: Endocrine regulation of cell behaviour
A novel modulator of cell invasion and metastasis
Mon 24 16:00
OC2.2
Oral Communications 2: Endocrine regulation of cell behaviour
Inhibition of human NET cell proliferation by a peptide identified through phage display screening
Mon 24 16:15
OC2.3
Oral Communications 2: Endocrine regulation of cell behaviour
A20 confers protection against TRAIL-induced apoptosis in the pancreatic beta-cell
Mon 24 16:30
OC2.4
Oral Communications 2: Endocrine regulation of cell behaviour
Influence of glucocorticoid receptor density on development and remodelling of the heart
Mon 24 16:45
OC2.5
Oral Communications 2: Endocrine regulation of cell behaviour
Beta-cells require CFTR for glucose-induced insulin secretion
Mon 24 17:00
OC2.6
Oral Communications 2: Endocrine regulation of cell behaviour
A potential role for food-derived microRNAs in human placental development
Mon 24 15:45
Symposium 5: Endocrine consequences of major trauma
1C
Chairs: A Logan (Birmingham) & M Sherlock (Dublin, Ireland)
Pathophysiological changes associated with injury
Mon 24 15:45
S5.1
Symposium 5: Endocrine consequences of major trauma
Endocrine mechanisms of sarcopenia
Mon 24 16:15
S5.2
Symposium 5: Endocrine consequences of major trauma
Pituitary sequelae of traumatic brain injury
Dublin, Ireland
Mon 24 16:45
S5.3
Symposium 5: Endocrine consequences of major trauma
Thyroid hormone economy in critical illness
Amsterdam, The Netherlands
Mon 24 17:25
SfE Young Endocrinologists' Prize Lectures
1A
Chairs: J Franklyn (Birmingham) & K Chapman (Edinburgh)
Mon 24
YEP1.1
SfE Young Endocrinologists' Prize Lectures
Basic Prize Lecture: Sox2+ cells of the postnatal pituitary can differentiate into hormone producing cells in vivo and have tumour-inducing potential
Mon 24
YEP1.2
SfE Young Endocrinologists' Prize Lectures
Clinical Prize Lecture: Clinical effects of kisspeptin on reproductive hormone secretion, LH pulsatility and oocyte maturation during IVF treatment
Mon 24 18:25
Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
1A
Chair: B Walker (Edinburgh)
Mon 24
Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
For:
Mon 24
Debate: This house believes Genome Wide Association Studies will have no impact upon clinical endocrinology
Against:
Mon 24 19:15
Welcome Reception
Hall 2A
Mon 24 20:15
Young Endocrinologists' Social Evening and Quiz
3AB
Tue 25 07:45
Breakfast
Tue 25 08:00
Meet the Expert 3
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
1B
Chair: H Jones (Barnsley)
Tue 25
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Tue 25 08:00
Meet the Expert 4
Supported by Clinical Endocrinology
1C
Chair: L Heisler (Cambridge)
Tue 25
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
Tue 25 09:00
Symposium 6: Thyroid cell biology comes to your clinic
Supported by Journal of Molecular Endocrinology
1C
Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
Emerging models of clinical relevance to thyroid disease
Tue 25 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
Tue 25 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
Tue 25 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
Tue 25 09:00
Clinical Management Workshop 2: How do I do it?
Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
1A
Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
Tue 25 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Tue 25 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Tue 25 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Tue 25 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Tue 25 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Tue 25 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Tue 25 09:00
Oral Communications 3: Steroids
3B
Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
Tue 25 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
Tue 25 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
Tue 25 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
Tue 25 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
Tue 25 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
Tue 25 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Tue 25 09:00
Symposium 7: Natriuretic peptides: so much more than salt and water
1B
Chairs: C McArdle (Bristol) & S Mirczuk (London)
Novel functions for natriuretic peptides
Tue 25 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
Tue 25 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
Tue 25 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
Tue 25 10:30
Tea & Coffee
Hall 2A
Tue 25 11:00
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
1A
Chair: A Grossman (Oxford)
Tue 25
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Tue 25 11:30
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
1A
Chair: A Grossman (Oxford)
Tue 25
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
Tue 25 12:00
Lunch & poster viewing
Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
Hall 2A
Tue 25 12:45
Ipsen Industry Sponsored Satellite Symposia
Optimising outcomes for patients with acromegaly and NETs
3AB
Chair: A Grossman (Oxford)
Tue 25
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
Tue 25
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
Tue 25
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
Tue 25 14:00
Oral Communications 4: Thyroid and Bone
1C
Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
Tue 25 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Tue 25 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
Tue 25 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
Tue 25 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
Tue 25 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
Tue 25 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
Tue 25 14:00
Young Endocrinologists' Symposium: Establishing successful collaborations
1B
Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
Making the most of interdisciplinary collaborations and peer-to-peer networking
Tue 25 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
Tue 25 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Tue 25 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
Tue 25 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
Tue 25 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Tue 25 15:15
Young Endocrinologists' Symposium: Establishing successful collaborations
Panel discussion
Tue 25 14:00
Symposium 8: Chronic disease and growth
3B
Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
Chronic inflammation and growth hormone signalling
Tue 25 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
Tue 25 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
Tue 25 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
Tue 25 14:00
Symposium 9: MEN1- from molecular pathology to therapies
Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
1A
Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
Current understanding and future perspectives in MEN1
Tue 25 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
Tue 25 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
Tue 25 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
Tue 25 15:30
Tea & Coffee
Hall 2A
Tue 25 16:00
Meet the Expert 3 (repeat)
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
3B
Chair: H Jones (Barnsley)
Tue 25
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
Tue 25 16:00
Oral Communications 5: Pituitary
1B
Chairs: J Davies (Manchester) & R Watkins (Birmingham)
Tue 25 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
Tue 25 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Tue 25 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
Tue 25 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
Tue 25 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
Tue 25 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
Tue 25 16:00
Symposium 10: Fat and bone
Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
1A
Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
Body composition and bone
Tue 25 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
Tue 25 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
Tue 25 17:00
S10.3
Symposium 10: Fat and bone
Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
Tue 25 16:45
Meet the Expert 5
Supported by Clinical Endocrinology
3B
Chair: P Trainer (Manchester)
Tue 25
MTE5
Meet the Expert 5
Pituitary replacement therapy
Tue 25 17:40
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: J Connell (Dundee)
Tue 25
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
Tue 25 19:30
Conference dinner and Awards Ceremony
Tue 25 07:45
Breakfast
Tue 25 08:00
Meet the Expert 5 (repeat)
Supported by Clinical Endocrinology
1A
Chair: P Trainer (Manchester)
Tue 25
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
Tue 25 08:00
Meet the Expert 6
Supported by Clinical Endocrinology
3B
Chair: C Brain (London)
Tue 25
MTE6
Meet the Expert 6
Delayed puberty
Tue 25 08:00
Meet the Expert 7
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Tue 25
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Tue 25 08:00
Society for Endocrinology Journal Awards
1C
Chair: D Ray (Manchester)
Tue 25 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
Tue 25 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
Tue 25 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
Tue 25 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
Tue 25 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
Tue 25 08:45
Society for Endocrinology AGM
1A
Tue 25 09:30
Education Workshop 2: Practical publishing advice
3B
Chair: D Ray (Manchester)
Tue 25 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Tue 25 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
Tue 25 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
Tue 25 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
Tue 25 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
Tue 25 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
Tue 25 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
Tue 25 10:35
Education Workshop 2: Practical publishing advice
Questions and discussion
Tue 25 09:30
Nurse Session 1 - Cushing's Syndrome
1B
Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
Tue 25 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
Tue 25 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
Tue 25 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
Tue 25 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
Tue 25 09:30
Symposium 11: Some like it hot - new insights into brown adipose tissue
1C
Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
Emerging biology of brown adipose tissue
Tue 25 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
Tue 25 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
Tue 25 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
Tue 25 09:30
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Supported by Clinical Endocrinology
1A
Chairs: H Gleeson (Leicester) & R El-Khairi (London)
Tue 25 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
Tue 25 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
Tue 25 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
Tue 25 11:00
Tea & Coffee
Exhibtion Hall
Tue 25 11:30
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
1A
Chair: G Williams (London)
Tue 25
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
Tue 25 12:00
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
1A
Chair: D Ray (Manchester)
Tue 25
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
Tue 25 12:30
Lunch & poster viewing
Shortlisted posters attended
Hall 2A
Tue 25 12:45
Viropharma Industry Sponsored Satellite Symposia
New insights in the management of Adrenal Insufficiency in the UK
3AB
Chair: S Pearce (Newcastle-Upon-Tyne)
Tue 25 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Tue 25 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
Tue 25 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Tue 25 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
Tue 25 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
Tue 25 13:45
Meet the Expert 8
1C
Chair: C McCabe (Birmingham)
Tue 25
MTE8
Meet the Expert 8
Growing organs in the lab
Tue 25 13:45
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
1B
Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
Tue 25 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
Tue 25 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Tue 25 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
Tue 25 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
Tue 25 15:05
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Questions and discussion
Tue 25 13:45
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Supported by Endocrine Connections
1A
Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
How the brain orchestrates glucose metabolism
Tue 25 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Tue 25 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
Tue 25 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
Tue 25 13:45
Oral Communications 6: Clinical
3B
Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
Tue 25 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Tue 25 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
Tue 25 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
Tue 25 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
Tue 25 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
Tue 25 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
Tue 25 14:30
Meet the Expert 9
1C
Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
Tue 25
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
Tue 25 15:15
Tea & Coffee
Hall 2A
Tue 25 15:45
Oral Communication and Poster Prize Ceremony
1A
Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
Tue 25 16:15
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: G Williams (London)
Tue 25
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
Tue 25 16:45
Plenary Lecture 7: Society for Endocrinology Medal Lecture
1A
Chair: D Ray (Manchester)
Tue 25
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
Tue 25 07:45
Breakfast
Tue 25 08:00
Meet the Expert 1 (repeat)
Supported by Clinical Endocrinology
1B
Chair: J Newell-Price (Sheffield)
Tue 25
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Tue 25 08:00
Meet the Expert 2 (repeat)
Supported by Clinical Endocrinology
1C
Chair: N Gittoes (Birmingham)
Tue 25
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
Tue 25 08:45
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Supported by the Clinical Endocrinology Trust
1A
Chair: JS Bevan (Aberdeen)
Tue 25
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
Tue 25 09:15
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
1A
Chair: C McCabe (Birmingham)
Tue 25
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
Tue 25 09:45
Society for Endocrinology Emergency Endocrine Guidance
1A
Chair: J Franklyn (Birmingham)
Tue 25
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
Tue 25
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
Tue 25 10:15
Tea & Coffee
3AB
Tue 25 10:45
Meet the Expert 6 (repeat)
1B
Chair: C Brain (London)
Tue 25
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
Tue 25 10:45
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
1A
Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
Tue 25 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Tue 25 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Tue 25 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
Tue 25 10:45
Senior Endocrinologists' Session
1C
Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
Tue 25 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Tue 25 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
Tue 25 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
Tue 25 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
Tue 25 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
Tue 25 11:30
Meet the Expert 7 (repeat)
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Tue 25
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK
Wed 26 07:45
Breakfast
Wed 26 08:00
Meet the Expert 3
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
1B
Chair: H Jones (Barnsley)
Wed 26
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Wed 26 08:00
Meet the Expert 4
Supported by Clinical Endocrinology
1C
Chair: L Heisler (Cambridge)
Wed 26
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
Wed 26 09:00
Symposium 6: Thyroid cell biology comes to your clinic
Supported by Journal of Molecular Endocrinology
1C
Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
Emerging models of clinical relevance to thyroid disease
Wed 26 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
Wed 26 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
Wed 26 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
Wed 26 09:00
Clinical Management Workshop 2: How do I do it?
Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
1A
Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
Wed 26 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Wed 26 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Wed 26 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Wed 26 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Wed 26 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Wed 26 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Wed 26 09:00
Oral Communications 3: Steroids
3B
Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
Wed 26 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
Wed 26 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
Wed 26 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
Wed 26 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
Wed 26 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
Wed 26 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Wed 26 09:00
Symposium 7: Natriuretic peptides: so much more than salt and water
1B
Chairs: C McArdle (Bristol) & S Mirczuk (London)
Novel functions for natriuretic peptides
Wed 26 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
Wed 26 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
Wed 26 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
Wed 26 10:30
Tea & Coffee
Hall 2A
Wed 26 11:00
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
1A
Chair: A Grossman (Oxford)
Wed 26
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Wed 26 11:30
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
1A
Chair: A Grossman (Oxford)
Wed 26
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
Wed 26 12:00
Lunch & poster viewing
Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
Hall 2A
Wed 26 12:45
Ipsen Industry Sponsored Satellite Symposia
Optimising outcomes for patients with acromegaly and NETs
3AB
Chair: A Grossman (Oxford)
Wed 26
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
Wed 26
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
Wed 26
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
Wed 26 14:00
Oral Communications 4: Thyroid and Bone
1C
Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
Wed 26 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Wed 26 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
Wed 26 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
Wed 26 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
Wed 26 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
Wed 26 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
Wed 26 14:00
Young Endocrinologists' Symposium: Establishing successful collaborations
1B
Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
Making the most of interdisciplinary collaborations and peer-to-peer networking
Wed 26 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
Wed 26 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Wed 26 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
Wed 26 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
Wed 26 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Wed 26 15:15
Young Endocrinologists' Symposium: Establishing successful collaborations
Panel discussion
Wed 26 14:00
Symposium 8: Chronic disease and growth
3B
Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
Chronic inflammation and growth hormone signalling
Wed 26 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
Wed 26 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
Wed 26 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
Wed 26 14:00
Symposium 9: MEN1- from molecular pathology to therapies
Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
1A
Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
Current understanding and future perspectives in MEN1
Wed 26 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
Wed 26 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
Wed 26 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
Wed 26 15:30
Tea & Coffee
Hall 2A
Wed 26 16:00
Meet the Expert 3 (repeat)
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
3B
Chair: H Jones (Barnsley)
Wed 26
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
Wed 26 16:00
Oral Communications 5: Pituitary
1B
Chairs: J Davies (Manchester) & R Watkins (Birmingham)
Wed 26 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
Wed 26 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Wed 26 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
Wed 26 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
Wed 26 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
Wed 26 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
Wed 26 16:00
Symposium 10: Fat and bone
Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
1A
Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
Body composition and bone
Wed 26 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
Wed 26 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
Wed 26 17:00
S10.3
Symposium 10: Fat and bone
Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
Wed 26 16:45
Meet the Expert 5
Supported by Clinical Endocrinology
3B
Chair: P Trainer (Manchester)
Wed 26
MTE5
Meet the Expert 5
Pituitary replacement therapy
Wed 26 17:40
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: J Connell (Dundee)
Wed 26
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
Wed 26 19:30
Conference dinner and Awards Ceremony
Wed 26 07:45
Breakfast
Wed 26 08:00
Meet the Expert 5 (repeat)
Supported by Clinical Endocrinology
1A
Chair: P Trainer (Manchester)
Wed 26
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
Wed 26 08:00
Meet the Expert 6
Supported by Clinical Endocrinology
3B
Chair: C Brain (London)
Wed 26
MTE6
Meet the Expert 6
Delayed puberty
Wed 26 08:00
Meet the Expert 7
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Wed 26
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Wed 26 08:00
Society for Endocrinology Journal Awards
1C
Chair: D Ray (Manchester)
Wed 26 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
Wed 26 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
Wed 26 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
Wed 26 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
Wed 26 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
Wed 26 08:45
Society for Endocrinology AGM
1A
Wed 26 09:30
Education Workshop 2: Practical publishing advice
3B
Chair: D Ray (Manchester)
Wed 26 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Wed 26 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
Wed 26 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
Wed 26 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
Wed 26 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
Wed 26 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
Wed 26 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
Wed 26 10:35
Education Workshop 2: Practical publishing advice
Questions and discussion
Wed 26 09:30
Nurse Session 1 - Cushing's Syndrome
1B
Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
Wed 26 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
Wed 26 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
Wed 26 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
Wed 26 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
Wed 26 09:30
Symposium 11: Some like it hot - new insights into brown adipose tissue
1C
Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
Emerging biology of brown adipose tissue
Wed 26 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
Wed 26 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
Wed 26 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
Wed 26 09:30
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Supported by Clinical Endocrinology
1A
Chairs: H Gleeson (Leicester) & R El-Khairi (London)
Wed 26 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
Wed 26 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
Wed 26 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
Wed 26 11:00
Tea & Coffee
Exhibtion Hall
Wed 26 11:30
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
1A
Chair: G Williams (London)
Wed 26
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
Wed 26 12:00
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
1A
Chair: D Ray (Manchester)
Wed 26
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
Wed 26 12:30
Lunch & poster viewing
Shortlisted posters attended
Hall 2A
Wed 26 12:45
Viropharma Industry Sponsored Satellite Symposia
New insights in the management of Adrenal Insufficiency in the UK
3AB
Chair: S Pearce (Newcastle-Upon-Tyne)
Wed 26 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Wed 26 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
Wed 26 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Wed 26 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
Wed 26 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
Wed 26 13:45
Meet the Expert 8
1C
Chair: C McCabe (Birmingham)
Wed 26
MTE8
Meet the Expert 8
Growing organs in the lab
Wed 26 13:45
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
1B
Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
Wed 26 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
Wed 26 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Wed 26 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
Wed 26 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
Wed 26 15:05
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Questions and discussion
Wed 26 13:45
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Supported by Endocrine Connections
1A
Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
How the brain orchestrates glucose metabolism
Wed 26 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Wed 26 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
Wed 26 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
Wed 26 13:45
Oral Communications 6: Clinical
3B
Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
Wed 26 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Wed 26 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
Wed 26 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
Wed 26 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
Wed 26 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
Wed 26 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
Wed 26 14:30
Meet the Expert 9
1C
Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
Wed 26
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
Wed 26 15:15
Tea & Coffee
Hall 2A
Wed 26 15:45
Oral Communication and Poster Prize Ceremony
1A
Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
Wed 26 16:15
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: G Williams (London)
Wed 26
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
Wed 26 16:45
Plenary Lecture 7: Society for Endocrinology Medal Lecture
1A
Chair: D Ray (Manchester)
Wed 26
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
Wed 26 07:45
Breakfast
Wed 26 08:00
Meet the Expert 1 (repeat)
Supported by Clinical Endocrinology
1B
Chair: J Newell-Price (Sheffield)
Wed 26
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Wed 26 08:00
Meet the Expert 2 (repeat)
Supported by Clinical Endocrinology
1C
Chair: N Gittoes (Birmingham)
Wed 26
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
Wed 26 08:45
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Supported by the Clinical Endocrinology Trust
1A
Chair: JS Bevan (Aberdeen)
Wed 26
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
Wed 26 09:15
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
1A
Chair: C McCabe (Birmingham)
Wed 26
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
Wed 26 09:45
Society for Endocrinology Emergency Endocrine Guidance
1A
Chair: J Franklyn (Birmingham)
Wed 26
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
Wed 26
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
Wed 26 10:15
Tea & Coffee
3AB
Wed 26 10:45
Meet the Expert 6 (repeat)
1B
Chair: C Brain (London)
Wed 26
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
Wed 26 10:45
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
1A
Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
Wed 26 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Wed 26 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Wed 26 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
Wed 26 10:45
Senior Endocrinologists' Session
1C
Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
Wed 26 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Wed 26 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
Wed 26 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
Wed 26 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
Wed 26 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
Wed 26 11:30
Meet the Expert 7 (repeat)
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Wed 26
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK
Thu 27 07:45
Breakfast
Thu 27 08:00
Meet the Expert 3
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
1B
Chair: H Jones (Barnsley)
Thu 27
MTE3
Meet the Expert 3
Endocrine and non-endocrine management of Klinefelter's Syndrome
London, UK
Thu 27 08:00
Meet the Expert 4
Supported by Clinical Endocrinology
1C
Chair: L Heisler (Cambridge)
Thu 27
MTE4
Meet the Expert 4
Optogenetics illuminates neuroendocrinology
Thu 27 09:00
Symposium 6: Thyroid cell biology comes to your clinic
Supported by Journal of Molecular Endocrinology
1C
Chairs: C Spitzweg (Munich, Germany) & V Smith (Birmingham)
Emerging models of clinical relevance to thyroid disease
Thu 27 09:00
S6.1
Symposium 6: Thyroid cell biology comes to your clinic
Development of functional thyroid tissue from embryonic stem cells
Brussels, Belgium
Thu 27 09:30
S6.2
Symposium 6: Thyroid cell biology comes to your clinic
Factors involved in thyroid gland development and survival
Thu 27 10:00
S6.3
Symposium 6: Thyroid cell biology comes to your clinic
PBF signalling in thyroid tumourigenesis
Birmingham, UK
Thu 27 09:00
Clinical Management Workshop 2: How do I do it?
Supported by Endocrinology, Diabetes and Metabolism Case Reports CMW2.1 supported by Hypopara UK
1A
Chairs: J Ahlquist (Southend) & C Napier (Newcastle upon Tyne)
Thu 27 09:00
CMW2.1
Clinical Management Workshop 2: How do I do it?
How do I localise parathyroid tumours?
Thu 27 09:15
CMW2.2
Clinical Management Workshop 2: How do I do it?
How and when do I initiate treatment for central hypothyroidism?
Milan, Italy
Thu 27 09:30
CMW2.3
Clinical Management Workshop 2: How do I do it?
How do I manage adrenal replacement in pregnancy?
Thu 27 09:45
CMW2.4
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage sweating?
Thu 27 10:00
CMW2.5
Clinical Management Workshop 2: How do I do it?
How and when do I treat the older male with a borderline testosterone?
Thu 27 10:15
CMW2.6
Clinical Management Workshop 2: How do I do it?
How do I investigate and manage hyponatraemia?
Thu 27 09:00
Oral Communications 3: Steroids
3B
Chairs: C Cummins (Toronto, Canada) & D Nanus (Birmingham)
Thu 27 09:00
OC3.1
Oral Communications 3: Steroids
Lack of 11β-hydroxysteroid dehydrogenase type 1 ameliorates the adverse features of Cushing’s syndrome
Thu 27 09:15
OC3.2
Oral Communications 3: Steroids
5α-Reductase is a regulator of glucocorticoid action and metabolic phenotype in human liver
Thu 27 09:30
OC3.3
Oral Communications 3: Steroids
The 21-hydroxylase pseudogene may have a role in induction of tolerance to steroidogenic machinery
Thu 27 09:45
OC3.4
Oral Communications 3: Steroids
Pre-receptor glucocorticoid metabolism across human ageing: the impact of gender and menopausal status
Thu 27 10:00
OC3.5
Oral Communications 3: Steroids
Linking GWAS to gene function - CYP17A1 in hypertension
Thu 27 10:15
OC3.6
Oral Communications 3: Steroids
Targeting of lysyl oxidase by steroids to reduce peritoneal fibrosis and scarring
Thu 27 09:00
Symposium 7: Natriuretic peptides: so much more than salt and water
1B
Chairs: C McArdle (Bristol) & S Mirczuk (London)
Novel functions for natriuretic peptides
Thu 27 09:00
S7.1
Symposium 7: Natriuretic peptides: so much more than salt and water
Guanylyl cyclases in cardiomyopathy
Wuerzburg, Germany
Thu 27 09:30
S7.2
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in pituitary development and function
Thu 27 10:00
S7.3
Symposium 7: Natriuretic peptides: so much more than salt and water
Natriuretic peptides in cardiovascular disease
Thu 27 10:30
Tea & Coffee
Hall 2A
Thu 27 11:00
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
1A
Chair: A Grossman (Oxford)
Thu 27
PL1
Plenary Lecture 1: Society for Endocrinology Dale Medal Lecture 2013
Nuclear receptors, metabolism and the hunger games
La Jolla, USA
Thu 27 11:30
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
1A
Chair: A Grossman (Oxford)
Thu 27
PL2
Plenary Lecture 2: Society for Endocrinology Dale Medal Lecture 2014
Coactivators: Master Genes for Physiology and Pathology
Pittsburg, USA
Thu 27 12:00
Lunch & poster viewing
Odd-numbered posters attended 12:00 - 13:00; Even-numbered posters attended 13:00 - 14:00
Hall 2A
Thu 27 12:45
Ipsen Industry Sponsored Satellite Symposia
Optimising outcomes for patients with acromegaly and NETs
3AB
Chair: A Grossman (Oxford)
Thu 27
Ipsen Industry Sponsored Satellite Symposia
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the results of the PRIMARYS trial
Thu 27
Ipsen Industry Sponsored Satellite Symposia
SAGIT – A disease staging tool to personalise patient management for acromegaly
Hamburg, Germany
Thu 27
Ipsen Industry Sponsored Satellite Symposia
New data confirming the beneficial role of lanreotide Autogel in the management of patients with a NET
Cardiff University, United Kingdom
Thu 27 14:00
Oral Communications 4: Thyroid and Bone
1C
Chairs: K Boelaert (Birmingham) & F Hannan (Liverpool)
Thu 27 14:00
OC4.1
Oral Communications 4: Thyroid and Bone
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 exert dominant-negative effects
Thu 27 14:15
OC4.2
Oral Communications 4: Thyroid and Bone
PHOSPHO1: roles beyond skeletal mineralisation
Thu 27 14:30
OC4.3
Oral Communications 4: Thyroid and Bone
TRα mutation causes a severe and thyroxine-resistant skeletal dysplasia
Thu 27 14:45
OC4.4
Oral Communications 4: Thyroid and Bone
Thyroid hormones stimulate osteoclastogenesis via TRα-dependent actions in osteoblasts
Thu 27 15:00
OC4.5
Oral Communications 4: Thyroid and Bone
A mutation in the 5’UTR of GNA11 causes familial hypocalciuric hypercalcemia type 2 (FHH2) due to reduced translational efficiency
Thu 27 15:15
OC4.6
Oral Communications 4: Thyroid and Bone
An ENU-induced Tyr265Stop mutation in Polg2 is associated with renal calcification in RCALC2 mice
Birmingham, UK
Thu 27 14:00
Young Endocrinologists' Symposium: Establishing successful collaborations
1B
Chairs: A Lansdown (Cardiff) & G Begum (Manchester)
Making the most of interdisciplinary collaborations and peer-to-peer networking
Thu 27 14:00
YE1.1
Young Endocrinologists' Symposium: Establishing successful collaborations
What makes a successful collaboration between a basic scientist and a clinician?
Thu 27 14:15
YE1.2
Young Endocrinologists' Symposium: Establishing successful collaborations
How do I talk to a bioinformatician/mathematician/engineer?
Thu 27 14:30
YE1.3
Young Endocrinologists' Symposium: Establishing successful collaborations
Industrial collaborations - where to start?
Thu 27 14:45
YE1.4
Young Endocrinologists' Symposium: Establishing successful collaborations
Biobanking – what is it, and how could they be beneficial to me?
Thu 27 15:00
YE1.5
Young Endocrinologists' Symposium: Establishing successful collaborations
Peer-to-peer collaborations: Importance of YE groups
Thu 27 15:15
Young Endocrinologists' Symposium: Establishing successful collaborations
Panel discussion
Thu 27 14:00
Symposium 8: Chronic disease and growth
3B
Chairs: F Ahmed (Glasgow) & L Dunford (Leicester)
Chronic inflammation and growth hormone signalling
Thu 27 14:00
S8.1
Symposium 8: Chronic disease and growth
Understanding growth hormone action through the growth plate
Thu 27 14:30
S8.2
Symposium 8: Chronic disease and growth
Targeting SOCS Proteins to Combat Inflammation
Thu 27 15:00
S8.3
Symposium 8: Chronic disease and growth
Managing abnormalities of growth in chronic disease
Paris, France
Thu 27 14:00
Symposium 9: MEN1- from molecular pathology to therapies
Supported by Endocrine-Related Cancer and the Association of Multiple Endocrine Neoplasia Disorders
1A
Chairs: J Newell-Price (Sheffield) & G Walls (Oxford)
Current understanding and future perspectives in MEN1
Thu 27 14:00
S9.1
Symposium 9: MEN1- from molecular pathology to therapies
Current understanding and future perspectives in MEN1
Bethesda, USA
Thu 27 14:30
S9.2
Symposium 9: MEN1- from molecular pathology to therapies
Genetics, pathophysiology and translational models of MEN1
Oxford, United Kingdom
Thu 27 15:00
S9.3
Symposium 9: MEN1- from molecular pathology to therapies
Practical management of patients with MEN1
Uppsala, Sweden
Thu 27 15:30
Tea & Coffee
Hall 2A
Thu 27 16:00
Meet the Expert 3 (repeat)
Supported by Clinical Endocrinology and the Klinefelter’s Syndrome Association UK
3B
Chair: H Jones (Barnsley)
Thu 27
MTE3
Meet the Expert 3 (repeat)
Endocrine and non-endocrine management of Klinefelter's Syndrome (repeat)
London, UK
Thu 27 16:00
Oral Communications 5: Pituitary
1B
Chairs: J Davies (Manchester) & R Watkins (Birmingham)
Thu 27 16:00
OC5.1
Oral Communications 5: Pituitary
Increased frequency and earlier onset of pituitary tumours in mice deleted for a multiple endocrine neoplasia type 1 (MEN1) allele and null for prolyl hydroxylase domain protein 1 (PHD1) (Men1+/-/Phd1-/-)
Thu 27 16:15
OC5.2
Oral Communications 5: Pituitary
Implications of the upregulation of lysine specific demethylase (LSD) 1 in the pathogenesis of pituitary adenomas
Thu 27 16:30
OC5.3
Oral Communications 5: Pituitary
The Wnt/β-catenin effector Tcf3/TCF7L1 is required for normal hypothalamic-pituitary development and mutation in this gene is associated with congenital hypopituitarism
Thu 27 16:45
OC5.4
Oral Communications 5: Pituitary
GnRH pulse frequency-dependent regulation of ICER, a modulator of FSHβ transcription, is attenuated by MEKI/II blockade
Thu 27 17:00
OC5.5
Oral Communications 5: Pituitary
Spatio-temporal analysis of prolactin gene transcription dynamics reveals short range co-ordination of lactotroph transcription activity in pituitary tissue
Thu 27 17:15
OC5.6
Oral Communications 5: Pituitary
A GH antagonist fusion with GH binding protein is biologically active, shows delayed clearance and inhibits growth in a rabbit model
Thu 27 16:00
Symposium 10: Fat and bone
Supported by Endocrine Connections and the Klinefelter’s Syndrome Association UK
1A
Chairs: P Dimitri (Sheffield) & R Crowley (Birmingham)
Body composition and bone
Thu 27 16:00
S10.1
Symposium 10: Fat and bone
Fat and its influence on bone
Thu 27 16:30
S10.2
Symposium 10: Fat and bone
Obesity and fractures - what is the inter-relationship?
Thu 27 17:00
S10.3
Symposium 10: Fat and bone
Energy Deficiency, Amenorrhea and the Skeleton:  Challenges and Therapies
Thu 27 16:45
Meet the Expert 5
Supported by Clinical Endocrinology
3B
Chair: P Trainer (Manchester)
Thu 27
MTE5
Meet the Expert 5
Pituitary replacement therapy
Thu 27 17:40
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: J Connell (Dundee)
Thu 27
PL3
Plenary Lecture 3: Clinical Endocrinology Trust Visiting Professor Lecture
Adrenocortical tumours - from bench to bedside and back
Würzburg, Germany
Thu 27 19:30
Conference dinner and Awards Ceremony
Thu 27 07:45
Breakfast
Thu 27 08:00
Meet the Expert 5 (repeat)
Supported by Clinical Endocrinology
1A
Chair: P Trainer (Manchester)
Thu 27
MTE5
Meet the Expert 5 (repeat)
Pituitary replacement therapy (repeat)
Thu 27 08:00
Meet the Expert 6
Supported by Clinical Endocrinology
3B
Chair: C Brain (London)
Thu 27
MTE6
Meet the Expert 6
Delayed puberty
Thu 27 08:00
Meet the Expert 7
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Thu 27
MTE7
Meet the Expert 7
Who should the endocrinologist ask the ophtalmologist to review?
London, UK
Thu 27 08:00
Society for Endocrinology Journal Awards
1C
Chair: D Ray (Manchester)
Thu 27 08:00 - 08:09
JA 1
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology: Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy
Rochester, USA on behalf of the author group
Thu 27 08:09 - 08:18
JA 2
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology:Thyroid-specific inactivation of KIF3A alters TSH signaling pathway and leads to hypothyroidism
Louvain-la-Neuve, Belgium on behalf of the author group
Thu 27 08:18 - 08:27
JA 3
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine-Related Cancer: Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Baltimore, USA on behalf of the author group
Thu 27 08:27 - 08:36
JA 4
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Clinical Endocrinology: What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)
Thu 27 08:36 - 08:45
JA 5
Society for Endocrinology Journal Awards
Society for Endocrinology Journal Award - Endocrine Connections: PKA regulatory subunit R2B is required for murine and human adipocyte differentiation
Milan, Italy on behalf of the author group
Thu 27 08:45
Society for Endocrinology AGM
1A
Thu 27 09:30
Education Workshop 2: Practical publishing advice
3B
Chair: D Ray (Manchester)
Thu 27 09:30
EW2.1
Education Workshop 2: Practical publishing advice
Introduction
Thu 27 09:35
EW2.2
Education Workshop 2: Practical publishing advice
Publishing ethics: Fabrication, Falsification and Plagiarism
Thu 27 09:45
EW2.3
Education Workshop 2: Practical publishing advice
The peer review process
Stockholm, Sweden
Thu 27 09:55
EW2.4
Education Workshop 2: Practical publishing advice
Writing an attention grabbing abstract
Essen, Germany
Thu 27 10:05
EW2.5
Education Workshop 2: Practical publishing advice
Responding to reviewer comments
Thu 27 10:15
EW2.6
Education Workshop 2: Practical publishing advice
The art of scientific writing
London, UK
Thu 27 10:25
EW2.7
Education Workshop 2: Practical publishing advice
Open Access
Thu 27 10:35
Education Workshop 2: Practical publishing advice
Questions and discussion
Thu 27 09:30
Nurse Session 1 - Cushing's Syndrome
1B
Chairs: N Kieffer (Leicester) & J Andrew (Leeds)
Thu 27 09:30
N1.1
Nurse Session 1 - Cushing's Syndrome
Investigating and Diagnosing Cushing’s Syndrome -not as straightforward as it seems?
Thu 27 09:55
N1.2
Nurse Session 1 - Cushing's Syndrome
The role of the Endocrine Nurse in the Management of patients with Cushing’s syndrome
Rotterdam, The Netherlands
Thu 27 10:20
N1.3
Nurse Session 1 - Cushing's Syndrome
Why do ‘cured’ Cushing’s patients need long-term follow up?
Barcelona, Spain
Thu 27 10:45
N1.4
Nurse Session 1 - Cushing's Syndrome
Cushing’s patient experience
Thu 27 09:30
Symposium 11: Some like it hot - new insights into brown adipose tissue
1C
Chairs: S O'Rahilly (Cambridge) & S Virtue (Cambridge)
Emerging biology of brown adipose tissue
Thu 27 09:30
S11.1
Symposium 11: Some like it hot - new insights into brown adipose tissue
Mechanisms of brown adipocyte determination
Philadelphia, USA
Thu 27 10:00
S11.2
Symposium 11: Some like it hot - new insights into brown adipose tissue
The metabolic capacities of brown adipose tissue
Stockholm, Sweden
Thu 27 10:30
S11.3
Symposium 11: Some like it hot - new insights into brown adipose tissue
How brown is human brown adipose tissue?
Gothenburg, Sweden
Thu 27 09:30
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Supported by Clinical Endocrinology
1A
Chairs: H Gleeson (Leicester) & R El-Khairi (London)
Thu 27 09:30
CMW3.1
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adolescent health care in the UK in 2014
Thu 27 10:00
CMW3.2
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Adrenal replacement in adolescents and young adults
London, UK
Thu 27 10:30
CMW3.3
Clinical Management Workshop 3: Improving the care of young people in endocrinology
Optimising bone health in adolescents and young adults
Birmingham, UK
Thu 27 11:00
Tea & Coffee
Exhibtion Hall
Thu 27 11:30
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
1A
Chair: G Williams (London)
Thu 27
PL4
Plenary Lecture 4: Society for Endocrinology European Medal Lecture
Mechanisms of thyroid hormone resistance
Rotterdam, Netherlands
Thu 27 12:00
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
1A
Chair: D Ray (Manchester)
Thu 27
PL5
Plenary Lecture 5: Society for Endocrinology Transatlantic Medal Lecture
Transcriptional Coordination of Circadian and Metabolic Physiology
Philadelphia, USA
Thu 27 12:30
Lunch & poster viewing
Shortlisted posters attended
Hall 2A
Thu 27 12:45
Viropharma Industry Sponsored Satellite Symposia
New insights in the management of Adrenal Insufficiency in the UK
3AB
Chair: S Pearce (Newcastle-Upon-Tyne)
Thu 27 12:45 - 12:55
Viropharma Industry Sponsored Satellite Symposia
Introduction: The unmet medical need in adrenal insufficiency and the importance of circadian rhythm
Newcastle, UK
Thu 27 12:55 - 13:10
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: the Salford project
Thu 27 13:10 - 13:25
Viropharma Industry Sponsored Satellite Symposia
Adrenal Insufficiency today: a report from the EU-AIR registry
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Thu 27 13:25 - 13:40
Viropharma Industry Sponsored Satellite Symposia
Patient cases and physician experience
Naples, Italy
Thu 27 13:40 - 13:45
Viropharma Industry Sponsored Satellite Symposia
Closing remarks
Newcastle, UK
Thu 27 13:45
Meet the Expert 8
1C
Chair: C McCabe (Birmingham)
Thu 27
MTE8
Meet the Expert 8
Growing organs in the lab
Thu 27 13:45
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
1B
Chairs: L Shephard (Birmingham) & V Fazal-Sanderson (Oxford)
Thu 27 13:45
N2.1
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Background on the journey of endocrine nursing research
Thu 27 13:50
N2.2
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
How to audit and evaluate your own practice
Thu 27 14:15
N2.3
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
The role of the endocrine nurse in clinical trials
Thu 27 14:40
N2.4
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Independent nursing research
Thu 27 15:05
Nurses Session 2: The journey of endocrine nursing research: from evidence based practice to independent research
Questions and discussion
Thu 27 13:45
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Supported by Endocrine Connections
1A
Chairs: R McCrimmon (Dundee) & B Challis (Cambridge)
How the brain orchestrates glucose metabolism
Thu 27 13:45
S12.1
Symposium 12: Getting excited about sugar - the brain and blood glucose control
How the brain senses blood glucose
Thu 27 14:15
S12.2
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Vagal control of energy metabolism
Thu 27 14:45
S12.3
Symposium 12: Getting excited about sugar - the brain and blood glucose control
Does glucagon need the brain for its effects on blood glucose?
Thu 27 13:45
Oral Communications 6: Clinical
3B
Chairs: R Semple (Cambridge) & A Puttanna (Walsall)
Thu 27 13:45
OC6.1
Oral Communications 6: Clinical
Adverse outcome in glucocorticoid-induced adrenal suppression; an analysis of short synacthen tests in 2782 patients
Thu 27 14:00
OC6.2
Oral Communications 6: Clinical
Localising parathyroid adenomas. Which imaging modality is best? Pre-operative localisation studies in patients with primary hyperparathyroidism: a large audit in a London tertiary centre
Thu 27 14:15
OC6.3
Oral Communications 6: Clinical
Sirolimus therapy for a patient with segmental overgrowth due to a mosaic activating mutation in phosphatidylinositol-3-kinase (PI3K)
Thu 27 14:30
OC6.4
Oral Communications 6: Clinical
Reduced cognitive performance and altered white matter microstructure in young insulin-resistant women with polycystic ovary syndrome
Thu 27 14:45
OC6.5
Oral Communications 6: Clinical
Effectiveness of metyrapone in 195 patients with Cushing’s syndrome
Thu 27 15:00
OC6.6
Oral Communications 6: Clinical
11C-Methionine PET-CT co-registered with volume MRI: a novel adjunctive imaging modality to aid diagnosis and management in patients with pituitary adenomas
Thu 27 14:30
Meet the Expert 9
1C
Chairs: H Turner (Oxford) & P Hadoke (Edinburgh)
Thu 27
MTE9
Meet the Expert 9
Novel techniques to assess angiogenesis
Paris, France
Thu 27 15:15
Tea & Coffee
Hall 2A
Thu 27 15:45
Oral Communication and Poster Prize Ceremony
1A
Chairs: A Grossman (Oxford) & C McCabe (Birmingham)
Thu 27 16:15
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Supported by Clinical Endocrinology Trust
1A
Chair: G Williams (London)
Thu 27
PL6
Plenary Lecture 6: British Tyroid Association Pitt-Rivers Lecture
Disorders of thyroid hormone action: insights from human genetics
Cambridge, UK
Thu 27 16:45
Plenary Lecture 7: Society for Endocrinology Medal Lecture
1A
Chair: D Ray (Manchester)
Thu 27
PL7
Plenary Lecture 7: Society for Endocrinology Medal Lecture
The clock in the pituitary gland: timing annual cycles
Thu 27 07:45
Breakfast
Thu 27 08:00
Meet the Expert 1 (repeat)
Supported by Clinical Endocrinology
1B
Chair: J Newell-Price (Sheffield)
Thu 27
MTE1
Meet the Expert 1 (repeat)
Medical management of Cushing's syndrome (repeat)
Thu 27 08:00
Meet the Expert 2 (repeat)
Supported by Clinical Endocrinology
1C
Chair: N Gittoes (Birmingham)
Thu 27
MTE2
Meet the Expert 2 (repeat)
Vitamin D replacement: how much, how often and for whom? (repeat)
Thu 27 08:45
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Supported by the Clinical Endocrinology Trust
1A
Chair: JS Bevan (Aberdeen)
Thu 27
PL8
Plenary Lecture 8: Clinical Endocrinology Trust Lecture
Understanding glucocorticoid action, and the role of the glucocorticoid receptor
Thu 27 09:15
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
1A
Chair: C McCabe (Birmingham)
Thu 27
PL9
Plenary Lecture 9: Society for Endocrinology Hoffenberg International Medal Lecture
Male Fertility Regulation; achievements and frustrations
Clayton, Australia
Thu 27 09:45
Society for Endocrinology Emergency Endocrine Guidance
1A
Chair: J Franklyn (Birmingham)
Thu 27
SFE1.1
Society for Endocrinology Emergency Endocrine Guidance
Acute Hypercalcaemia and Acute Hypocalcaemia
UK
Thu 27
SFE1.2
Society for Endocrinology Emergency Endocrine Guidance
Pituitary Apoplexy
Thu 27 10:15
Tea & Coffee
3AB
Thu 27 10:45
Meet the Expert 6 (repeat)
1B
Chair: C Brain (London)
Thu 27
MTE6
Meet the Expert 6 (repeat)
Delayed puberty (repeat)
Thu 27 10:45
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Supported by Endocrinology, Diabetes & Metabolism Case Reports and the Turner Syndrome Support Society
1A
Chairs: A Bates (Stourbridge) & J Thomas (Taunton)
Thu 27 10:45
CMW4.1
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in Turner's syndrome
Thu 27 11:15
CMW4.2
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Valvular disease in prolactinomas- weighing up the evidence
London, UK
Thu 27 11:45
CMW4.3
Clinical Management Workshop 4: Cardiovascular risk in endocrine disease
Cardiovascular risk in childhood cancer survivors
Thu 27 10:45
Senior Endocrinologists' Session
1C
Chairs: B Cooke (Harpenden) & P Belchetz (Wetherby)
Thu 27 10:45
SE1.4
Senior Endocrinologists' Session
The Foundling Hospital
Thu 27 11:09
SE1.2
Senior Endocrinologists' Session
1776 Revolution in Liverpool. Matthew Dobson discovers Hyperglycaemia!
Thu 27 11:33
SE1.3
Senior Endocrinologists' Session
Macroprolacin - To seek or ignore : a Trans-Atlantic Divide
Dublin, Ireland
Thu 27 11:57
SE1.1
Senior Endocrinologists' Session
How important is luck for major discoveries?
Thu 27 12:21
SE1.5
Senior Endocrinologists' Session
Steroid Merchants of Edinburgh
Thu 27 11:30
Meet the Expert 7 (repeat)
Supported by Clinical Endocrinology and the Thyroid Eye Disease Charitable Trust
1B
Chair: J Gilbert (London)
Thu 27
MTE7
Meet the Expert 7 (repeat)
Whom should the endocrinologist ask the ophtalmologist to review? (repeat)
London, UK

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract